{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":null,"value":72},{"name":null,"value":26},{"name":null,"value":40},{"name":null,"value":27},{"name":null,"value":80},{"name":null,"value":28},{"name":null,"value":35},{"name":null,"value":10},{"name":null,"value":134},{"name":null,"value":121},{"name":null,"value":78},{"name":null,"value":29},{"name":null,"value":32},{"name":null,"value":31},{"name":null,"value":33},{"name":null,"value":126},{"name":null,"value":36},{"name":null,"value":82},{"name":null,"value":37},{"name":null,"value":115},{"name":"Government Matters","value":"cg-2"},{"name":null,"value":1},{"name":null,"value":6},{"name":null,"value":71},{"name":null,"value":21},{"name":null,"value":23},{"name":null,"value":116},{"name":null,"value":24},{"name":null,"value":135},{"name":null,"value":25},{"name":null,"value":110},{"name":null,"value":20},{"name":null,"value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":null,"value":129},{"name":null,"value":2},{"name":null,"value":38},{"name":null,"value":3},{"name":null,"value":5},{"name":null,"value":19},{"name":null,"value":7},{"name":null,"value":4},{"name":null,"value":136},{"name":null,"value":13},{"name":null,"value":14},{"name":null,"value":15},{"name":null,"value":17},{"name":null,"value":18},{"name":null,"value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":null,"value":133},{"name":null,"value":106},{"name":null,"value":124},{"name":null,"value":111},{"name":null,"value":132},{"name":null,"value":131},{"name":null,"value":102},{"name":null,"value":125},{"name":null,"value":127},{"name":null,"value":107},{"name":null,"value":112},{"name":null,"value":105},{"name":null,"value":109},{"name":null,"value":103},{"name":null,"value":128},{"name":null,"value":123},{"name":null,"value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"103","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"K","per_page":12,"people":[{"id":442342,"version":1,"owner_type":"Person","owner_id":644,"payload":{"bio":"\u003cp\u003eJosh Kamin is a nationally-recognized private equity lawyer\u0026nbsp;focusing\u0026nbsp;on the real estate industry. He specializes in equity transactions, including joint ventures, recapitalizations, restructurings, acquisitions, dispositions and borrower-side financings, for domestic and non-US clients.\u0026nbsp; Josh is the Managing Partner of the Atlanta Office.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHe is a sought-after trusted advisor known for spearheading market-leading transactions, designing efficient platforms and programmatic relationships, and providing essential insight for C-suite leadership. \u0026nbsp;Josh delivers advice in a clear, practical and business-friendly manner. \u0026nbsp;Clients seek out Josh for his creativity, and consider Josh a \"go-to\" lawyer for their most important transactions and initiatives.\u0026nbsp;\u0026nbsp; In addition, Josh is experienced in portfolio transactions, company recapitalizations, infrastructure projects and healthcare real estate.\u003c/p\u003e\n\u003cp\u003eJosh\u0026rsquo;s clients include private equity, financial institutions, public and public/private entities, sponsors, investors and developers. Josh played lead roles in some of the most important real estate industry transactions over the last decade, both on a national scale (such as the sale of GE Capital Real Estate's real estate equity and investment platform) and within the Southeastern United States\u0026nbsp;(such as the acquisition and redevelopment of Turner Field in Atlanta, Georgia).\u003c/p\u003e\n\u003cp\u003eJosh is a fellow of the American College of Real Estate Lawyers (ACREL), and former Chair of the ACREL Equity Investment Structures Committee\u0026nbsp;and Vice Chair of the Acquisitions Committee. Josh is recognized by\u0026nbsp;\u003cem\u003eChambers USA\u0026nbsp;\u003c/em\u003eas a Band 1 lawyer\u003cem\u003e,\u003c/em\u003e\u0026nbsp;and by\u0026nbsp;\u003cem\u003eThe Best Lawyers in America,\u003c/em\u003e\u0026nbsp;which identified him as the 2012 Best Real Estate Lawyer in Atlanta. Josh is an active community leader, and serves as a trustee and on the Nominating \u0026amp; Governance Committee of the Woodruff Arts Center, Vice Chairman of Atlanta Police Foundation, and board member of\u0026nbsp;Metro Atlanta Chamber of Commerce and Camp Twin Lakes.\u0026nbsp;\u003c/p\u003e","slug":"joshua-kamin","email":"jkamin@kslaw.com","phone":"+1 678 596 5408","matters":null,"taggings":{"tags":[],"meta_tags":[{"id":109}]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":36,"guid":"36.capabilities","index":1,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":2,"source":"capabilities"},{"id":26,"guid":"26.capabilities","index":3,"source":"capabilities"},{"id":35,"guid":"35.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":104,"guid":"104.capabilities","index":6,"source":"capabilities"},{"id":78,"guid":"78.capabilities","index":7,"source":"capabilities"},{"id":29,"guid":"29.capabilities","index":8,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":9,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":10,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":11,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":12,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":13,"source":"capabilities"},{"id":1255,"guid":"1255.smart_tags","index":14,"source":"smartTags"},{"id":1270,"guid":"1270.smart_tags","index":15,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":16,"source":"smartTags"}],"is_active":true,"last_name":"Kamin","nick_name":"Josh","clerkships":[],"first_name":"Joshua","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"Band 1 for Georgia Real Estate","detail":"Chambers USA"},{"title":"2012 Best Real Estate Lawyer in Atlanta ","detail":"The Best Lawyers in America"},{"title":"Legal Elite ","detail":"Georgia Trend magazine"},{"title":"Super Lawyer ","detail":"Atlanta Magazine"},{"title":"Fellow of the American College of Real Estate Lawyers ","detail":"American College of Real Estate Lawyers "}],"linked_in_url":null,"seodescription":null,"primary_title_id":106,"translated_fields":{"en":{"bio":"\u003cp\u003eJosh Kamin is a nationally-recognized private equity lawyer\u0026nbsp;focusing\u0026nbsp;on the real estate industry. He specializes in equity transactions, including joint ventures, recapitalizations, restructurings, acquisitions, dispositions and borrower-side financings, for domestic and non-US clients.\u0026nbsp; Josh is the Managing Partner of the Atlanta Office.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHe is a sought-after trusted advisor known for spearheading market-leading transactions, designing efficient platforms and programmatic relationships, and providing essential insight for C-suite leadership. \u0026nbsp;Josh delivers advice in a clear, practical and business-friendly manner. \u0026nbsp;Clients seek out Josh for his creativity, and consider Josh a \"go-to\" lawyer for their most important transactions and initiatives.\u0026nbsp;\u0026nbsp; In addition, Josh is experienced in portfolio transactions, company recapitalizations, infrastructure projects and healthcare real estate.\u003c/p\u003e\n\u003cp\u003eJosh\u0026rsquo;s clients include private equity, financial institutions, public and public/private entities, sponsors, investors and developers. Josh played lead roles in some of the most important real estate industry transactions over the last decade, both on a national scale (such as the sale of GE Capital Real Estate's real estate equity and investment platform) and within the Southeastern United States\u0026nbsp;(such as the acquisition and redevelopment of Turner Field in Atlanta, Georgia).\u003c/p\u003e\n\u003cp\u003eJosh is a fellow of the American College of Real Estate Lawyers (ACREL), and former Chair of the ACREL Equity Investment Structures Committee\u0026nbsp;and Vice Chair of the Acquisitions Committee. Josh is recognized by\u0026nbsp;\u003cem\u003eChambers USA\u0026nbsp;\u003c/em\u003eas a Band 1 lawyer\u003cem\u003e,\u003c/em\u003e\u0026nbsp;and by\u0026nbsp;\u003cem\u003eThe Best Lawyers in America,\u003c/em\u003e\u0026nbsp;which identified him as the 2012 Best Real Estate Lawyer in Atlanta. Josh is an active community leader, and serves as a trustee and on the Nominating \u0026amp; Governance Committee of the Woodruff Arts Center, Vice Chairman of Atlanta Police Foundation, and board member of\u0026nbsp;Metro Atlanta Chamber of Commerce and Camp Twin Lakes.\u0026nbsp;\u003c/p\u003e","recognitions":[{"title":"Band 1 for Georgia Real Estate","detail":"Chambers USA"},{"title":"2012 Best Real Estate Lawyer in Atlanta ","detail":"The Best Lawyers in America"},{"title":"Legal Elite ","detail":"Georgia Trend magazine"},{"title":"Super Lawyer ","detail":"Atlanta Magazine"},{"title":"Fellow of the American College of Real Estate Lawyers ","detail":"American College of Real Estate Lawyers "}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12884}]},"capability_group_id":1},"created_at":"2025-11-05T05:03:00.000Z","updated_at":"2025-11-05T05:03:00.000Z","searchable_text":"Kamin{{ FIELD }}{:title=\u0026gt;\"Band 1 for Georgia Real Estate\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"2012 Best Real Estate Lawyer in Atlanta \", :detail=\u0026gt;\"The Best Lawyers in America\"}{{ FIELD }}{:title=\u0026gt;\"Legal Elite \", :detail=\u0026gt;\"Georgia Trend magazine\"}{{ FIELD }}{:title=\u0026gt;\"Super Lawyer \", :detail=\u0026gt;\"Atlanta Magazine\"}{{ FIELD }}{:title=\u0026gt;\"Fellow of the American College of Real Estate Lawyers \", :detail=\u0026gt;\"American College of Real Estate Lawyers \"}{{ FIELD }}Josh Kamin is a nationally-recognized private equity lawyer focusing on the real estate industry. He specializes in equity transactions, including joint ventures, recapitalizations, restructurings, acquisitions, dispositions and borrower-side financings, for domestic and non-US clients.  Josh is the Managing Partner of the Atlanta Office. \nHe is a sought-after trusted advisor known for spearheading market-leading transactions, designing efficient platforms and programmatic relationships, and providing essential insight for C-suite leadership.  Josh delivers advice in a clear, practical and business-friendly manner.  Clients seek out Josh for his creativity, and consider Josh a \"go-to\" lawyer for their most important transactions and initiatives.   In addition, Josh is experienced in portfolio transactions, company recapitalizations, infrastructure projects and healthcare real estate.\nJosh’s clients include private equity, financial institutions, public and public/private entities, sponsors, investors and developers. Josh played lead roles in some of the most important real estate industry transactions over the last decade, both on a national scale (such as the sale of GE Capital Real Estate's real estate equity and investment platform) and within the Southeastern United States (such as the acquisition and redevelopment of Turner Field in Atlanta, Georgia).\nJosh is a fellow of the American College of Real Estate Lawyers (ACREL), and former Chair of the ACREL Equity Investment Structures Committee and Vice Chair of the Acquisitions Committee. Josh is recognized by Chambers USA as a Band 1 lawyer, and by The Best Lawyers in America, which identified him as the 2012 Best Real Estate Lawyer in Atlanta. Josh is an active community leader, and serves as a trustee and on the Nominating \u0026amp; Governance Committee of the Woodruff Arts Center, Vice Chairman of Atlanta Police Foundation, and board member of Metro Atlanta Chamber of Commerce and Camp Twin Lakes.  Joshua M Kamin Managing Partner Atlanta Office Band 1 for Georgia Real Estate Chambers USA 2012 Best Real Estate Lawyer in Atlanta  The Best Lawyers in America Legal Elite  Georgia Trend magazine Super Lawyer  Atlanta Magazine Fellow of the American College of Real Estate Lawyers  American College of Real Estate Lawyers  Emory University Emory University School of Law University of Pennsylvania University of Pennsylvania Law School Georgia American Bar Association State Bar of Georgia Atlanta Bar Association American Health Lawyers Association","searchable_name":"Joshua M. Kamin (Josh)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":446718,"version":1,"owner_type":"Person","owner_id":6414,"payload":{"bio":"\u003cp\u003eAmit Kataria is a Mergers \u0026amp; Acquisitions/Private Equity corporate partner based in King \u0026amp; Spalding\u0026rsquo;s London and New York offices. Amit has extensive experience advising on mergers and acquisitions, private equity investments, securities offerings, as well as a broad range of cross-border transactional and corporate advisory matters. He represents corporations, financial sponsors, and their portfolio companies in global mergers and acquisitions across a wide range of industries, including Technology, Energy, Infrastructure (including renewables, digital energy, power, media, telecommunications, fiber and telecom), Financial services, Biotech, Life Sciences, Hospitality, Insurance, Logistics, Manufacturing, Pharmaceuticals, and Real estate.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmit focuses on advising strategic acquirers and financial investors in connection with global cross-border transactions involving the United States of America, Europe, Latin America, China, South Korea, India, rest of South Asia, and South East Asia.\u003c/p\u003e\n\u003cp\u003eAmit is distinguished by his clients and peers who describe him as a \u0026ldquo;\u003cem\u003eferocious negotiator [who] understands the market extremely well\u003c/em\u003e\u0026rdquo; and as being \u0026ldquo;\u003cem\u003ehead and shoulders above the competitors\u003c/em\u003e\u0026rdquo; (IBLJ, 2022). Amit's expertise is further highlighted by his clients who praise his \u0026ldquo;\u003cem\u003emeticulous attention to detail in drafting\u003c/em\u003e\u0026rdquo; (Chambers Global) and describe him as a \u0026ldquo;\u003cem\u003ea seasoned partner who is able to negotiate [his clients] interests and give valuable insights into structure and risk\u003c/em\u003e\u0026rdquo; and that he has a \u0026ldquo;\u003cem\u003elaser-focus on delivering high-quality commercial results\u003c/em\u003e\u0026rdquo;.\u003c/p\u003e\n\u003cp\u003eAmit is admitted to practice in New York, Hong Kong, and India.\u003c/p\u003e","slug":"amit-kataria","email":"akataria@kslaw.com","phone":null,"matters":["\u003cp\u003eMacquarie Asset Management in its US$1.725 billion acquisition of a minority stake in D.E. Shaw Renewable Investments, which currently has over 6 GWAC of gross capacity of projects in operations or under construction, including 4 GWAC of contracted preconstruction projects.\u003c/p\u003e","\u003cp\u003eStory Capital\u0026rsquo;s investment in SpendLab, a Netherlands-headquartered company that supports finance departments with identifying and recovering risks in outbound payments based on more than 450 in-house developed algorithms, artificial intelligence and machine learning.\u003c/p\u003e","\u003cp\u003eLW Subsea Holdings, a developer of submarine fibre cable systems, on a joint venture for the construction, financing, and operation of the Trans-Caribbean Fiber System (involving multiple international jurisdictions in North America, Central and South America).\u003c/p\u003e","\u003cp\u003eSoftBank Vision Fund on multiple investments in Asia, Europe and rest of the world including in TravelPerk, which operates a B2B travel platform for travel and expense management services for business travelers. TravelPerk has global operations including in Europe, Asia, and the United States of America, with reportedly, the world\u0026rsquo;s largest travel inventory.\u003c/p\u003e","\u003cp\u003eDallah Albaraka Investment Holding Company, on its Series D investment into FreshToHome. The round raised $104 million and was led by Amazon, through its India-focused Smbhav Venture Fund, and Investcorp, Iron Pillar and Investment Corporation of Dubai.\u003c/p\u003e","\u003cp\u003eJadwa Investment\u0026rsquo;s acquisition of Dubai-headquartered food and beverage operator, Blackspoon Group, a leading casual dining player with 10 branches across three award-winning restaurant chains in the UAE, including its flagship brand, Allo Beirut.\u003c/p\u003e","\u003cp\u003eAlma Limited in its nvestment in Em Sherif Restaurants through a co-investment with GCC Asia Growth Fund LP, a private equity fund managed by Turmeric Capital.\u003c/p\u003e","\u003cp\u003eOne Investment Management US LLC on the completion of a $470 million investment in a junior tranche letter of credit facility provided to SoftBank Vision Fund II-2, L.P.\u003c/p\u003e","\u003cp\u003eBlackRock, on its investment in an affordable housing finance company in India.\u003c/p\u003e","\u003cp\u003eSteel Perlot Management, LLC on its investment and asset contribution in Tokenalysis, Inc.\u003c/p\u003e","\u003cp\u003eAxium Infrastructure Inc. (through its SPV, Marigold Care Homes Ltd) in the acquisition of the entire issued share capital of the holding company of Scimitar Care Hotels PLC.\u003c/p\u003e","\u003cp\u003eMorgan Stanley Infrastructure Partners on multiple infrastructure investments in Asia.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3195}]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":1,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":2,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":3,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":27,"guid":"27.capabilities","index":6,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":7,"source":"capabilities"},{"id":1166,"guid":"1166.smart_tags","index":8,"source":"smartTags"},{"id":1220,"guid":"1220.smart_tags","index":9,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":10,"source":"capabilities"}],"is_active":true,"last_name":"Kataria","nick_name":"Amit","clerkships":[],"first_name":"Amit","title_rank":9999,"updated_by":202,"law_schools":[{"id":485,"meta":{"degree":"LL.M.","honors":"","is_law_school":"1","graduation_date":"2007-01-01 00:00:00"},"order":2,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"\"Amit is who you want on your side in an Indian negotiation.\"","detail":"Chambers Asia-Pacific, Corporate/M\u0026A (International Firms), India (2025)"},{"title":"“Laser-focused on delivering high-quality commercial results” ","detail":"Legal 500 UK (2022)"},{"title":"\"One of the most responsive partners we have ever worked with.” ","detail":"Legal 500 UK (2022)"},{"title":"“Seasoned partner able to negotiate our interests and give valuable insights into structure and risk.\"","detail":"Legal 500 UK (2022)"},{"title":"“Seasoned partner able to negotiate our interests and give valuable insights. His knowledge of the subject is vast.”","detail":"Legal 500 UK (2022)"},{"title":"“Maintains a robust practice acting on India-related M\u0026A mandates.\"","detail":"Chambers Global (2022)"},{"title":"\"Meticulous attention to detail in drafting.\" ","detail":"Chambers Global (2022)"},{"title":"\"Working with Amit has been a fantastic experience.\" ","detail":"Chambers Global (2022)"},{"title":"“His strength is his attention to detail and ability to negotiate in multiple languages and formats.” ","detail":"Chambers Asia-Pacific (2022)"},{"title":"“Ferocious negotiator and understands the market extremely well”","detail":"India Business Law Journal (2022)"},{"title":"“Head and shoulders above their competitors\" ","detail":"India Business Law Journal (2022)"},{"title":"Named Leading Cross Border Lawyer of the Year","detail":"Legal Era Global Achievers Award (2021)"},{"title":"Deal of the Year, Capital Markets – Equity","detail":"India Law Business Journal (2021)"},{"title":"Deal of the Year, M\u0026A/JV/PE","detail":"India Law Business Journal (2021)"}],"linked_in_url":"https://www.linkedin.com/in/amit-kataria-69641b5","seodescription":"Amit Kataria is a Mergers \u0026 Acquisitions/Private Equity corporate partner based in King \u0026 Spalding’s London and New York offices. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAmit Kataria is a Mergers \u0026amp; Acquisitions/Private Equity corporate partner based in King \u0026amp; Spalding\u0026rsquo;s London and New York offices. Amit has extensive experience advising on mergers and acquisitions, private equity investments, securities offerings, as well as a broad range of cross-border transactional and corporate advisory matters. He represents corporations, financial sponsors, and their portfolio companies in global mergers and acquisitions across a wide range of industries, including Technology, Energy, Infrastructure (including renewables, digital energy, power, media, telecommunications, fiber and telecom), Financial services, Biotech, Life Sciences, Hospitality, Insurance, Logistics, Manufacturing, Pharmaceuticals, and Real estate.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmit focuses on advising strategic acquirers and financial investors in connection with global cross-border transactions involving the United States of America, Europe, Latin America, China, South Korea, India, rest of South Asia, and South East Asia.\u003c/p\u003e\n\u003cp\u003eAmit is distinguished by his clients and peers who describe him as a \u0026ldquo;\u003cem\u003eferocious negotiator [who] understands the market extremely well\u003c/em\u003e\u0026rdquo; and as being \u0026ldquo;\u003cem\u003ehead and shoulders above the competitors\u003c/em\u003e\u0026rdquo; (IBLJ, 2022). Amit's expertise is further highlighted by his clients who praise his \u0026ldquo;\u003cem\u003emeticulous attention to detail in drafting\u003c/em\u003e\u0026rdquo; (Chambers Global) and describe him as a \u0026ldquo;\u003cem\u003ea seasoned partner who is able to negotiate [his clients] interests and give valuable insights into structure and risk\u003c/em\u003e\u0026rdquo; and that he has a \u0026ldquo;\u003cem\u003elaser-focus on delivering high-quality commercial results\u003c/em\u003e\u0026rdquo;.\u003c/p\u003e\n\u003cp\u003eAmit is admitted to practice in New York, Hong Kong, and India.\u003c/p\u003e","matters":["\u003cp\u003eMacquarie Asset Management in its US$1.725 billion acquisition of a minority stake in D.E. Shaw Renewable Investments, which currently has over 6 GWAC of gross capacity of projects in operations or under construction, including 4 GWAC of contracted preconstruction projects.\u003c/p\u003e","\u003cp\u003eStory Capital\u0026rsquo;s investment in SpendLab, a Netherlands-headquartered company that supports finance departments with identifying and recovering risks in outbound payments based on more than 450 in-house developed algorithms, artificial intelligence and machine learning.\u003c/p\u003e","\u003cp\u003eLW Subsea Holdings, a developer of submarine fibre cable systems, on a joint venture for the construction, financing, and operation of the Trans-Caribbean Fiber System (involving multiple international jurisdictions in North America, Central and South America).\u003c/p\u003e","\u003cp\u003eSoftBank Vision Fund on multiple investments in Asia, Europe and rest of the world including in TravelPerk, which operates a B2B travel platform for travel and expense management services for business travelers. TravelPerk has global operations including in Europe, Asia, and the United States of America, with reportedly, the world\u0026rsquo;s largest travel inventory.\u003c/p\u003e","\u003cp\u003eDallah Albaraka Investment Holding Company, on its Series D investment into FreshToHome. The round raised $104 million and was led by Amazon, through its India-focused Smbhav Venture Fund, and Investcorp, Iron Pillar and Investment Corporation of Dubai.\u003c/p\u003e","\u003cp\u003eJadwa Investment\u0026rsquo;s acquisition of Dubai-headquartered food and beverage operator, Blackspoon Group, a leading casual dining player with 10 branches across three award-winning restaurant chains in the UAE, including its flagship brand, Allo Beirut.\u003c/p\u003e","\u003cp\u003eAlma Limited in its nvestment in Em Sherif Restaurants through a co-investment with GCC Asia Growth Fund LP, a private equity fund managed by Turmeric Capital.\u003c/p\u003e","\u003cp\u003eOne Investment Management US LLC on the completion of a $470 million investment in a junior tranche letter of credit facility provided to SoftBank Vision Fund II-2, L.P.\u003c/p\u003e","\u003cp\u003eBlackRock, on its investment in an affordable housing finance company in India.\u003c/p\u003e","\u003cp\u003eSteel Perlot Management, LLC on its investment and asset contribution in Tokenalysis, Inc.\u003c/p\u003e","\u003cp\u003eAxium Infrastructure Inc. (through its SPV, Marigold Care Homes Ltd) in the acquisition of the entire issued share capital of the holding company of Scimitar Care Hotels PLC.\u003c/p\u003e","\u003cp\u003eMorgan Stanley Infrastructure Partners on multiple infrastructure investments in Asia.\u003c/p\u003e"],"recognitions":[{"title":"\"Amit is who you want on your side in an Indian negotiation.\"","detail":"Chambers Asia-Pacific, Corporate/M\u0026A (International Firms), India (2025)"},{"title":"“Laser-focused on delivering high-quality commercial results” ","detail":"Legal 500 UK (2022)"},{"title":"\"One of the most responsive partners we have ever worked with.” ","detail":"Legal 500 UK (2022)"},{"title":"“Seasoned partner able to negotiate our interests and give valuable insights into structure and risk.\"","detail":"Legal 500 UK (2022)"},{"title":"“Seasoned partner able to negotiate our interests and give valuable insights. His knowledge of the subject is vast.”","detail":"Legal 500 UK (2022)"},{"title":"“Maintains a robust practice acting on India-related M\u0026A mandates.\"","detail":"Chambers Global (2022)"},{"title":"\"Meticulous attention to detail in drafting.\" ","detail":"Chambers Global (2022)"},{"title":"\"Working with Amit has been a fantastic experience.\" ","detail":"Chambers Global (2022)"},{"title":"“His strength is his attention to detail and ability to negotiate in multiple languages and formats.” ","detail":"Chambers Asia-Pacific (2022)"},{"title":"“Ferocious negotiator and understands the market extremely well”","detail":"India Business Law Journal (2022)"},{"title":"“Head and shoulders above their competitors\" ","detail":"India Business Law Journal (2022)"},{"title":"Named Leading Cross Border Lawyer of the Year","detail":"Legal Era Global Achievers Award (2021)"},{"title":"Deal of the Year, Capital Markets – Equity","detail":"India Law Business Journal (2021)"},{"title":"Deal of the Year, M\u0026A/JV/PE","detail":"India Law Business Journal (2021)"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9922}]},"capability_group_id":1},"created_at":"2026-03-13T19:39:00.000Z","updated_at":"2026-03-13T19:39:00.000Z","searchable_text":"Kataria{{ FIELD }}{:title=\u0026gt;\"\\\"Amit is who you want on your side in an Indian negotiation.\\\"\", :detail=\u0026gt;\"Chambers Asia-Pacific, Corporate/M\u0026amp;A (International Firms), India (2025)\"}{{ FIELD }}{:title=\u0026gt;\"“Laser-focused on delivering high-quality commercial results” \", :detail=\u0026gt;\"Legal 500 UK (2022)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"One of the most responsive partners we have ever worked with.” \", :detail=\u0026gt;\"Legal 500 UK (2022)\"}{{ FIELD }}{:title=\u0026gt;\"“Seasoned partner able to negotiate our interests and give valuable insights into structure and risk.\\\"\", :detail=\u0026gt;\"Legal 500 UK (2022)\"}{{ FIELD }}{:title=\u0026gt;\"“Seasoned partner able to negotiate our interests and give valuable insights. His knowledge of the subject is vast.”\", :detail=\u0026gt;\"Legal 500 UK (2022)\"}{{ FIELD }}{:title=\u0026gt;\"“Maintains a robust practice acting on India-related M\u0026amp;A mandates.\\\"\", :detail=\u0026gt;\"Chambers Global (2022)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Meticulous attention to detail in drafting.\\\" \", :detail=\u0026gt;\"Chambers Global (2022)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Working with Amit has been a fantastic experience.\\\" \", :detail=\u0026gt;\"Chambers Global (2022)\"}{{ FIELD }}{:title=\u0026gt;\"“His strength is his attention to detail and ability to negotiate in multiple languages and formats.” \", :detail=\u0026gt;\"Chambers Asia-Pacific (2022)\"}{{ FIELD }}{:title=\u0026gt;\"“Ferocious negotiator and understands the market extremely well”\", :detail=\u0026gt;\"India Business Law Journal (2022)\"}{{ FIELD }}{:title=\u0026gt;\"“Head and shoulders above their competitors\\\" \", :detail=\u0026gt;\"India Business Law Journal (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Named Leading Cross Border Lawyer of the Year\", :detail=\u0026gt;\"Legal Era Global Achievers Award (2021)\"}{{ FIELD }}{:title=\u0026gt;\"Deal of the Year, Capital Markets – Equity\", :detail=\u0026gt;\"India Law Business Journal (2021)\"}{{ FIELD }}{:title=\u0026gt;\"Deal of the Year, M\u0026amp;A/JV/PE\", :detail=\u0026gt;\"India Law Business Journal (2021)\"}{{ FIELD }}Macquarie Asset Management in its US$1.725 billion acquisition of a minority stake in D.E. Shaw Renewable Investments, which currently has over 6 GWAC of gross capacity of projects in operations or under construction, including 4 GWAC of contracted preconstruction projects.{{ FIELD }}Story Capital’s investment in SpendLab, a Netherlands-headquartered company that supports finance departments with identifying and recovering risks in outbound payments based on more than 450 in-house developed algorithms, artificial intelligence and machine learning.{{ FIELD }}LW Subsea Holdings, a developer of submarine fibre cable systems, on a joint venture for the construction, financing, and operation of the Trans-Caribbean Fiber System (involving multiple international jurisdictions in North America, Central and South America).{{ FIELD }}SoftBank Vision Fund on multiple investments in Asia, Europe and rest of the world including in TravelPerk, which operates a B2B travel platform for travel and expense management services for business travelers. TravelPerk has global operations including in Europe, Asia, and the United States of America, with reportedly, the world’s largest travel inventory.{{ FIELD }}Dallah Albaraka Investment Holding Company, on its Series D investment into FreshToHome. The round raised $104 million and was led by Amazon, through its India-focused Smbhav Venture Fund, and Investcorp, Iron Pillar and Investment Corporation of Dubai.{{ FIELD }}Jadwa Investment’s acquisition of Dubai-headquartered food and beverage operator, Blackspoon Group, a leading casual dining player with 10 branches across three award-winning restaurant chains in the UAE, including its flagship brand, Allo Beirut.{{ FIELD }}Alma Limited in its nvestment in Em Sherif Restaurants through a co-investment with GCC Asia Growth Fund LP, a private equity fund managed by Turmeric Capital.{{ FIELD }}One Investment Management US LLC on the completion of a $470 million investment in a junior tranche letter of credit facility provided to SoftBank Vision Fund II-2, L.P.{{ FIELD }}BlackRock, on its investment in an affordable housing finance company in India.{{ FIELD }}Steel Perlot Management, LLC on its investment and asset contribution in Tokenalysis, Inc.{{ FIELD }}Axium Infrastructure Inc. (through its SPV, Marigold Care Homes Ltd) in the acquisition of the entire issued share capital of the holding company of Scimitar Care Hotels PLC.{{ FIELD }}Morgan Stanley Infrastructure Partners on multiple infrastructure investments in Asia.{{ FIELD }}Amit Kataria is a Mergers \u0026amp; Acquisitions/Private Equity corporate partner based in King \u0026amp; Spalding’s London and New York offices. Amit has extensive experience advising on mergers and acquisitions, private equity investments, securities offerings, as well as a broad range of cross-border transactional and corporate advisory matters. He represents corporations, financial sponsors, and their portfolio companies in global mergers and acquisitions across a wide range of industries, including Technology, Energy, Infrastructure (including renewables, digital energy, power, media, telecommunications, fiber and telecom), Financial services, Biotech, Life Sciences, Hospitality, Insurance, Logistics, Manufacturing, Pharmaceuticals, and Real estate.\nAmit focuses on advising strategic acquirers and financial investors in connection with global cross-border transactions involving the United States of America, Europe, Latin America, China, South Korea, India, rest of South Asia, and South East Asia.\nAmit is distinguished by his clients and peers who describe him as a “ferocious negotiator [who] understands the market extremely well” and as being “head and shoulders above the competitors” (IBLJ, 2022). Amit's expertise is further highlighted by his clients who praise his “meticulous attention to detail in drafting” (Chambers Global) and describe him as a “a seasoned partner who is able to negotiate [his clients] interests and give valuable insights into structure and risk” and that he has a “laser-focus on delivering high-quality commercial results”.\nAmit is admitted to practice in New York, Hong Kong, and India. amit kataria lawyer Partner \"Amit is who you want on your side in an Indian negotiation.\" Chambers Asia-Pacific, Corporate/M\u0026amp;A (International Firms), India (2025) “Laser-focused on delivering high-quality commercial results”  Legal 500 UK (2022) \"One of the most responsive partners we have ever worked with.”  Legal 500 UK (2022) “Seasoned partner able to negotiate our interests and give valuable insights into structure and risk.\" Legal 500 UK (2022) “Seasoned partner able to negotiate our interests and give valuable insights. His knowledge of the subject is vast.” Legal 500 UK (2022) “Maintains a robust practice acting on India-related M\u0026amp;A mandates.\" Chambers Global (2022) \"Meticulous attention to detail in drafting.\"  Chambers Global (2022) \"Working with Amit has been a fantastic experience.\"  Chambers Global (2022) “His strength is his attention to detail and ability to negotiate in multiple languages and formats.”  Chambers Asia-Pacific (2022) “Ferocious negotiator and understands the market extremely well” India Business Law Journal (2022) “Head and shoulders above their competitors\"  India Business Law Journal (2022) Named Leading Cross Border Lawyer of the Year Legal Era Global Achievers Award (2021) Deal of the Year, Capital Markets – Equity India Law Business Journal (2021) Deal of the Year, M\u0026amp;A/JV/PE India Law Business Journal (2021) Delhi University  Delhi University  Columbia University Columbia University School of Law New York Hong Kong Macquarie Asset Management in its US$1.725 billion acquisition of a minority stake in D.E. Shaw Renewable Investments, which currently has over 6 GWAC of gross capacity of projects in operations or under construction, including 4 GWAC of contracted preconstruction projects. Story Capital’s investment in SpendLab, a Netherlands-headquartered company that supports finance departments with identifying and recovering risks in outbound payments based on more than 450 in-house developed algorithms, artificial intelligence and machine learning. LW Subsea Holdings, a developer of submarine fibre cable systems, on a joint venture for the construction, financing, and operation of the Trans-Caribbean Fiber System (involving multiple international jurisdictions in North America, Central and South America). SoftBank Vision Fund on multiple investments in Asia, Europe and rest of the world including in TravelPerk, which operates a B2B travel platform for travel and expense management services for business travelers. TravelPerk has global operations including in Europe, Asia, and the United States of America, with reportedly, the world’s largest travel inventory. Dallah Albaraka Investment Holding Company, on its Series D investment into FreshToHome. The round raised $104 million and was led by Amazon, through its India-focused Smbhav Venture Fund, and Investcorp, Iron Pillar and Investment Corporation of Dubai. Jadwa Investment’s acquisition of Dubai-headquartered food and beverage operator, Blackspoon Group, a leading casual dining player with 10 branches across three award-winning restaurant chains in the UAE, including its flagship brand, Allo Beirut. Alma Limited in its nvestment in Em Sherif Restaurants through a co-investment with GCC Asia Growth Fund LP, a private equity fund managed by Turmeric Capital. One Investment Management US LLC on the completion of a $470 million investment in a junior tranche letter of credit facility provided to SoftBank Vision Fund II-2, L.P. BlackRock, on its investment in an affordable housing finance company in India. Steel Perlot Management, LLC on its investment and asset contribution in Tokenalysis, Inc. Axium Infrastructure Inc. (through its SPV, Marigold Care Homes Ltd) in the acquisition of the entire issued share capital of the holding company of Scimitar Care Hotels PLC. Morgan Stanley Infrastructure Partners on multiple infrastructure investments in Asia.","searchable_name":"Amit Kataria","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":427592,"version":1,"owner_type":"Person","owner_id":832,"payload":{"bio":"\u003cp\u003eRob Keenan focuses on healthcare regulatory, transactional, and contracting matters. A partner in both our Healthcare practice and Data Security and Privacy practices, Rob represents health industry clients with respect to a broad range of issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRob advises health systems, hospitals, academic medical centers, clinical laboratories, home health and hospice providers, pharmacy benefit managers, and physician groups on a wide range of federal and state regulatory matters, with a particular focus on health information privacy and security as well as healthcare fraud and abuse laws, including the federal Anti-Kickback Statute and the Stark Law.\u003c/p\u003e\n\u003cp\u003eRob also advises hospitals, health systems, academic medical centers and large physician groups concerning regulatory and structuring issues related to physician contracting, including practice acquisitions, professional services arrangements and evolving value-based arrangements. Rob regularly assists clients with the design of Stark Law-compliant physician compensation methodologies, including within group practices. Rob has considerable experience troubleshooting existing arrangements, often finding compliant pathways, and has filed a number Stark Law voluntary disclosures with the Centers for Medicare \u0026amp; Medicaid Services when a Stark-compliant pathway could not be identified.\u003c/p\u003e\n\u003cp\u003eRob represents health industry clients in transactional matters, including performing healthcare regulatory due diligence in connection with mergers and acquisitions. Rob also advises clinical laboratories regarding CLIA and state law compliance, including in the context of sanction proceedings before the Centers for Medicare \u0026amp; Medicaid Services.\u003c/p\u003e\n\u003cp\u003eRob advises clients on federal and state health information privacy issues and has significant experience representing HIPAA covered entities and business associates, as well as medical device and pharmaceutical companies that encounter HIPAA-related issues. He provides advice regarding covered entity and business associate regulated status, proactive compliance, data use and sharing, incident response and breach reporting, de-identification, and clinical research issues.\u003c/p\u003e\n\u003cp\u003eRob regularly assists clients with managed care contracting issues, including contract review and negotiation; development of template language; and evaluation of regulated content, including applicability of federal law and state insurance codes. Rob served as the Editor of the American Health Law Association\u0026rsquo;s \u003cem\u003eHealth Plans Contracting Handbook\u003c/em\u003e, 7th ed. (2015), and served as Co-Editor of the 5th and 6th editions. Rob also spent time in-house at a national health insurance company advising managed care organization clients on various contracting and regulatory issues before returning to King \u0026amp; Spalding.\u003c/p\u003e\n\u003cp\u003eA regular speaker and writer, Rob is ranked as Band 1 for Healthcare in Georgia in Chambers USA Client's Guide to America's Leading Lawyers for Business and also is recognized in recent editions of The Best Lawyers in America and Expert Guides Best of the Best USA. He is a member of the American Health Law Association, the Health Law Section of the American Bar Association, and the State Bar of Georgia, and is a member and past President of the Georgia Academy of Healthcare Attorneys.\u0026nbsp;Rob was named \u0026ldquo;Lawyer of the Year\u0026rdquo; for Health Care Law in the 2023 Georgia edition of Best Lawyers.\u003c/p\u003e","slug":"robert-keenan","email":"rkeenan@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":115}]},"expertise":[{"id":6,"guid":"6.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":3,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":4,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":5,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"},{"id":122,"guid":"122.capabilities","index":7,"source":"capabilities"},{"id":1202,"guid":"1202.smart_tags","index":8,"source":"smartTags"},{"id":107,"guid":"107.capabilities","index":9,"source":"capabilities"},{"id":740,"guid":"740.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Keenan","nick_name":"Rob","clerkships":[],"first_name":"Robert","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"M.","name_suffix":"III","recognitions":[{"title":"\"Rob provides excellent and practical guidance on complex HIPAA topics.\"","detail":"Chambers USA, 2022"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Georgia, 2005-2024"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRob Keenan focuses on healthcare regulatory, transactional, and contracting matters. A partner in both our Healthcare practice and Data Security and Privacy practices, Rob represents health industry clients with respect to a broad range of issues.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRob advises health systems, hospitals, academic medical centers, clinical laboratories, home health and hospice providers, pharmacy benefit managers, and physician groups on a wide range of federal and state regulatory matters, with a particular focus on health information privacy and security as well as healthcare fraud and abuse laws, including the federal Anti-Kickback Statute and the Stark Law.\u003c/p\u003e\n\u003cp\u003eRob also advises hospitals, health systems, academic medical centers and large physician groups concerning regulatory and structuring issues related to physician contracting, including practice acquisitions, professional services arrangements and evolving value-based arrangements. Rob regularly assists clients with the design of Stark Law-compliant physician compensation methodologies, including within group practices. Rob has considerable experience troubleshooting existing arrangements, often finding compliant pathways, and has filed a number Stark Law voluntary disclosures with the Centers for Medicare \u0026amp; Medicaid Services when a Stark-compliant pathway could not be identified.\u003c/p\u003e\n\u003cp\u003eRob represents health industry clients in transactional matters, including performing healthcare regulatory due diligence in connection with mergers and acquisitions. Rob also advises clinical laboratories regarding CLIA and state law compliance, including in the context of sanction proceedings before the Centers for Medicare \u0026amp; Medicaid Services.\u003c/p\u003e\n\u003cp\u003eRob advises clients on federal and state health information privacy issues and has significant experience representing HIPAA covered entities and business associates, as well as medical device and pharmaceutical companies that encounter HIPAA-related issues. He provides advice regarding covered entity and business associate regulated status, proactive compliance, data use and sharing, incident response and breach reporting, de-identification, and clinical research issues.\u003c/p\u003e\n\u003cp\u003eRob regularly assists clients with managed care contracting issues, including contract review and negotiation; development of template language; and evaluation of regulated content, including applicability of federal law and state insurance codes. Rob served as the Editor of the American Health Law Association\u0026rsquo;s \u003cem\u003eHealth Plans Contracting Handbook\u003c/em\u003e, 7th ed. (2015), and served as Co-Editor of the 5th and 6th editions. Rob also spent time in-house at a national health insurance company advising managed care organization clients on various contracting and regulatory issues before returning to King \u0026amp; Spalding.\u003c/p\u003e\n\u003cp\u003eA regular speaker and writer, Rob is ranked as Band 1 for Healthcare in Georgia in Chambers USA Client's Guide to America's Leading Lawyers for Business and also is recognized in recent editions of The Best Lawyers in America and Expert Guides Best of the Best USA. He is a member of the American Health Law Association, the Health Law Section of the American Bar Association, and the State Bar of Georgia, and is a member and past President of the Georgia Academy of Healthcare Attorneys.\u0026nbsp;Rob was named \u0026ldquo;Lawyer of the Year\u0026rdquo; for Health Care Law in the 2023 Georgia edition of Best Lawyers.\u003c/p\u003e","recognitions":[{"title":"\"Rob provides excellent and practical guidance on complex HIPAA topics.\"","detail":"Chambers USA, 2022"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Georgia, 2005-2024"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4242}]},"capability_group_id":2},"created_at":"2025-05-26T05:02:31.000Z","updated_at":"2025-05-26T05:02:31.000Z","searchable_text":"Keenan{{ FIELD }}{:title=\u0026gt;\"\\\"Rob provides excellent and practical guidance on complex HIPAA topics.\\\"\", :detail=\u0026gt;\"Chambers USA, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Healthcare\", :detail=\u0026gt;\"Chambers USA, Georgia, 2005-2024\"}{{ FIELD }}Rob Keenan focuses on healthcare regulatory, transactional, and contracting matters. A partner in both our Healthcare practice and Data Security and Privacy practices, Rob represents health industry clients with respect to a broad range of issues.\nRob advises health systems, hospitals, academic medical centers, clinical laboratories, home health and hospice providers, pharmacy benefit managers, and physician groups on a wide range of federal and state regulatory matters, with a particular focus on health information privacy and security as well as healthcare fraud and abuse laws, including the federal Anti-Kickback Statute and the Stark Law.\nRob also advises hospitals, health systems, academic medical centers and large physician groups concerning regulatory and structuring issues related to physician contracting, including practice acquisitions, professional services arrangements and evolving value-based arrangements. Rob regularly assists clients with the design of Stark Law-compliant physician compensation methodologies, including within group practices. Rob has considerable experience troubleshooting existing arrangements, often finding compliant pathways, and has filed a number Stark Law voluntary disclosures with the Centers for Medicare \u0026amp; Medicaid Services when a Stark-compliant pathway could not be identified.\nRob represents health industry clients in transactional matters, including performing healthcare regulatory due diligence in connection with mergers and acquisitions. Rob also advises clinical laboratories regarding CLIA and state law compliance, including in the context of sanction proceedings before the Centers for Medicare \u0026amp; Medicaid Services.\nRob advises clients on federal and state health information privacy issues and has significant experience representing HIPAA covered entities and business associates, as well as medical device and pharmaceutical companies that encounter HIPAA-related issues. He provides advice regarding covered entity and business associate regulated status, proactive compliance, data use and sharing, incident response and breach reporting, de-identification, and clinical research issues.\nRob regularly assists clients with managed care contracting issues, including contract review and negotiation; development of template language; and evaluation of regulated content, including applicability of federal law and state insurance codes. Rob served as the Editor of the American Health Law Association’s Health Plans Contracting Handbook, 7th ed. (2015), and served as Co-Editor of the 5th and 6th editions. Rob also spent time in-house at a national health insurance company advising managed care organization clients on various contracting and regulatory issues before returning to King \u0026amp; Spalding.\nA regular speaker and writer, Rob is ranked as Band 1 for Healthcare in Georgia in Chambers USA Client's Guide to America's Leading Lawyers for Business and also is recognized in recent editions of The Best Lawyers in America and Expert Guides Best of the Best USA. He is a member of the American Health Law Association, the Health Law Section of the American Bar Association, and the State Bar of Georgia, and is a member and past President of the Georgia Academy of Healthcare Attorneys. Rob was named “Lawyer of the Year” for Health Care Law in the 2023 Georgia edition of Best Lawyers. Robert M Keenan Partner \"Rob provides excellent and practical guidance on complex HIPAA topics.\" Chambers USA, 2022 Top Ranked Lawyer, Healthcare Chambers USA, Georgia, 2005-2024 University of Illinois  University of Georgia University of Georgia School of Law Georgia","searchable_name":"Robert M. Keenan III (Rob)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":445387,"version":1,"owner_type":"Person","owner_id":2473,"payload":{"bio":"\u003cp\u003eChris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.\u0026nbsp; For the past nine years, Chris has been recognized by \u003cem\u003eChambers USA\u003c/em\u003e as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith in-depth knowledge of payment systems and regulations, Chris\u0026nbsp;regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition,\u0026nbsp;medical staff relations, the operation\u0026nbsp;and expansion of graduate medical education and allied health training programs,\u0026nbsp;organ acquisition program management, participation in the 340B Drug Pricing Program,\u0026nbsp;and telehealth expansion.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation\u0026nbsp;and before Congress and the administrative branch, as well as in\u0026nbsp;False Claims Act investigations by the U.S. Department of Justice.\u003c/p\u003e\n\u003cp\u003eHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients\u0026rsquo; positions in payment disputes and government investigations.\u003c/p\u003e\n\u003cp\u003eA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the \u003cem\u003eReimbursement Advisor,\u003c/em\u003e the leading national healthcare reimbursement publication, and serves as co-editor of our firm\u0026rsquo;s award-winning \u003cem\u003eHealth Headlines\u003c/em\u003e, a weekly newsletter summarizing healthcare law and policy developments.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA\u003c/strong\u003e\u003c/p\u003e","slug":"christopher-kenny","email":"ckenny@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory.\u0026nbsp;\u003cem\u003eSee Bethesda Health v. Azar\u003c/em\u003e, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.\u003c/p\u003e","\u003cp\u003eRepresented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere.\u0026nbsp;\u003cem\u003eCitrus HMA v. Azar\u003c/em\u003e, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).\u003c/p\u003e","\u003cp\u003eSuccessfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\"\u0026nbsp;\u003cem\u003eMercy Health-St. Vincent Medical Center v. Becerra\u003c/em\u003e, Case No. 22-3578 (D.D.C. 2024).\u003c/p\u003e","\u003cp\u003eRegularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.\u003c/p\u003e","\u003cp\u003eRecovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":116}]},"expertise":[{"id":103,"guid":"103.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":2,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":3,"source":"capabilities"},{"id":12,"guid":"12.capabilities","index":4,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":5,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":7,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":8,"source":"capabilities"},{"id":1185,"guid":"1185.smart_tags","index":9,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":10,"source":"smartTags"}],"is_active":true,"last_name":"Kenny","nick_name":"Chris","clerkships":[],"first_name":"Christopher","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"P.","name_suffix":"","recognitions":[{"title":"2020 Top Attorneys Under 40 - Healthcare","detail":"Law360"},{"title":"Ranked in Chambers USA for Healthcare 2017-2021","detail":"Chambers USA"},{"title":"Named a Rising Star in Healthcare","detail":"SUPER LAWYERS, 2018"},{"title":"Named a Rising Star in Healthcare","detail":"Super Lawyers, 2017"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.\u0026nbsp; For the past nine years, Chris has been recognized by \u003cem\u003eChambers USA\u003c/em\u003e as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by\u0026nbsp;\u003cem\u003eLaw 360\u003c/em\u003e.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith in-depth knowledge of payment systems and regulations, Chris\u0026nbsp;regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition,\u0026nbsp;medical staff relations, the operation\u0026nbsp;and expansion of graduate medical education and allied health training programs,\u0026nbsp;organ acquisition program management, participation in the 340B Drug Pricing Program,\u0026nbsp;and telehealth expansion.\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation\u0026nbsp;and before Congress and the administrative branch, as well as in\u0026nbsp;False Claims Act investigations by the U.S. Department of Justice.\u003c/p\u003e\n\u003cp\u003eHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients\u0026rsquo; positions in payment disputes and government investigations.\u003c/p\u003e\n\u003cp\u003eA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the \u003cem\u003eReimbursement Advisor,\u003c/em\u003e the leading national healthcare reimbursement publication, and serves as co-editor of our firm\u0026rsquo;s award-winning \u003cem\u003eHealth Headlines\u003c/em\u003e, a weekly newsletter summarizing healthcare law and policy developments.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA\u003c/strong\u003e\u003c/p\u003e","matters":["\u003cp\u003eRepresented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory.\u0026nbsp;\u003cem\u003eSee Bethesda Health v. Azar\u003c/em\u003e, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.\u003c/p\u003e","\u003cp\u003eRepresented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere.\u0026nbsp;\u003cem\u003eCitrus HMA v. Azar\u003c/em\u003e, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).\u003c/p\u003e","\u003cp\u003eSuccessfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\"\u0026nbsp;\u003cem\u003eMercy Health-St. Vincent Medical Center v. Becerra\u003c/em\u003e, Case No. 22-3578 (D.D.C. 2024).\u003c/p\u003e","\u003cp\u003eRegularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.\u003c/p\u003e","\u003cp\u003eSuccessfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.\u003c/p\u003e","\u003cp\u003eRecovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.\u003c/p\u003e"],"recognitions":[{"title":"2020 Top Attorneys Under 40 - Healthcare","detail":"Law360"},{"title":"Ranked in Chambers USA for Healthcare 2017-2021","detail":"Chambers USA"},{"title":"Named a Rising Star in Healthcare","detail":"SUPER LAWYERS, 2018"},{"title":"Named a Rising Star in Healthcare","detail":"Super Lawyers, 2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10000}]},"capability_group_id":2},"created_at":"2026-01-30T19:46:10.000Z","updated_at":"2026-01-30T19:46:10.000Z","searchable_text":"Kenny{{ FIELD }}{:title=\u0026gt;\"2020 Top Attorneys Under 40 - Healthcare\", :detail=\u0026gt;\"Law360\"}{{ FIELD }}{:title=\u0026gt;\"Ranked in Chambers USA for Healthcare 2017-2021\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in Healthcare\", :detail=\u0026gt;\"SUPER LAWYERS, 2018\"}{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star in Healthcare\", :detail=\u0026gt;\"Super Lawyers, 2017\"}{{ FIELD }}Represented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory. See Bethesda Health v. Azar, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars.{{ FIELD }}Represented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere. Citrus HMA v. Azar, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022).{{ FIELD }}Successfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\" Mercy Health-St. Vincent Medical Center v. Becerra, Case No. 22-3578 (D.D.C. 2024).{{ FIELD }}Regularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships.{{ FIELD }}Successfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations.{{ FIELD }}Recovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.{{ FIELD }}Chris Kenny is a partner in our Healthcare practice and specializes in providing strategic payment and compliance advice to hospitals, health systems, academic medical centers, and other organizations participating in Medicare, Medicaid and commercial insurance plans.  For the past nine years, Chris has been recognized by Chambers USA as a leading healthcare lawyer and in 2020 was named a Top Attorney Under 40 by Law 360.\nWith in-depth knowledge of payment systems and regulations, Chris regularly advises in-house lawyers and C-suite executives on the payment implications of major business decisions including facility construction/acquisition, medical staff relations, the operation and expansion of graduate medical education and allied health training programs, organ acquisition program management, participation in the 340B Drug Pricing Program, and telehealth expansion.  \nApplying his regulatory and reimbursement experience, Chris represents hospitals in Medicare payment litigation and before Congress and the administrative branch, as well as in False Claims Act investigations by the U.S. Department of Justice.\nHe strives to provide creative, proactive advice in an ever-changing healthcare regulatory environment, and to vigorously defend his clients’ positions in payment disputes and government investigations.\nA member of the Healthcare Financial Management Association and the American Health Lawyers Association, Chris regularly speaks and writes on reimbursement and compliance issues. He is the co-editor of the Reimbursement Advisor, the leading national healthcare reimbursement publication, and serves as co-editor of our firm’s award-winning Health Headlines, a weekly newsletter summarizing healthcare law and policy developments.\nADMITTED TO PRACTICE IN DISTRICT OF COLUMBIA AND MARYLAND; NOT ADMITTED TO PRACTICE IN FLORIDA Christopher P Kenny Partner 2020 Top Attorneys Under 40 - Healthcare Law360 Ranked in Chambers USA for Healthcare 2017-2021 Chambers USA Named a Rising Star in Healthcare SUPER LAWYERS, 2018 Named a Rising Star in Healthcare Super Lawyers, 2017 Northwestern University Northwestern Pritzker School of Law George Washington University George Washington University Law School U.S. Court of Appeals for the D.C. Circuit U.S. District Court for the District of Columbia District of Columbia Maryland American Health Lawyers Association Healthcare Financial Management Association Represented the Florida Hospital Association and 12 of its members in a precedent-setting challenge to CMS's exclusion of section 1115 waiver days from the Medicare DSH payment adjustment, resulting in a multi-million dollar victory. See Bethesda Health v. Azar, 980 F.3d 121 (D.C. Cir. 2020). Mr. Kenny is currently pursuing the same issue on behalf of dozens more hospitals in Florida, Texas, California, Tennessee and elsewhere, with total amounts in controversy worth hundreds of millions of dollars. Represented 34 hospitals in overturning CMS's unlawful policy understating the so-called \"rural floor,\" generating hundreds of millions of dollars in additional wage-related payments for providers in Arizona, Connecticut, Florida, and elsewhere. Citrus HMA v. Azar, Case No. 20-00707, 2022 WL 1062990 (D.D.C. 2022). Successfully represented five major health systems in overturning CMS's disallowance of millions of dollars in financial support for the hospitals' nursing and other training programs. The court noted \"the hosptials are right, and it is not even close.\" Mercy Health-St. Vincent Medical Center v. Becerra, Case No. 22-3578 (D.D.C. 2024). Regularly provides day-to-day counseling to more than a dozen major health systems in the establishment and operation of large outpatient provider-based facilities and rural health clinics. Issues involved include the structuring of complex management agreements, joint ventures, 340B considerations, service line collaborations, and hospital-physician relationships. Successfully represented a Medicaid managed care organization in multiple False Claims Act investigations by local U.S. Attorneys' Offices resulting in declinations. Recovered millions of dollars in additional cost reimbursement for an organ procurement organization's clinical laboratory activities.","searchable_name":"Christopher P. Kenny (Chris)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":430859,"version":1,"owner_type":"Person","owner_id":227,"payload":{"bio":"\u003cp\u003eJustin King specializes in representing public and private companies, including private equity firms and their portfolio companies, with respect to mergers and acquisitions, governance matters, restructurings and other significant transactions. Justin is a member of King \u0026amp; Spalding's Public Company, Private Equity, and Technology Industry Teams, and Co-Leader of the Firm's FinTech group.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJustin's M\u0026amp;A and corporate transaction experience includes public company acquisitions and sales, leveraged buyouts, add-on transactions, joint ventures, tender offers, corporate reorganizations, strategic and growth-stage investments and corporate governance matters. \u0026nbsp;Justin's work crosses a broad range of industries and geographies and includes numerous transactions in the following sectors: payments, sports, healthcare and life sciences, software, retail (including e-commerce), semiconductor, food \u0026amp; beverage, building products, technology and entertainment. \u0026nbsp;Justin's international transaction experience spans Mexico, Canada, Central and South America, Asia, Europe and Australia.\u003c/p\u003e\n\u003cp\u003eIn the sports industry, Justin has significant experience representing professional sports franchises regarding stadium development, sponsorship matters and general corporate transactions. Sports franchise clients include the Atlanta Falcons, a National Football League team, and the Atlanta United Football Club, a Major League Soccer team. Justin represented the Atlanta Host Committee for the 2019 Super Bowl and currently represents the Atlanta Host Committee in connection with its 2026 World Cup bid.\u003c/p\u003e\n\u003cp\u003eJustin has been recognized as a Georgia Super Lawyers Rising Star, and by The Daily Report as one of the Top 30 Lawyers Under 40 in Georgia.\u003c/p\u003e\n\u003cp\u003eJustin has also been recognized as a key leading lawyer in Legal 500\u0026rsquo;s 2025 USA guide for his M\u0026amp;A/Corporate expertise, noting: \u003cem\u003e\u0026ldquo;Justin King is a go-to for sports-related deals.\u0026rdquo;\u003c/em\u003e\u003c/p\u003e","slug":"justin-king","email":"jking@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cstrong\u003eRepresentative Matters\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFinTech and Payments\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFleetCor\u0026nbsp;\u003c/strong\u003ein numerous transactions, including the following:\u003c/p\u003e\n\u003cp\u003eMultiple equity financing and subsequent IPO\u003c/p\u003e\n\u003cp\u003eAcquisition of Telenav\u0026rsquo;s mobile business unit\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGlobal Payments\u0026nbsp;\u003c/strong\u003ein numerous acquisitions and strategic transactions, including the following:\u003c/p\u003e\n\u003cp\u003eAcquisition of AdvancedMD from Marlin Equity Partners\u003c/p\u003e\n\u003cp\u003eAcquisition of SICOM Systems from LLR Partners\u003c/p\u003e\n\u003cp\u003eJoint venture with HSBC in Mexico\u003c/p\u003e\n\u003cp\u003eAcquisition of Desjardins\u0026rsquo; merchant acquiring business in Canada\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTSYS\u003c/strong\u003e\u0026nbsp;in its acquisition of TransFirst from Vista Equity Partners.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eTechnology and Software\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eClimavision\u003c/strong\u003e\u0026nbsp;in connection with its $100 million investment by TPG\u0026rsquo;s The Rise Fund.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMailchimp\u003c/strong\u003e\u0026nbsp;in numerous transactions, including its sale to Intuit for $12 billion and the acquisitions of Reaction Commerce, Chatitive and BigTeam.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eOversight Systems\u0026nbsp;\u003c/strong\u003ein connection with a strategic investment by Luminate Capital Partners.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResurgens Technology Partners\u003c/strong\u003e\u0026nbsp;in numerous transactions, including the acquisitions of Assurance Software, Clearview Continuity, OfficeSpace Software, Avalution Consulting, EnergyCap and AgencyBloc.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eRetail and Consumer\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCarter\u0026rsquo;s\u003c/strong\u003e\u0026nbsp;in several acquisitions, including Skip Hop (portfolio company of Fireman Capital Partners), and Industrias Bunny Baby in Mexico.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eUnder Armour\u003c/strong\u003e\u0026nbsp;in numerous transactions, including the following:\u003c/p\u003e\n\u003cp\u003eAcquisition of MapMyFitness\u003c/p\u003e\n\u003cp\u003eAcquisition of Endomondo\u003c/p\u003e\n\u003cp\u003eAcquisition and subsequent sale of MyFitnessPal\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eW.C. Bradley\u0026nbsp;\u003c/strong\u003ein the sale of\u0026nbsp;\u003cstrong\u003eZebco Brands\u0026nbsp;\u003c/strong\u003eto Rather Outdoors.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eZebco Brands\u0026nbsp;\u003c/strong\u003ein the sale of its Fin-Nor and Van Staal brands to Pure Fishing.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eSports and Entertainment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAMB Group\u003c/strong\u003e\u0026nbsp;in entering into an expansion agreement with Major League Soccer for an expansion franchise.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAtlanta Falcons\u003c/strong\u003e\u0026nbsp;in negotiations for a new multi-purpose stadium in Atlanta.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAtlanta Falcons and the Atlanta Host Committee\u003c/strong\u003e\u0026nbsp;in their successful bid to host Super Bowl LIII.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAtlanta Falcons Physical Therapy Centers\u003c/strong\u003e\u0026nbsp;in its joint venture with U.S. Physical Therapy.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCarmike Cinemas\u003c/strong\u003e\u0026nbsp;in several transactions, including its acquisition of Muvico Theatres, its all-stock acquisition of Digital Cinema Destinations Corp., and its sale to AMC Entertainment.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSkybound Entertainment\u0026nbsp;\u003c/strong\u003ein several transactions and equity financings.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eFood \u0026amp; Beverage and Franchise\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRoark Capital Group\u003c/strong\u003e\u0026nbsp;in numerous transactions, including the following:\u003c/p\u003e\n\u003cp\u003eAcquisition of Primrose Schools\u003c/p\u003e\n\u003cp\u003eInvestment in Waste Pro USA\u003c/p\u003e\n\u003cp\u003eAcquisition of the data processing, printing and mailing unit of North Shore Agency, Inc.\u003c/p\u003e\n\u003cp\u003eAcquisition of Wingstop Restaurants\u003c/p\u003e\n\u003cp\u003eAcquisition of Massage Envy\u003c/p\u003e\n\u003cp\u003eSale of Peachtree Business Products\u003c/p\u003e\n\u003cp\u003eSale of Professional Systems Corporation\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eScofflaw Brewing\u003c/strong\u003e\u0026nbsp;in several transactions and equity financings.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrive Capital\u003c/strong\u003e\u0026nbsp;in its acquisition of Rubicon Bakers.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrive Capital\u003c/strong\u003e\u0026nbsp;and its portfolio company\u0026nbsp;\u003cstrong\u003eRubicon Bakers\u003c/strong\u003e\u0026nbsp;in the acquisition of Just Desserts.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eIndustrials and Manufacturing\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcuity Brands\u003c/strong\u003e\u0026nbsp;in its acquisition of Juno Lighting from Schneider Electric.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBig Time Products\u0026nbsp;\u003c/strong\u003ein its recapitalization transaction with Falcon Investment Advisors and Hauslein \u0026amp; Company.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuckner HeavyLift Cranes\u003c/strong\u003e\u0026nbsp;in its sale of a majority interest to Markel Corporation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCirrus Industries,\u003c/strong\u003e\u0026nbsp;a manufacturer of airplanes and a portfolio company of Arcapita Bank B.S.C.(c), in its sale to China Aviation Industry General Aircraft Co., Ltd.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCrown Paper Group,\u003c/strong\u003e\u0026nbsp;a portfolio company of Lindsay Goldberg, in its acquisition of Montebello Container Corporation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eElectrolux Professional AB\u003c/strong\u003e\u0026nbsp;in its acquisition of Unified Brands from Dover Corporation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGE Aviation\u003c/strong\u003e\u0026nbsp;in the formation of its Taleris joint venture with Accenture.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGE Aviation\u003c/strong\u003e\u0026nbsp;in the formation of a joint venture with SeaCast, Inc. to produce jet engine components.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHunter Douglas\u003c/strong\u003e\u0026nbsp;in its acquisition of the Levolor and Kirsch businesses from Newell Rubbermaid.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHuntington Ingalls Industries\u003c/strong\u003e\u0026nbsp;in its acquisition of Hydroid from Kongsberg Maritime.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHusqvarna\u003c/strong\u003e\u0026nbsp;in numerous transactions, including the following:\u003c/p\u003e\n\u003cp\u003eSale of its BlueBird International business\u003c/p\u003e\n\u003cp\u003eSale of Peerless Gear business\u003c/p\u003e\n\u003cp\u003eAcquisition of Diamond Tool\u003c/p\u003e\n\u003cp\u003eAcquisition of the Concrete Power Trowel business from Wacker Neuson Group AG\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMcCleskey Mills,\u003c/strong\u003e\u0026nbsp;a peanut sheller in South Georgia, in its sale to Olam International.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMicromeritics Instrument Corporation\u0026nbsp;\u003c/strong\u003ein its sale to SFW Capital Partners.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMueller Water Products\u003c/strong\u003e\u0026nbsp;in the sale of its Anvil division to One Equity Partners.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrive Capital\u003c/strong\u003e\u0026nbsp;in its acquisition of AceCo Precision Manufacturing\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrive Capital\u0026nbsp;\u003c/strong\u003ein its investment in Premium Guard, and Premium Guard\u0026rsquo;s acquisition of IPC Global Solutions.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eZep,\u003c/strong\u003e\u0026nbsp;a provider of specialty chemical products, in its sale to affiliates of New Mountain Capital.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eHealthcare and Life Sciences\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAmerican HomePatient,\u0026nbsp;\u003c/strong\u003ea portfolio company of Highland Capital Management, in its sale to Lincare.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEclipsys Corporation\u0026nbsp;\u003c/strong\u003ein its $1.3 billion stock-for-stock merger with Allscripts-Misys Healthcare Solutions, Inc.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eiHealth Technologies\u003c/strong\u003e, a provider of payment policy management solutions and services to healthcare organizations, in its merger with Connolly LLC, a portfolio company of Advent International.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmucor,\u0026nbsp;\u003c/strong\u003ea provider of automated instrument-reagent systems to the blood transfusion industry, in its $1.9 billion sale to an affiliate of TPG Capital.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eOwens and Minor\u0026nbsp;\u003c/strong\u003ein its acquisition of Byram Healthcare from Mediq.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSaint Joseph\u0026rsquo;s Health System\u0026nbsp;\u003c/strong\u003ein its joint venture transaction with Emory Healthcare.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSaint Joseph\u0026rsquo;s Health System\u0026nbsp;\u003c/strong\u003ein the sale of Saint Joseph\u0026rsquo;s East Georgia hospital to St. Mary\u0026rsquo;s Health Care System.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eOther Significant Transactions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCousins Properties\u003c/strong\u003e\u0026nbsp;in its sale of its third-party client services business to Cushman \u0026amp; Wakefield.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGevity HR\u003c/strong\u003e\u0026nbsp;in its cash merger with TriNet Group, a portfolio company of General Atlantic.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLodgian\u003c/strong\u003e\u0026nbsp;in its cash merger with an affiliate of Lone Star Funds.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":172}]},"expertise":[{"id":27,"guid":"27.capabilities","index":0,"source":"capabilities"},{"id":35,"guid":"35.capabilities","index":1,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":763,"guid":"763.smart_tags","index":3,"source":"smartTags"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":5,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":6,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":7,"source":"capabilities"},{"id":765,"guid":"765.smart_tags","index":8,"source":"smartTags"},{"id":75,"guid":"75.capabilities","index":9,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":10,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":11,"source":"capabilities"},{"id":1141,"guid":"1141.smart_tags","index":12,"source":"smartTags"},{"id":118,"guid":"118.capabilities","index":13,"source":"capabilities"},{"id":124,"guid":"124.capabilities","index":14,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":15,"source":"capabilities"},{"id":1220,"guid":"1220.smart_tags","index":16,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":17,"source":"capabilities"}],"is_active":true,"last_name":"King","nick_name":"Justin","clerkships":[],"first_name":"Justin","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"A Georgia Super Lawyers Rising Star ","detail":"Super Lawyers, 2016, 2015"},{"title":"Top 30 Lawyers Under 40 in Georgia ","detail":"The Daily Report, 2017"}],"linked_in_url":"https://www.linkedin.com/in/justin-king-72a68064/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJustin King specializes in representing public and private companies, including private equity firms and their portfolio companies, with respect to mergers and acquisitions, governance matters, restructurings and other significant transactions. Justin is a member of King \u0026amp; Spalding's Public Company, Private Equity, and Technology Industry Teams, and Co-Leader of the Firm's FinTech group.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJustin's M\u0026amp;A and corporate transaction experience includes public company acquisitions and sales, leveraged buyouts, add-on transactions, joint ventures, tender offers, corporate reorganizations, strategic and growth-stage investments and corporate governance matters. \u0026nbsp;Justin's work crosses a broad range of industries and geographies and includes numerous transactions in the following sectors: payments, sports, healthcare and life sciences, software, retail (including e-commerce), semiconductor, food \u0026amp; beverage, building products, technology and entertainment. \u0026nbsp;Justin's international transaction experience spans Mexico, Canada, Central and South America, Asia, Europe and Australia.\u003c/p\u003e\n\u003cp\u003eIn the sports industry, Justin has significant experience representing professional sports franchises regarding stadium development, sponsorship matters and general corporate transactions. Sports franchise clients include the Atlanta Falcons, a National Football League team, and the Atlanta United Football Club, a Major League Soccer team. Justin represented the Atlanta Host Committee for the 2019 Super Bowl and currently represents the Atlanta Host Committee in connection with its 2026 World Cup bid.\u003c/p\u003e\n\u003cp\u003eJustin has been recognized as a Georgia Super Lawyers Rising Star, and by The Daily Report as one of the Top 30 Lawyers Under 40 in Georgia.\u003c/p\u003e\n\u003cp\u003eJustin has also been recognized as a key leading lawyer in Legal 500\u0026rsquo;s 2025 USA guide for his M\u0026amp;A/Corporate expertise, noting: \u003cem\u003e\u0026ldquo;Justin King is a go-to for sports-related deals.\u0026rdquo;\u003c/em\u003e\u003c/p\u003e","matters":["\u003cp\u003e\u003cstrong\u003eRepresentative Matters\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFinTech and Payments\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFleetCor\u0026nbsp;\u003c/strong\u003ein numerous transactions, including the following:\u003c/p\u003e\n\u003cp\u003eMultiple equity financing and subsequent IPO\u003c/p\u003e\n\u003cp\u003eAcquisition of Telenav\u0026rsquo;s mobile business unit\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGlobal Payments\u0026nbsp;\u003c/strong\u003ein numerous acquisitions and strategic transactions, including the following:\u003c/p\u003e\n\u003cp\u003eAcquisition of AdvancedMD from Marlin Equity Partners\u003c/p\u003e\n\u003cp\u003eAcquisition of SICOM Systems from LLR Partners\u003c/p\u003e\n\u003cp\u003eJoint venture with HSBC in Mexico\u003c/p\u003e\n\u003cp\u003eAcquisition of Desjardins\u0026rsquo; merchant acquiring business in Canada\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTSYS\u003c/strong\u003e\u0026nbsp;in its acquisition of TransFirst from Vista Equity Partners.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eTechnology and Software\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eClimavision\u003c/strong\u003e\u0026nbsp;in connection with its $100 million investment by TPG\u0026rsquo;s The Rise Fund.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMailchimp\u003c/strong\u003e\u0026nbsp;in numerous transactions, including its sale to Intuit for $12 billion and the acquisitions of Reaction Commerce, Chatitive and BigTeam.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eOversight Systems\u0026nbsp;\u003c/strong\u003ein connection with a strategic investment by Luminate Capital Partners.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eResurgens Technology Partners\u003c/strong\u003e\u0026nbsp;in numerous transactions, including the acquisitions of Assurance Software, Clearview Continuity, OfficeSpace Software, Avalution Consulting, EnergyCap and AgencyBloc.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eRetail and Consumer\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCarter\u0026rsquo;s\u003c/strong\u003e\u0026nbsp;in several acquisitions, including Skip Hop (portfolio company of Fireman Capital Partners), and Industrias Bunny Baby in Mexico.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eUnder Armour\u003c/strong\u003e\u0026nbsp;in numerous transactions, including the following:\u003c/p\u003e\n\u003cp\u003eAcquisition of MapMyFitness\u003c/p\u003e\n\u003cp\u003eAcquisition of Endomondo\u003c/p\u003e\n\u003cp\u003eAcquisition and subsequent sale of MyFitnessPal\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eW.C. Bradley\u0026nbsp;\u003c/strong\u003ein the sale of\u0026nbsp;\u003cstrong\u003eZebco Brands\u0026nbsp;\u003c/strong\u003eto Rather Outdoors.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eZebco Brands\u0026nbsp;\u003c/strong\u003ein the sale of its Fin-Nor and Van Staal brands to Pure Fishing.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eSports and Entertainment\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAMB Group\u003c/strong\u003e\u0026nbsp;in entering into an expansion agreement with Major League Soccer for an expansion franchise.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAtlanta Falcons\u003c/strong\u003e\u0026nbsp;in negotiations for a new multi-purpose stadium in Atlanta.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAtlanta Falcons and the Atlanta Host Committee\u003c/strong\u003e\u0026nbsp;in their successful bid to host Super Bowl LIII.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAtlanta Falcons Physical Therapy Centers\u003c/strong\u003e\u0026nbsp;in its joint venture with U.S. Physical Therapy.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCarmike Cinemas\u003c/strong\u003e\u0026nbsp;in several transactions, including its acquisition of Muvico Theatres, its all-stock acquisition of Digital Cinema Destinations Corp., and its sale to AMC Entertainment.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSkybound Entertainment\u0026nbsp;\u003c/strong\u003ein several transactions and equity financings.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eFood \u0026amp; Beverage and Franchise\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eRoark Capital Group\u003c/strong\u003e\u0026nbsp;in numerous transactions, including the following:\u003c/p\u003e\n\u003cp\u003eAcquisition of Primrose Schools\u003c/p\u003e\n\u003cp\u003eInvestment in Waste Pro USA\u003c/p\u003e\n\u003cp\u003eAcquisition of the data processing, printing and mailing unit of North Shore Agency, Inc.\u003c/p\u003e\n\u003cp\u003eAcquisition of Wingstop Restaurants\u003c/p\u003e\n\u003cp\u003eAcquisition of Massage Envy\u003c/p\u003e\n\u003cp\u003eSale of Peachtree Business Products\u003c/p\u003e\n\u003cp\u003eSale of Professional Systems Corporation\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eScofflaw Brewing\u003c/strong\u003e\u0026nbsp;in several transactions and equity financings.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrive Capital\u003c/strong\u003e\u0026nbsp;in its acquisition of Rubicon Bakers.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrive Capital\u003c/strong\u003e\u0026nbsp;and its portfolio company\u0026nbsp;\u003cstrong\u003eRubicon Bakers\u003c/strong\u003e\u0026nbsp;in the acquisition of Just Desserts.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eIndustrials and Manufacturing\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcuity Brands\u003c/strong\u003e\u0026nbsp;in its acquisition of Juno Lighting from Schneider Electric.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBig Time Products\u0026nbsp;\u003c/strong\u003ein its recapitalization transaction with Falcon Investment Advisors and Hauslein \u0026amp; Company.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eBuckner HeavyLift Cranes\u003c/strong\u003e\u0026nbsp;in its sale of a majority interest to Markel Corporation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCirrus Industries,\u003c/strong\u003e\u0026nbsp;a manufacturer of airplanes and a portfolio company of Arcapita Bank B.S.C.(c), in its sale to China Aviation Industry General Aircraft Co., Ltd.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCrown Paper Group,\u003c/strong\u003e\u0026nbsp;a portfolio company of Lindsay Goldberg, in its acquisition of Montebello Container Corporation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eElectrolux Professional AB\u003c/strong\u003e\u0026nbsp;in its acquisition of Unified Brands from Dover Corporation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGE Aviation\u003c/strong\u003e\u0026nbsp;in the formation of its Taleris joint venture with Accenture.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGE Aviation\u003c/strong\u003e\u0026nbsp;in the formation of a joint venture with SeaCast, Inc. to produce jet engine components.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHunter Douglas\u003c/strong\u003e\u0026nbsp;in its acquisition of the Levolor and Kirsch businesses from Newell Rubbermaid.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHuntington Ingalls Industries\u003c/strong\u003e\u0026nbsp;in its acquisition of Hydroid from Kongsberg Maritime.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eHusqvarna\u003c/strong\u003e\u0026nbsp;in numerous transactions, including the following:\u003c/p\u003e\n\u003cp\u003eSale of its BlueBird International business\u003c/p\u003e\n\u003cp\u003eSale of Peerless Gear business\u003c/p\u003e\n\u003cp\u003eAcquisition of Diamond Tool\u003c/p\u003e\n\u003cp\u003eAcquisition of the Concrete Power Trowel business from Wacker Neuson Group AG\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMcCleskey Mills,\u003c/strong\u003e\u0026nbsp;a peanut sheller in South Georgia, in its sale to Olam International.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMicromeritics Instrument Corporation\u0026nbsp;\u003c/strong\u003ein its sale to SFW Capital Partners.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMueller Water Products\u003c/strong\u003e\u0026nbsp;in the sale of its Anvil division to One Equity Partners.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrive Capital\u003c/strong\u003e\u0026nbsp;in its acquisition of AceCo Precision Manufacturing\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTrive Capital\u0026nbsp;\u003c/strong\u003ein its investment in Premium Guard, and Premium Guard\u0026rsquo;s acquisition of IPC Global Solutions.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eZep,\u003c/strong\u003e\u0026nbsp;a provider of specialty chemical products, in its sale to affiliates of New Mountain Capital.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eHealthcare and Life Sciences\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAmerican HomePatient,\u0026nbsp;\u003c/strong\u003ea portfolio company of Highland Capital Management, in its sale to Lincare.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eEclipsys Corporation\u0026nbsp;\u003c/strong\u003ein its $1.3 billion stock-for-stock merger with Allscripts-Misys Healthcare Solutions, Inc.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eiHealth Technologies\u003c/strong\u003e, a provider of payment policy management solutions and services to healthcare organizations, in its merger with Connolly LLC, a portfolio company of Advent International.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmucor,\u0026nbsp;\u003c/strong\u003ea provider of automated instrument-reagent systems to the blood transfusion industry, in its $1.9 billion sale to an affiliate of TPG Capital.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eOwens and Minor\u0026nbsp;\u003c/strong\u003ein its acquisition of Byram Healthcare from Mediq.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSaint Joseph\u0026rsquo;s Health System\u0026nbsp;\u003c/strong\u003ein its joint venture transaction with Emory Healthcare.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eSaint Joseph\u0026rsquo;s Health System\u0026nbsp;\u003c/strong\u003ein the sale of Saint Joseph\u0026rsquo;s East Georgia hospital to St. Mary\u0026rsquo;s Health Care System.\u003c/p\u003e","\u003cp\u003e\u003cstrong\u003eOther Significant Transactions\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCousins Properties\u003c/strong\u003e\u0026nbsp;in its sale of its third-party client services business to Cushman \u0026amp; Wakefield.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGevity HR\u003c/strong\u003e\u0026nbsp;in its cash merger with TriNet Group, a portfolio company of General Atlantic.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eLodgian\u003c/strong\u003e\u0026nbsp;in its cash merger with an affiliate of Lone Star Funds.\u003c/p\u003e"],"recognitions":[{"title":"A Georgia Super Lawyers Rising Star ","detail":"Super Lawyers, 2016, 2015"},{"title":"Top 30 Lawyers Under 40 in Georgia ","detail":"The Daily Report, 2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12126}]},"capability_group_id":1},"created_at":"2025-06-25T18:47:17.000Z","updated_at":"2025-06-25T18:47:17.000Z","searchable_text":"King{{ FIELD }}{:title=\u0026gt;\"A Georgia Super Lawyers Rising Star \", :detail=\u0026gt;\"Super Lawyers, 2016, 2015\"}{{ FIELD }}{:title=\u0026gt;\"Top 30 Lawyers Under 40 in Georgia \", :detail=\u0026gt;\"The Daily Report, 2017\"}{{ FIELD }}Representative Matters\nFinTech and Payments\nFleetCor in numerous transactions, including the following:\nMultiple equity financing and subsequent IPO\nAcquisition of Telenav’s mobile business unit\nGlobal Payments in numerous acquisitions and strategic transactions, including the following:\nAcquisition of AdvancedMD from Marlin Equity Partners\nAcquisition of SICOM Systems from LLR Partners\nJoint venture with HSBC in Mexico\nAcquisition of Desjardins’ merchant acquiring business in Canada\nTSYS in its acquisition of TransFirst from Vista Equity Partners.{{ FIELD }}Technology and Software\nClimavision in connection with its $100 million investment by TPG’s The Rise Fund.\nMailchimp in numerous transactions, including its sale to Intuit for $12 billion and the acquisitions of Reaction Commerce, Chatitive and BigTeam.\nOversight Systems in connection with a strategic investment by Luminate Capital Partners.\nResurgens Technology Partners in numerous transactions, including the acquisitions of Assurance Software, Clearview Continuity, OfficeSpace Software, Avalution Consulting, EnergyCap and AgencyBloc.{{ FIELD }}Retail and Consumer\nCarter’s in several acquisitions, including Skip Hop (portfolio company of Fireman Capital Partners), and Industrias Bunny Baby in Mexico.\nUnder Armour in numerous transactions, including the following:\nAcquisition of MapMyFitness\nAcquisition of Endomondo\nAcquisition and subsequent sale of MyFitnessPal\nW.C. Bradley in the sale of Zebco Brands to Rather Outdoors.\nZebco Brands in the sale of its Fin-Nor and Van Staal brands to Pure Fishing.{{ FIELD }}Sports and Entertainment\nAMB Group in entering into an expansion agreement with Major League Soccer for an expansion franchise.\nAtlanta Falcons in negotiations for a new multi-purpose stadium in Atlanta.\nAtlanta Falcons and the Atlanta Host Committee in their successful bid to host Super Bowl LIII.\nAtlanta Falcons Physical Therapy Centers in its joint venture with U.S. Physical Therapy.\nCarmike Cinemas in several transactions, including its acquisition of Muvico Theatres, its all-stock acquisition of Digital Cinema Destinations Corp., and its sale to AMC Entertainment.\nSkybound Entertainment in several transactions and equity financings.{{ FIELD }}Food \u0026amp; Beverage and Franchise\nRoark Capital Group in numerous transactions, including the following:\nAcquisition of Primrose Schools\nInvestment in Waste Pro USA\nAcquisition of the data processing, printing and mailing unit of North Shore Agency, Inc.\nAcquisition of Wingstop Restaurants\nAcquisition of Massage Envy\nSale of Peachtree Business Products\nSale of Professional Systems Corporation\nScofflaw Brewing in several transactions and equity financings.\nTrive Capital in its acquisition of Rubicon Bakers.\nTrive Capital and its portfolio company Rubicon Bakers in the acquisition of Just Desserts.{{ FIELD }}Industrials and Manufacturing\nAcuity Brands in its acquisition of Juno Lighting from Schneider Electric.\nBig Time Products in its recapitalization transaction with Falcon Investment Advisors and Hauslein \u0026amp; Company.\nBuckner HeavyLift Cranes in its sale of a majority interest to Markel Corporation.\nCirrus Industries, a manufacturer of airplanes and a portfolio company of Arcapita Bank B.S.C.(c), in its sale to China Aviation Industry General Aircraft Co., Ltd.\nCrown Paper Group, a portfolio company of Lindsay Goldberg, in its acquisition of Montebello Container Corporation.\nElectrolux Professional AB in its acquisition of Unified Brands from Dover Corporation.\nGE Aviation in the formation of its Taleris joint venture with Accenture.\nGE Aviation in the formation of a joint venture with SeaCast, Inc. to produce jet engine components.\nHunter Douglas in its acquisition of the Levolor and Kirsch businesses from Newell Rubbermaid.\nHuntington Ingalls Industries in its acquisition of Hydroid from Kongsberg Maritime.\nHusqvarna in numerous transactions, including the following:\nSale of its BlueBird International business\nSale of Peerless Gear business\nAcquisition of Diamond Tool\nAcquisition of the Concrete Power Trowel business from Wacker Neuson Group AG\nMcCleskey Mills, a peanut sheller in South Georgia, in its sale to Olam International.\nMicromeritics Instrument Corporation in its sale to SFW Capital Partners.\nMueller Water Products in the sale of its Anvil division to One Equity Partners.\nTrive Capital in its acquisition of AceCo Precision Manufacturing\nTrive Capital in its investment in Premium Guard, and Premium Guard’s acquisition of IPC Global Solutions.\nZep, a provider of specialty chemical products, in its sale to affiliates of New Mountain Capital.{{ FIELD }}Healthcare and Life Sciences\nAmerican HomePatient, a portfolio company of Highland Capital Management, in its sale to Lincare.\nEclipsys Corporation in its $1.3 billion stock-for-stock merger with Allscripts-Misys Healthcare Solutions, Inc.\niHealth Technologies, a provider of payment policy management solutions and services to healthcare organizations, in its merger with Connolly LLC, a portfolio company of Advent International.\nImmucor, a provider of automated instrument-reagent systems to the blood transfusion industry, in its $1.9 billion sale to an affiliate of TPG Capital.\nOwens and Minor in its acquisition of Byram Healthcare from Mediq.\nSaint Joseph’s Health System in its joint venture transaction with Emory Healthcare.\nSaint Joseph’s Health System in the sale of Saint Joseph’s East Georgia hospital to St. Mary’s Health Care System.{{ FIELD }}Other Significant Transactions\nCousins Properties in its sale of its third-party client services business to Cushman \u0026amp; Wakefield.\nGevity HR in its cash merger with TriNet Group, a portfolio company of General Atlantic.\nLodgian in its cash merger with an affiliate of Lone Star Funds.{{ FIELD }}Justin King specializes in representing public and private companies, including private equity firms and their portfolio companies, with respect to mergers and acquisitions, governance matters, restructurings and other significant transactions. Justin is a member of King \u0026amp; Spalding's Public Company, Private Equity, and Technology Industry Teams, and Co-Leader of the Firm's FinTech group.\nJustin's M\u0026amp;A and corporate transaction experience includes public company acquisitions and sales, leveraged buyouts, add-on transactions, joint ventures, tender offers, corporate reorganizations, strategic and growth-stage investments and corporate governance matters.  Justin's work crosses a broad range of industries and geographies and includes numerous transactions in the following sectors: payments, sports, healthcare and life sciences, software, retail (including e-commerce), semiconductor, food \u0026amp; beverage, building products, technology and entertainment.  Justin's international transaction experience spans Mexico, Canada, Central and South America, Asia, Europe and Australia.\nIn the sports industry, Justin has significant experience representing professional sports franchises regarding stadium development, sponsorship matters and general corporate transactions. Sports franchise clients include the Atlanta Falcons, a National Football League team, and the Atlanta United Football Club, a Major League Soccer team. Justin represented the Atlanta Host Committee for the 2019 Super Bowl and currently represents the Atlanta Host Committee in connection with its 2026 World Cup bid.\nJustin has been recognized as a Georgia Super Lawyers Rising Star, and by The Daily Report as one of the Top 30 Lawyers Under 40 in Georgia.\nJustin has also been recognized as a key leading lawyer in Legal 500’s 2025 USA guide for his M\u0026amp;A/Corporate expertise, noting: “Justin King is a go-to for sports-related deals.” Justin M King Partner A Georgia Super Lawyers Rising Star  Super Lawyers, 2016, 2015 Top 30 Lawyers Under 40 in Georgia  The Daily Report, 2017 Bowdoin College  American University Washington College of Law Georgia Representative Matters\nFinTech and Payments\nFleetCor in numerous transactions, including the following:\nMultiple equity financing and subsequent IPO\nAcquisition of Telenav’s mobile business unit\nGlobal Payments in numerous acquisitions and strategic transactions, including the following:\nAcquisition of AdvancedMD from Marlin Equity Partners\nAcquisition of SICOM Systems from LLR Partners\nJoint venture with HSBC in Mexico\nAcquisition of Desjardins’ merchant acquiring business in Canada\nTSYS in its acquisition of TransFirst from Vista Equity Partners. Technology and Software\nClimavision in connection with its $100 million investment by TPG’s The Rise Fund.\nMailchimp in numerous transactions, including its sale to Intuit for $12 billion and the acquisitions of Reaction Commerce, Chatitive and BigTeam.\nOversight Systems in connection with a strategic investment by Luminate Capital Partners.\nResurgens Technology Partners in numerous transactions, including the acquisitions of Assurance Software, Clearview Continuity, OfficeSpace Software, Avalution Consulting, EnergyCap and AgencyBloc. Retail and Consumer\nCarter’s in several acquisitions, including Skip Hop (portfolio company of Fireman Capital Partners), and Industrias Bunny Baby in Mexico.\nUnder Armour in numerous transactions, including the following:\nAcquisition of MapMyFitness\nAcquisition of Endomondo\nAcquisition and subsequent sale of MyFitnessPal\nW.C. Bradley in the sale of Zebco Brands to Rather Outdoors.\nZebco Brands in the sale of its Fin-Nor and Van Staal brands to Pure Fishing. Sports and Entertainment\nAMB Group in entering into an expansion agreement with Major League Soccer for an expansion franchise.\nAtlanta Falcons in negotiations for a new multi-purpose stadium in Atlanta.\nAtlanta Falcons and the Atlanta Host Committee in their successful bid to host Super Bowl LIII.\nAtlanta Falcons Physical Therapy Centers in its joint venture with U.S. Physical Therapy.\nCarmike Cinemas in several transactions, including its acquisition of Muvico Theatres, its all-stock acquisition of Digital Cinema Destinations Corp., and its sale to AMC Entertainment.\nSkybound Entertainment in several transactions and equity financings. Food \u0026amp; Beverage and Franchise\nRoark Capital Group in numerous transactions, including the following:\nAcquisition of Primrose Schools\nInvestment in Waste Pro USA\nAcquisition of the data processing, printing and mailing unit of North Shore Agency, Inc.\nAcquisition of Wingstop Restaurants\nAcquisition of Massage Envy\nSale of Peachtree Business Products\nSale of Professional Systems Corporation\nScofflaw Brewing in several transactions and equity financings.\nTrive Capital in its acquisition of Rubicon Bakers.\nTrive Capital and its portfolio company Rubicon Bakers in the acquisition of Just Desserts. Industrials and Manufacturing\nAcuity Brands in its acquisition of Juno Lighting from Schneider Electric.\nBig Time Products in its recapitalization transaction with Falcon Investment Advisors and Hauslein \u0026amp; Company.\nBuckner HeavyLift Cranes in its sale of a majority interest to Markel Corporation.\nCirrus Industries, a manufacturer of airplanes and a portfolio company of Arcapita Bank B.S.C.(c), in its sale to China Aviation Industry General Aircraft Co., Ltd.\nCrown Paper Group, a portfolio company of Lindsay Goldberg, in its acquisition of Montebello Container Corporation.\nElectrolux Professional AB in its acquisition of Unified Brands from Dover Corporation.\nGE Aviation in the formation of its Taleris joint venture with Accenture.\nGE Aviation in the formation of a joint venture with SeaCast, Inc. to produce jet engine components.\nHunter Douglas in its acquisition of the Levolor and Kirsch businesses from Newell Rubbermaid.\nHuntington Ingalls Industries in its acquisition of Hydroid from Kongsberg Maritime.\nHusqvarna in numerous transactions, including the following:\nSale of its BlueBird International business\nSale of Peerless Gear business\nAcquisition of Diamond Tool\nAcquisition of the Concrete Power Trowel business from Wacker Neuson Group AG\nMcCleskey Mills, a peanut sheller in South Georgia, in its sale to Olam International.\nMicromeritics Instrument Corporation in its sale to SFW Capital Partners.\nMueller Water Products in the sale of its Anvil division to One Equity Partners.\nTrive Capital in its acquisition of AceCo Precision Manufacturing\nTrive Capital in its investment in Premium Guard, and Premium Guard’s acquisition of IPC Global Solutions.\nZep, a provider of specialty chemical products, in its sale to affiliates of New Mountain Capital. Healthcare and Life Sciences\nAmerican HomePatient, a portfolio company of Highland Capital Management, in its sale to Lincare.\nEclipsys Corporation in its $1.3 billion stock-for-stock merger with Allscripts-Misys Healthcare Solutions, Inc.\niHealth Technologies, a provider of payment policy management solutions and services to healthcare organizations, in its merger with Connolly LLC, a portfolio company of Advent International.\nImmucor, a provider of automated instrument-reagent systems to the blood transfusion industry, in its $1.9 billion sale to an affiliate of TPG Capital.\nOwens and Minor in its acquisition of Byram Healthcare from Mediq.\nSaint Joseph’s Health System in its joint venture transaction with Emory Healthcare.\nSaint Joseph’s Health System in the sale of Saint Joseph’s East Georgia hospital to St. Mary’s Health Care System. Other Significant Transactions\nCousins Properties in its sale of its third-party client services business to Cushman \u0026amp; Wakefield.\nGevity HR in its cash merger with TriNet Group, a portfolio company of General Atlantic.\nLodgian in its cash merger with an affiliate of Lone Star Funds.","searchable_name":"Justin M. King","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":445251,"version":1,"owner_type":"Person","owner_id":7300,"payload":{"bio":"\u003cp\u003eCat Kirkland is based in Washington, D.C. and is a partner in the firm\u0026rsquo;s Healthcare practice. Cat works closely with hospitals, providers and related stakeholders on reimbursement issues, policy development, financial modeling and business operations. Known for her collaborative, solution-oriented approach, Cat thrives on becoming a trusted partner for each client and takes pride in helping providers navigate challenging and complex legal and reimbursement environments.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eCat\u0026rsquo;s reimbursement experience includes advising clients on state-directed payment initiatives, Medicaid rate modeling, program financing, disproportionate share hospital (DSH) programs, upper payment limit (UPL) arrangements and value-based or incentive-driven payment models. She also regularly counsels providers in reimbursement disputes with commercial and Medicare Advantage payors, including those involving the 340B Drug Pricing Program.\u003c/p\u003e\n\u003cp\u003eOutside the office, Cat enjoys spending time with her husband and three children, traveling and volunteering in her community.\u003c/p\u003e","slug":"catherine-kirkland","email":"ckirkland@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented a children\u0026rsquo;s hospital in Medicaid reimbursement strategy, leading advocacy and financial modeling efforts that secured inclusion of the hospital in a supplemental Medicaid program through a regulatory exception, resulting in substantial new funding for the hospital.\u003c/p\u003e","\u003cp\u003eRepresented group of hospitals in the development of complex Medicaid financial models and strategic advocacy to support expansion of a directed payment program to a new beneficiary population, resulting in significant new funding for participating providers throughout the state.\u003c/p\u003e","\u003cp\u003eConducted comprehensive Medicaid market analyses for psychiatric hospitals entering new state footprints, assessing potential financial impact and reimbursement opportunities. Provided private equity clients with data-driven insights and modeling to inform investment decisions and strategy for expansion.\u003c/p\u003e","\u003cp\u003eRepresented a large healthcare system in arbitration against a national Medicare Advantage plan resulting in a decisive win and significant financial recovery for the system.\u003c/p\u003e","\u003cp\u003eRegularly analyze and prepare Medicaid DSH applications and audits, identifying new funding opportunities for clients and assisting in averting potential recoupments.\u003c/p\u003e","\u003cp\u003eAssisted clients in modeling the Medicaid financial impact of the One Big Beautiful Bill, developing a variety of scenarios to consider financing, projected payments, and potential operational changes. Provided actionable insights to help clients plan strategically and adapt to evolving policy and market conditions.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":3,"source":"smartTags"},{"id":740,"guid":"740.smart_tags","index":4,"source":"smartTags"}],"is_active":true,"last_name":"Kirkland","nick_name":"Cat","clerkships":[],"first_name":"Catherine","title_rank":9999,"updated_by":34,"law_schools":[{"id":2055,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2011-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/catherine-stanford-kirkland-a074b055/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eCat Kirkland is based in Washington, D.C. and is a partner in the firm\u0026rsquo;s Healthcare practice. Cat works closely with hospitals, providers and related stakeholders on reimbursement issues, policy development, financial modeling and business operations. Known for her collaborative, solution-oriented approach, Cat thrives on becoming a trusted partner for each client and takes pride in helping providers navigate challenging and complex legal and reimbursement environments.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eCat\u0026rsquo;s reimbursement experience includes advising clients on state-directed payment initiatives, Medicaid rate modeling, program financing, disproportionate share hospital (DSH) programs, upper payment limit (UPL) arrangements and value-based or incentive-driven payment models. She also regularly counsels providers in reimbursement disputes with commercial and Medicare Advantage payors, including those involving the 340B Drug Pricing Program.\u003c/p\u003e\n\u003cp\u003eOutside the office, Cat enjoys spending time with her husband and three children, traveling and volunteering in her community.\u003c/p\u003e","matters":["\u003cp\u003eRepresented a children\u0026rsquo;s hospital in Medicaid reimbursement strategy, leading advocacy and financial modeling efforts that secured inclusion of the hospital in a supplemental Medicaid program through a regulatory exception, resulting in substantial new funding for the hospital.\u003c/p\u003e","\u003cp\u003eRepresented group of hospitals in the development of complex Medicaid financial models and strategic advocacy to support expansion of a directed payment program to a new beneficiary population, resulting in significant new funding for participating providers throughout the state.\u003c/p\u003e","\u003cp\u003eConducted comprehensive Medicaid market analyses for psychiatric hospitals entering new state footprints, assessing potential financial impact and reimbursement opportunities. Provided private equity clients with data-driven insights and modeling to inform investment decisions and strategy for expansion.\u003c/p\u003e","\u003cp\u003eRepresented a large healthcare system in arbitration against a national Medicare Advantage plan resulting in a decisive win and significant financial recovery for the system.\u003c/p\u003e","\u003cp\u003eRegularly analyze and prepare Medicaid DSH applications and audits, identifying new funding opportunities for clients and assisting in averting potential recoupments.\u003c/p\u003e","\u003cp\u003eAssisted clients in modeling the Medicaid financial impact of the One Big Beautiful Bill, developing a variety of scenarios to consider financing, projected payments, and potential operational changes. Provided actionable insights to help clients plan strategically and adapt to evolving policy and market conditions.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13319}]},"capability_group_id":2},"created_at":"2026-01-26T14:43:19.000Z","updated_at":"2026-01-26T14:43:19.000Z","searchable_text":"Kirkland{{ FIELD }}Represented a children’s hospital in Medicaid reimbursement strategy, leading advocacy and financial modeling efforts that secured inclusion of the hospital in a supplemental Medicaid program through a regulatory exception, resulting in substantial new funding for the hospital.{{ FIELD }}Represented group of hospitals in the development of complex Medicaid financial models and strategic advocacy to support expansion of a directed payment program to a new beneficiary population, resulting in significant new funding for participating providers throughout the state.{{ FIELD }}Conducted comprehensive Medicaid market analyses for psychiatric hospitals entering new state footprints, assessing potential financial impact and reimbursement opportunities. Provided private equity clients with data-driven insights and modeling to inform investment decisions and strategy for expansion.{{ FIELD }}Represented a large healthcare system in arbitration against a national Medicare Advantage plan resulting in a decisive win and significant financial recovery for the system.{{ FIELD }}Regularly analyze and prepare Medicaid DSH applications and audits, identifying new funding opportunities for clients and assisting in averting potential recoupments.{{ FIELD }}Assisted clients in modeling the Medicaid financial impact of the One Big Beautiful Bill, developing a variety of scenarios to consider financing, projected payments, and potential operational changes. Provided actionable insights to help clients plan strategically and adapt to evolving policy and market conditions.{{ FIELD }}Cat Kirkland is based in Washington, D.C. and is a partner in the firm’s Healthcare practice. Cat works closely with hospitals, providers and related stakeholders on reimbursement issues, policy development, financial modeling and business operations. Known for her collaborative, solution-oriented approach, Cat thrives on becoming a trusted partner for each client and takes pride in helping providers navigate challenging and complex legal and reimbursement environments.\nCat’s reimbursement experience includes advising clients on state-directed payment initiatives, Medicaid rate modeling, program financing, disproportionate share hospital (DSH) programs, upper payment limit (UPL) arrangements and value-based or incentive-driven payment models. She also regularly counsels providers in reimbursement disputes with commercial and Medicare Advantage payors, including those involving the 340B Drug Pricing Program.\nOutside the office, Cat enjoys spending time with her husband and three children, traveling and volunteering in her community. Partner The University of Texas at Austin The University of Texas School of Law The University of Texas at Austin The University of Texas School of Law Alabama Texas Texas Bar Association The American Health Lawyers Association Mobile Bar Association Represented a children’s hospital in Medicaid reimbursement strategy, leading advocacy and financial modeling efforts that secured inclusion of the hospital in a supplemental Medicaid program through a regulatory exception, resulting in substantial new funding for the hospital. Represented group of hospitals in the development of complex Medicaid financial models and strategic advocacy to support expansion of a directed payment program to a new beneficiary population, resulting in significant new funding for participating providers throughout the state. Conducted comprehensive Medicaid market analyses for psychiatric hospitals entering new state footprints, assessing potential financial impact and reimbursement opportunities. Provided private equity clients with data-driven insights and modeling to inform investment decisions and strategy for expansion. Represented a large healthcare system in arbitration against a national Medicare Advantage plan resulting in a decisive win and significant financial recovery for the system. Regularly analyze and prepare Medicaid DSH applications and audits, identifying new funding opportunities for clients and assisting in averting potential recoupments. Assisted clients in modeling the Medicaid financial impact of the One Big Beautiful Bill, developing a variety of scenarios to consider financing, projected payments, and potential operational changes. Provided actionable insights to help clients plan strategically and adapt to evolving policy and market conditions.","searchable_name":"Catherine Kirkland (Cat)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":445242,"version":1,"owner_type":"Person","owner_id":6425,"payload":{"bio":"\u003cp\u003eMark Kirsch is a partner in King \u0026amp; Spalding\u0026rsquo;s New York office. He is an experienced trial lawyer whose practice focuses on complex securities, white collar, commercial and antitrust litigation. He is routinely named one of the leading litigators in the United States. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMark is ranked for Securities Litigation nationwide and in New York by \u003cem\u003eChambers USA: America\u0026rsquo;s Leading Lawyers for Business\u003c/em\u003e.\u0026nbsp; The 2022 edition of \u003cem\u003eChambers USA\u003c/em\u003e states that clients say he is \u0026ldquo;a very strategic thinker with a great demeanor in litigation, as well as providing good client service,\u0026rdquo; and that \u0026ldquo;he has incredible judgment, is very good on his feet and always prepared.\u0026rdquo;\u0026nbsp; The 2021 edition shares that clients believe he is \u0026ldquo;an amazingly quick study, and great at strategic decision-making.\u0026rdquo;\u0026nbsp; The 2020 edition notes that clients say Mark is \u0026ldquo;a brilliant lawyer and a great strategist, with excellent client service\u0026rdquo; and that \u0026ldquo;his way of handling cases and his ability to combine legal knowledge with the business risks is absolutely excellent.\u0026rdquo;\u0026nbsp; A client also comments that he has \u0026ldquo;fantastic cross-examination skills.\u0026rdquo;\u0026nbsp; Prior recent editions of \u003cem\u003eChambers USA\u003c/em\u003e refer to Mark as \u0026ldquo;one of the most extraordinary litigators I\u0026rsquo;ve seen,\u0026rdquo; \u0026ldquo;a very deep thinker who is always incredibly well prepared,\u0026rdquo; and who \u0026ldquo;does a fantastic job when arguing cases,\u0026rdquo; \u0026ldquo;is at the vanguard of the US securities litigation market and enjoys a stunning reputation,\u0026rdquo; is \u0026ldquo;a force to be reckoned with,\u0026rdquo; is \u0026ldquo;a great strategist who\u0026rsquo;s detail-oriented and fantastic on his feet,\u0026rdquo; is \u0026ldquo;very good at strategy and very responsive to client needs,\u0026rdquo; and who is \u0026ldquo;extremely pleasant to deal with.\u0026rdquo;\u0026nbsp; He is also recognized as a leading securities litigation attorney by \u003cem\u003eThe Legal 500 United States\u003c/em\u003e.\u0026nbsp; Mark is named as a leading commercial litigation attorney by \u003cem\u003eThe Best Lawyers in America\u0026reg;,\u003c/em\u003e and \u003cem\u003eBenchmark Litigation\u0026rsquo;s\u003c/em\u003e Guide to America\u0026rsquo;s Leading Litigation Firms and Attorneys recognized him as a \u0026ldquo;Litigation Star.\u0026rdquo;\u0026nbsp; In both 2019 and 2016, Law360 named Mark as one of five Securities Litigation MVPs nationwide.\u0026nbsp; In addition, he was named to \u003cem\u003eCity \u0026amp; State\u0026rsquo;s\u003c/em\u003e \u0026ldquo;50 Over 50\u0026rdquo; list of the most distinguished public servants in New York in 2020, a \u0026ldquo;Life Sciences Star\u0026rdquo; by \u003cem\u003eLMG Life Sciences 2017\u003c/em\u003e, and selected by \u003cem\u003eThe Lawyer\u003c/em\u003e as one of its \u0026ldquo;Global Hot 100 Attorneys\u0026rdquo; in 2006.\u003c/p\u003e\n\u003cp\u003eMark currently serves on the Board of Trustees of the American Friends of Hebrew University.\u003c/p\u003e\n\u003cp\u003eFrom 1991 to 1995, he served as Assistant United States Attorney in the Eastern District of New York, focusing on complex financial crimes.\u0026nbsp; In 1994, U.S. Attorney General Janet Reno personally awarded Mr. Kirsch the Justice Department Director\u0026rsquo;s Award for Superior Achievement as an Assistant U.S. Attorney.\u003c/p\u003e\n\u003cp\u003eMark was previously a partner at Gibson, Dunn \u0026amp; Crutcher where he served on the Executive Committee, as Co-Partner in Charge of the New York Office, and as Global Co-Chair of Gibson Dunn\u0026rsquo;s litigation practice. Prior to that, he was a partner at Clifford Chance where he served as Global Chair of the Litigation Practice and as a member of the Global Management Committee.\u003c/p\u003e\n\u003cp\u003eMark received his Juris Doctor from Yale University Law School, where he was Articles Editor of the Yale Law \u0026amp; Policy Review, and his Bachelor of Arts degree with distinction from Cornell University.\u0026nbsp; He clerked for the Honorable John M. Walker, Jr. in New York.\u003c/p\u003e","slug":"mark-kirsch","email":"mkirsch@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresent\u0026nbsp;\u003cspan style=\"font-weight: normal !msorm;\"\u003e\u003cstrong\u003eRio Tinto\u003c/strong\u003e\u003c/span\u003e, the world\u0026rsquo;s second largest mining company, in an SEC suit alleging violations of Section 10(b), 17(a), internal controls requirements and books and records requirements, concerning the timing of a more than $3 billion impairment taken in connection with a mining project in Mozambique. Prior to trial the SEC dropped the 10(b), 17(a) and all scienter-based charges, settling for non-scienter books and records violations, a historic outcome for Rio Tinto.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eRio Tinto\u003c/strong\u003e in defeating a Section 10(b) class action based on the same conduct as in the SEC case. The Second Circuit affirmed the dismissal by the District Court.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cspan style=\"font-weight: normal !msorm;\"\u003e\u003cstrong\u003eVale S.A.\u003c/strong\u003e\u003c/span\u003e\u0026nbsp;in massive class actions relating to the collapse of the Fundao dam in Brazil. Defeated class certification in one class action, effectively ending it, and obtained dismissal of a second that was affirmed by the Second Circuit.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eVale S.A.\u003c/strong\u003e\u0026nbsp;in another massive class action resulting from the collapse of the Brumadinho dam in Brazil. (Case still pending.)\u003c/p\u003e","\u003cp\u003eSuccessfully represented half the board of directors of \u003cstrong\u003eAeroJet RocketDyne\u003c/strong\u003e against the other half of the board in a proxy fight, including trial to verdict in Delaware Chancery.\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eBlackRock\u003c/strong\u003e\u0026nbsp;in a major suit\u0026nbsp;in Virgin Islands Superior Court by shareholders of two public companies alleging BlackRock fraudulently drove down the share price of the companies.\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;and its directors in an action in New York State court brought by common shareholders challenging distribution of $550 million in merger proceeds.\u003c/p\u003e","\u003cp\u003eDefending a\u0026nbsp;\u003cstrong\u003emajor global bank\u003c/strong\u003e\u0026nbsp;in a large arbitration brought by a corporate entity alleging breach of fiduciary duty and breach of contract in connection with the sale of a large energy asset.\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eFareva S.A.\u003c/strong\u003e, a large European manufacturer, in a breach of contract suit brought by LG and Avon the Southern District of New York.\u003c/p\u003e","\u003cp\u003e\u003cspan style=\"font-weight: normal !msorm;\"\u003e\u003cstrong\u003eGerald Metals\u003c/strong\u003e\u003c/span\u003e, the largest privately owned metals trading firm in the world, in litigation in Connecticut Superior Court brought by former senior executives and shareholders alleging breach of fiduciary duty and breach of contract in connection with shareholding and other agreements.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003eUBS\u003c/strong\u003e\u0026nbsp;in class actions alleging that primary dealers of the New York Federal Reserve Bank price-fixed the auction market for U.S. Treasury securities.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003eUBS\u003c/strong\u003e\u0026nbsp;in multiple LIBOR-related actions alleging price fixing, including cases where class certification was denied in connection with three separate putative classes.\u003c/p\u003e","\u003cp\u003eWon a complete trial verdict for global investment adviser \u003cstrong\u003eInvestcorp\u003c/strong\u003e in a case brought by hedge fund Kortright Partners for $250 million for negligent misrepresentation.\u003c/p\u003e","\u003cp\u003eWon a significant trial verdict for a \u003cstrong\u003eSusquehanna fund and two senior executives\u003c/strong\u003e after a bench trial asserting fraud claims in the $115 million sale of Plimus to Great Hill.\u003c/p\u003e","\u003cp\u003eObtained complete dismissal of a shareholder class action for\u0026nbsp;\u003cspan style=\"font-weight: normal !msorm;\"\u003e\u003cstrong\u003eAmTrust Financial\u003c/strong\u003e\u003c/span\u003e, a Fortune 500 insurer, alleging violations of Section 11 of the 1933 Act and Section 10(b) of the Exchange Act, despite the Company\u0026rsquo;s restatement of financials and a disclosed SEC investigation.\u003c/p\u003e","\u003cp\u003eServed as the co-lead lawyer for \u003cstrong\u003eLynn Tilton\u003c/strong\u003e, the \u0026ldquo;Diva of Distressed,\u0026rdquo; and defeated the SEC after a three-week trial in the SEC\u0026rsquo;s ALJ court, where the ALJ dismissed all fraud and negligence charges against Ms. Tilton.\u003c/p\u003e","\u003cp\u003eObtained a rare reversal of a denial of summary judgment from the New York Appellate Division, on behalf of \u003cstrong\u003eTrust Company of the West\u003c/strong\u003e, on grounds the plaintiff hedge fund failed to establish loss causation in a case where TCW was the collateral manager for a large portfolio of mortgage-backed securities that failed to perform in the wake of the global financial crisis. TCW successfully argued the financial crisis caused the loss, not TCW\u0026rsquo;s management.\u003c/p\u003e","\u003cp\u003eObtained affirmance by the New Jersey Appellate Division of a dismissal from the bench after oral argument of a complaint against \u003cstrong\u003eMerck\u003c/strong\u003e challenging its tax disclosures.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong\u003eCorvex Management\u003c/strong\u003e and \u003cstrong\u003eThe Related Companies\u003c/strong\u003e in a two-week arbitration (the result of which was publicly disclosed) that resulted in invalidating all material anti-shareholder defenses of CommonWealth REIT, whose Trustees Corvex/Related ultimately removed in a consent solicitation.\u0026nbsp; Many major media outlets described the outcome as a \u0026ldquo;major victory\u0026rdquo; for Corvex/Related.\u003c/p\u003e","\u003cp\u003eObtained the voluntary dismissal of a putative class action on behalf of \u003cstrong\u003eGoldman Sachs, Citigroup, Merrill Lynch, Morgan Stanley, UBS and BNY Mellon Capital Markets\u003c/strong\u003e \u0026ndash; after three years of litigation \u0026ndash; arising from BNYM\u0026rsquo;s foreign exchange business, alleging violation of the federal securities laws in connection with underwriting $2 billion of securities for BNYM.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong\u003eGoldman Sachs, Citigroup, Bank of America, Merrill Lynch, J.P. Morgan, Deutsche Bank and Royal Bank of Scotland\u003c/strong\u003e in a putative class action alleging violation of the federal securities laws in connection with underwriting $900 million of notes for MF Global Holdings.\u003c/p\u003e","\u003cp\u003eResolved favorably for \u003cstrong\u003eMoody\u0026rsquo;s\u003c/strong\u003e the two most significant cases it had faced concerning ratings of structured investment vehicles.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eObtained summary judgment for \u003cstrong\u003eCitigroup\u003c/strong\u003e in connection with a securities fraud claim for $13.2 billion brought by Parmalat investors after Parmalat\u0026rsquo;s collapse.\u003c/p\u003e","\u003cp\u003eLed the team that achieved five significant victories for \u003cstrong\u003eAllianceBernstein\u003c/strong\u003e in securities litigation arising out of the Enron collapse, including a seven-week state court jury trial in which Alliance defeated the Florida state pension fund\u0026rsquo;s attempt to recover $3.2 billion in losses the fund sustained in Enron and other stocks, and AllianceBernstein won its damages counterclaim and costs.\u0026nbsp;\u0026nbsp;\u003cem\u003eThe National Law Journal\u003c/em\u003e\u0026nbsp;selected the trial victory as one of its \u0026ldquo;Top 10 Defense Verdicts of 2006.\u0026rdquo;\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eAllianceBernstein\u003c/strong\u003e in the\u0026nbsp;\u003cem\u003eNewby\u003c/em\u003e\u0026nbsp;securities class action in Houston, in which Enron shareholders and bondholders sought over $1 billion in damages against the company. Obtained summary judgment for AllianceBernstein and costs against plaintiffs\u0026rsquo; counsel, a victory written about twice by the\u0026nbsp;\u003cem\u003eWall Street Journal\u003c/em\u003e\u0026nbsp;in editorials.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":1,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":2,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":3,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":4,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":5,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":6,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":7,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":8,"source":"capabilities"},{"id":762,"guid":"762.smart_tags","index":9,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":10,"source":"smartTags"},{"id":132,"guid":"132.capabilities","index":11,"source":"capabilities"},{"id":1434,"guid":"1434.smart_tags","index":12,"source":"smartTags"},{"id":129,"guid":"129.capabilities","index":13,"source":"capabilities"}],"is_active":true,"last_name":"Kirsch","nick_name":"Mark","clerkships":[{"name":"Judicial Clerk, Honorable John M. Waker, Jr., U.S. District Court for the Southern District of New York","years_held":"1987 - 1988"}],"first_name":"Mark","title_rank":9999,"updated_by":32,"law_schools":[{"id":2605,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1987-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"A.","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/mark-kirsch-525a3610/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMark Kirsch is a partner in King \u0026amp; Spalding\u0026rsquo;s New York office. He is an experienced trial lawyer whose practice focuses on complex securities, white collar, commercial and antitrust litigation. He is routinely named one of the leading litigators in the United States. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMark is ranked for Securities Litigation nationwide and in New York by \u003cem\u003eChambers USA: America\u0026rsquo;s Leading Lawyers for Business\u003c/em\u003e.\u0026nbsp; The 2022 edition of \u003cem\u003eChambers USA\u003c/em\u003e states that clients say he is \u0026ldquo;a very strategic thinker with a great demeanor in litigation, as well as providing good client service,\u0026rdquo; and that \u0026ldquo;he has incredible judgment, is very good on his feet and always prepared.\u0026rdquo;\u0026nbsp; The 2021 edition shares that clients believe he is \u0026ldquo;an amazingly quick study, and great at strategic decision-making.\u0026rdquo;\u0026nbsp; The 2020 edition notes that clients say Mark is \u0026ldquo;a brilliant lawyer and a great strategist, with excellent client service\u0026rdquo; and that \u0026ldquo;his way of handling cases and his ability to combine legal knowledge with the business risks is absolutely excellent.\u0026rdquo;\u0026nbsp; A client also comments that he has \u0026ldquo;fantastic cross-examination skills.\u0026rdquo;\u0026nbsp; Prior recent editions of \u003cem\u003eChambers USA\u003c/em\u003e refer to Mark as \u0026ldquo;one of the most extraordinary litigators I\u0026rsquo;ve seen,\u0026rdquo; \u0026ldquo;a very deep thinker who is always incredibly well prepared,\u0026rdquo; and who \u0026ldquo;does a fantastic job when arguing cases,\u0026rdquo; \u0026ldquo;is at the vanguard of the US securities litigation market and enjoys a stunning reputation,\u0026rdquo; is \u0026ldquo;a force to be reckoned with,\u0026rdquo; is \u0026ldquo;a great strategist who\u0026rsquo;s detail-oriented and fantastic on his feet,\u0026rdquo; is \u0026ldquo;very good at strategy and very responsive to client needs,\u0026rdquo; and who is \u0026ldquo;extremely pleasant to deal with.\u0026rdquo;\u0026nbsp; He is also recognized as a leading securities litigation attorney by \u003cem\u003eThe Legal 500 United States\u003c/em\u003e.\u0026nbsp; Mark is named as a leading commercial litigation attorney by \u003cem\u003eThe Best Lawyers in America\u0026reg;,\u003c/em\u003e and \u003cem\u003eBenchmark Litigation\u0026rsquo;s\u003c/em\u003e Guide to America\u0026rsquo;s Leading Litigation Firms and Attorneys recognized him as a \u0026ldquo;Litigation Star.\u0026rdquo;\u0026nbsp; In both 2019 and 2016, Law360 named Mark as one of five Securities Litigation MVPs nationwide.\u0026nbsp; In addition, he was named to \u003cem\u003eCity \u0026amp; State\u0026rsquo;s\u003c/em\u003e \u0026ldquo;50 Over 50\u0026rdquo; list of the most distinguished public servants in New York in 2020, a \u0026ldquo;Life Sciences Star\u0026rdquo; by \u003cem\u003eLMG Life Sciences 2017\u003c/em\u003e, and selected by \u003cem\u003eThe Lawyer\u003c/em\u003e as one of its \u0026ldquo;Global Hot 100 Attorneys\u0026rdquo; in 2006.\u003c/p\u003e\n\u003cp\u003eMark currently serves on the Board of Trustees of the American Friends of Hebrew University.\u003c/p\u003e\n\u003cp\u003eFrom 1991 to 1995, he served as Assistant United States Attorney in the Eastern District of New York, focusing on complex financial crimes.\u0026nbsp; In 1994, U.S. Attorney General Janet Reno personally awarded Mr. Kirsch the Justice Department Director\u0026rsquo;s Award for Superior Achievement as an Assistant U.S. Attorney.\u003c/p\u003e\n\u003cp\u003eMark was previously a partner at Gibson, Dunn \u0026amp; Crutcher where he served on the Executive Committee, as Co-Partner in Charge of the New York Office, and as Global Co-Chair of Gibson Dunn\u0026rsquo;s litigation practice. Prior to that, he was a partner at Clifford Chance where he served as Global Chair of the Litigation Practice and as a member of the Global Management Committee.\u003c/p\u003e\n\u003cp\u003eMark received his Juris Doctor from Yale University Law School, where he was Articles Editor of the Yale Law \u0026amp; Policy Review, and his Bachelor of Arts degree with distinction from Cornell University.\u0026nbsp; He clerked for the Honorable John M. Walker, Jr. in New York.\u003c/p\u003e","matters":["\u003cp\u003eRepresent\u0026nbsp;\u003cspan style=\"font-weight: normal !msorm;\"\u003e\u003cstrong\u003eRio Tinto\u003c/strong\u003e\u003c/span\u003e, the world\u0026rsquo;s second largest mining company, in an SEC suit alleging violations of Section 10(b), 17(a), internal controls requirements and books and records requirements, concerning the timing of a more than $3 billion impairment taken in connection with a mining project in Mozambique. Prior to trial the SEC dropped the 10(b), 17(a) and all scienter-based charges, settling for non-scienter books and records violations, a historic outcome for Rio Tinto.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eRio Tinto\u003c/strong\u003e in defeating a Section 10(b) class action based on the same conduct as in the SEC case. The Second Circuit affirmed the dismissal by the District Court.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cspan style=\"font-weight: normal !msorm;\"\u003e\u003cstrong\u003eVale S.A.\u003c/strong\u003e\u003c/span\u003e\u0026nbsp;in massive class actions relating to the collapse of the Fundao dam in Brazil. Defeated class certification in one class action, effectively ending it, and obtained dismissal of a second that was affirmed by the Second Circuit.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eVale S.A.\u003c/strong\u003e\u0026nbsp;in another massive class action resulting from the collapse of the Brumadinho dam in Brazil. (Case still pending.)\u003c/p\u003e","\u003cp\u003eSuccessfully represented half the board of directors of \u003cstrong\u003eAeroJet RocketDyne\u003c/strong\u003e against the other half of the board in a proxy fight, including trial to verdict in Delaware Chancery.\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eBlackRock\u003c/strong\u003e\u0026nbsp;in a major suit\u0026nbsp;in Virgin Islands Superior Court by shareholders of two public companies alleging BlackRock fraudulently drove down the share price of the companies.\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eFanDuel\u003c/strong\u003e\u0026nbsp;and its directors in an action in New York State court brought by common shareholders challenging distribution of $550 million in merger proceeds.\u003c/p\u003e","\u003cp\u003eDefending a\u0026nbsp;\u003cstrong\u003emajor global bank\u003c/strong\u003e\u0026nbsp;in a large arbitration brought by a corporate entity alleging breach of fiduciary duty and breach of contract in connection with the sale of a large energy asset.\u003c/p\u003e","\u003cp\u003eDefending\u0026nbsp;\u003cstrong\u003eFareva S.A.\u003c/strong\u003e, a large European manufacturer, in a breach of contract suit brought by LG and Avon the Southern District of New York.\u003c/p\u003e","\u003cp\u003e\u003cspan style=\"font-weight: normal !msorm;\"\u003e\u003cstrong\u003eGerald Metals\u003c/strong\u003e\u003c/span\u003e, the largest privately owned metals trading firm in the world, in litigation in Connecticut Superior Court brought by former senior executives and shareholders alleging breach of fiduciary duty and breach of contract in connection with shareholding and other agreements.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003eUBS\u003c/strong\u003e\u0026nbsp;in class actions alleging that primary dealers of the New York Federal Reserve Bank price-fixed the auction market for U.S. Treasury securities.\u003c/p\u003e","\u003cp\u003eDefended\u0026nbsp;\u003cstrong\u003eUBS\u003c/strong\u003e\u0026nbsp;in multiple LIBOR-related actions alleging price fixing, including cases where class certification was denied in connection with three separate putative classes.\u003c/p\u003e","\u003cp\u003eWon a complete trial verdict for global investment adviser \u003cstrong\u003eInvestcorp\u003c/strong\u003e in a case brought by hedge fund Kortright Partners for $250 million for negligent misrepresentation.\u003c/p\u003e","\u003cp\u003eWon a significant trial verdict for a \u003cstrong\u003eSusquehanna fund and two senior executives\u003c/strong\u003e after a bench trial asserting fraud claims in the $115 million sale of Plimus to Great Hill.\u003c/p\u003e","\u003cp\u003eObtained complete dismissal of a shareholder class action for\u0026nbsp;\u003cspan style=\"font-weight: normal !msorm;\"\u003e\u003cstrong\u003eAmTrust Financial\u003c/strong\u003e\u003c/span\u003e, a Fortune 500 insurer, alleging violations of Section 11 of the 1933 Act and Section 10(b) of the Exchange Act, despite the Company\u0026rsquo;s restatement of financials and a disclosed SEC investigation.\u003c/p\u003e","\u003cp\u003eServed as the co-lead lawyer for \u003cstrong\u003eLynn Tilton\u003c/strong\u003e, the \u0026ldquo;Diva of Distressed,\u0026rdquo; and defeated the SEC after a three-week trial in the SEC\u0026rsquo;s ALJ court, where the ALJ dismissed all fraud and negligence charges against Ms. Tilton.\u003c/p\u003e","\u003cp\u003eObtained a rare reversal of a denial of summary judgment from the New York Appellate Division, on behalf of \u003cstrong\u003eTrust Company of the West\u003c/strong\u003e, on grounds the plaintiff hedge fund failed to establish loss causation in a case where TCW was the collateral manager for a large portfolio of mortgage-backed securities that failed to perform in the wake of the global financial crisis. TCW successfully argued the financial crisis caused the loss, not TCW\u0026rsquo;s management.\u003c/p\u003e","\u003cp\u003eObtained affirmance by the New Jersey Appellate Division of a dismissal from the bench after oral argument of a complaint against \u003cstrong\u003eMerck\u003c/strong\u003e challenging its tax disclosures.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong\u003eCorvex Management\u003c/strong\u003e and \u003cstrong\u003eThe Related Companies\u003c/strong\u003e in a two-week arbitration (the result of which was publicly disclosed) that resulted in invalidating all material anti-shareholder defenses of CommonWealth REIT, whose Trustees Corvex/Related ultimately removed in a consent solicitation.\u0026nbsp; Many major media outlets described the outcome as a \u0026ldquo;major victory\u0026rdquo; for Corvex/Related.\u003c/p\u003e","\u003cp\u003eObtained the voluntary dismissal of a putative class action on behalf of \u003cstrong\u003eGoldman Sachs, Citigroup, Merrill Lynch, Morgan Stanley, UBS and BNY Mellon Capital Markets\u003c/strong\u003e \u0026ndash; after three years of litigation \u0026ndash; arising from BNYM\u0026rsquo;s foreign exchange business, alleging violation of the federal securities laws in connection with underwriting $2 billion of securities for BNYM.\u003c/p\u003e","\u003cp\u003eDefended \u003cstrong\u003eGoldman Sachs, Citigroup, Bank of America, Merrill Lynch, J.P. Morgan, Deutsche Bank and Royal Bank of Scotland\u003c/strong\u003e in a putative class action alleging violation of the federal securities laws in connection with underwriting $900 million of notes for MF Global Holdings.\u003c/p\u003e","\u003cp\u003eResolved favorably for \u003cstrong\u003eMoody\u0026rsquo;s\u003c/strong\u003e the two most significant cases it had faced concerning ratings of structured investment vehicles.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eObtained summary judgment for \u003cstrong\u003eCitigroup\u003c/strong\u003e in connection with a securities fraud claim for $13.2 billion brought by Parmalat investors after Parmalat\u0026rsquo;s collapse.\u003c/p\u003e","\u003cp\u003eLed the team that achieved five significant victories for \u003cstrong\u003eAllianceBernstein\u003c/strong\u003e in securities litigation arising out of the Enron collapse, including a seven-week state court jury trial in which Alliance defeated the Florida state pension fund\u0026rsquo;s attempt to recover $3.2 billion in losses the fund sustained in Enron and other stocks, and AllianceBernstein won its damages counterclaim and costs.\u0026nbsp;\u0026nbsp;\u003cem\u003eThe National Law Journal\u003c/em\u003e\u0026nbsp;selected the trial victory as one of its \u0026ldquo;Top 10 Defense Verdicts of 2006.\u0026rdquo;\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eAllianceBernstein\u003c/strong\u003e in the\u0026nbsp;\u003cem\u003eNewby\u003c/em\u003e\u0026nbsp;securities class action in Houston, in which Enron shareholders and bondholders sought over $1 billion in damages against the company. Obtained summary judgment for AllianceBernstein and costs against plaintiffs\u0026rsquo; counsel, a victory written about twice by the\u0026nbsp;\u003cem\u003eWall Street Journal\u003c/em\u003e\u0026nbsp;in editorials.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":9950}]},"capability_group_id":3},"created_at":"2026-01-23T22:00:07.000Z","updated_at":"2026-01-23T22:00:07.000Z","searchable_text":"Kirsch{{ FIELD }}Represent Rio Tinto, the world’s second largest mining company, in an SEC suit alleging violations of Section 10(b), 17(a), internal controls requirements and books and records requirements, concerning the timing of a more than $3 billion impairment taken in connection with a mining project in Mozambique. Prior to trial the SEC dropped the 10(b), 17(a) and all scienter-based charges, settling for non-scienter books and records violations, a historic outcome for Rio Tinto.{{ FIELD }}Represented Rio Tinto in defeating a Section 10(b) class action based on the same conduct as in the SEC case. The Second Circuit affirmed the dismissal by the District Court.{{ FIELD }}Represented Vale S.A. in massive class actions relating to the collapse of the Fundao dam in Brazil. Defeated class certification in one class action, effectively ending it, and obtained dismissal of a second that was affirmed by the Second Circuit.{{ FIELD }}Represented Vale S.A. in another massive class action resulting from the collapse of the Brumadinho dam in Brazil. (Case still pending.){{ FIELD }}Successfully represented half the board of directors of AeroJet RocketDyne against the other half of the board in a proxy fight, including trial to verdict in Delaware Chancery.{{ FIELD }}Defending BlackRock in a major suit in Virgin Islands Superior Court by shareholders of two public companies alleging BlackRock fraudulently drove down the share price of the companies.{{ FIELD }}Defending FanDuel and its directors in an action in New York State court brought by common shareholders challenging distribution of $550 million in merger proceeds.{{ FIELD }}Defending a major global bank in a large arbitration brought by a corporate entity alleging breach of fiduciary duty and breach of contract in connection with the sale of a large energy asset.{{ FIELD }}Defending Fareva S.A., a large European manufacturer, in a breach of contract suit brought by LG and Avon the Southern District of New York.{{ FIELD }}Gerald Metals, the largest privately owned metals trading firm in the world, in litigation in Connecticut Superior Court brought by former senior executives and shareholders alleging breach of fiduciary duty and breach of contract in connection with shareholding and other agreements.{{ FIELD }}Defended UBS in class actions alleging that primary dealers of the New York Federal Reserve Bank price-fixed the auction market for U.S. Treasury securities.{{ FIELD }}Defended UBS in multiple LIBOR-related actions alleging price fixing, including cases where class certification was denied in connection with three separate putative classes.{{ FIELD }}Won a complete trial verdict for global investment adviser Investcorp in a case brought by hedge fund Kortright Partners for $250 million for negligent misrepresentation.{{ FIELD }}Won a significant trial verdict for a Susquehanna fund and two senior executives after a bench trial asserting fraud claims in the $115 million sale of Plimus to Great Hill.{{ FIELD }}Obtained complete dismissal of a shareholder class action for AmTrust Financial, a Fortune 500 insurer, alleging violations of Section 11 of the 1933 Act and Section 10(b) of the Exchange Act, despite the Company’s restatement of financials and a disclosed SEC investigation.{{ FIELD }}Served as the co-lead lawyer for Lynn Tilton, the “Diva of Distressed,” and defeated the SEC after a three-week trial in the SEC’s ALJ court, where the ALJ dismissed all fraud and negligence charges against Ms. Tilton.{{ FIELD }}Obtained a rare reversal of a denial of summary judgment from the New York Appellate Division, on behalf of Trust Company of the West, on grounds the plaintiff hedge fund failed to establish loss causation in a case where TCW was the collateral manager for a large portfolio of mortgage-backed securities that failed to perform in the wake of the global financial crisis. TCW successfully argued the financial crisis caused the loss, not TCW’s management.{{ FIELD }}Obtained affirmance by the New Jersey Appellate Division of a dismissal from the bench after oral argument of a complaint against Merck challenging its tax disclosures.{{ FIELD }}Defended Corvex Management and The Related Companies in a two-week arbitration (the result of which was publicly disclosed) that resulted in invalidating all material anti-shareholder defenses of CommonWealth REIT, whose Trustees Corvex/Related ultimately removed in a consent solicitation.  Many major media outlets described the outcome as a “major victory” for Corvex/Related.{{ FIELD }}Obtained the voluntary dismissal of a putative class action on behalf of Goldman Sachs, Citigroup, Merrill Lynch, Morgan Stanley, UBS and BNY Mellon Capital Markets – after three years of litigation – arising from BNYM’s foreign exchange business, alleging violation of the federal securities laws in connection with underwriting $2 billion of securities for BNYM.{{ FIELD }}Defended Goldman Sachs, Citigroup, Bank of America, Merrill Lynch, J.P. Morgan, Deutsche Bank and Royal Bank of Scotland in a putative class action alleging violation of the federal securities laws in connection with underwriting $900 million of notes for MF Global Holdings.{{ FIELD }}Resolved favorably for Moody’s the two most significant cases it had faced concerning ratings of structured investment vehicles. {{ FIELD }}Obtained summary judgment for Citigroup in connection with a securities fraud claim for $13.2 billion brought by Parmalat investors after Parmalat’s collapse.{{ FIELD }}Led the team that achieved five significant victories for AllianceBernstein in securities litigation arising out of the Enron collapse, including a seven-week state court jury trial in which Alliance defeated the Florida state pension fund’s attempt to recover $3.2 billion in losses the fund sustained in Enron and other stocks, and AllianceBernstein won its damages counterclaim and costs.  The National Law Journal selected the trial victory as one of its “Top 10 Defense Verdicts of 2006.”{{ FIELD }}Represented AllianceBernstein in the Newby securities class action in Houston, in which Enron shareholders and bondholders sought over $1 billion in damages against the company. Obtained summary judgment for AllianceBernstein and costs against plaintiffs’ counsel, a victory written about twice by the Wall Street Journal in editorials.{{ FIELD }}Mark Kirsch is a partner in King \u0026amp; Spalding’s New York office. He is an experienced trial lawyer whose practice focuses on complex securities, white collar, commercial and antitrust litigation. He is routinely named one of the leading litigators in the United States. \nMark is ranked for Securities Litigation nationwide and in New York by Chambers USA: America’s Leading Lawyers for Business.  The 2022 edition of Chambers USA states that clients say he is “a very strategic thinker with a great demeanor in litigation, as well as providing good client service,” and that “he has incredible judgment, is very good on his feet and always prepared.”  The 2021 edition shares that clients believe he is “an amazingly quick study, and great at strategic decision-making.”  The 2020 edition notes that clients say Mark is “a brilliant lawyer and a great strategist, with excellent client service” and that “his way of handling cases and his ability to combine legal knowledge with the business risks is absolutely excellent.”  A client also comments that he has “fantastic cross-examination skills.”  Prior recent editions of Chambers USA refer to Mark as “one of the most extraordinary litigators I’ve seen,” “a very deep thinker who is always incredibly well prepared,” and who “does a fantastic job when arguing cases,” “is at the vanguard of the US securities litigation market and enjoys a stunning reputation,” is “a force to be reckoned with,” is “a great strategist who’s detail-oriented and fantastic on his feet,” is “very good at strategy and very responsive to client needs,” and who is “extremely pleasant to deal with.”  He is also recognized as a leading securities litigation attorney by The Legal 500 United States.  Mark is named as a leading commercial litigation attorney by The Best Lawyers in America®, and Benchmark Litigation’s Guide to America’s Leading Litigation Firms and Attorneys recognized him as a “Litigation Star.”  In both 2019 and 2016, Law360 named Mark as one of five Securities Litigation MVPs nationwide.  In addition, he was named to City \u0026amp; State’s “50 Over 50” list of the most distinguished public servants in New York in 2020, a “Life Sciences Star” by LMG Life Sciences 2017, and selected by The Lawyer as one of its “Global Hot 100 Attorneys” in 2006.\nMark currently serves on the Board of Trustees of the American Friends of Hebrew University.\nFrom 1991 to 1995, he served as Assistant United States Attorney in the Eastern District of New York, focusing on complex financial crimes.  In 1994, U.S. Attorney General Janet Reno personally awarded Mr. Kirsch the Justice Department Director’s Award for Superior Achievement as an Assistant U.S. Attorney.\nMark was previously a partner at Gibson, Dunn \u0026amp; Crutcher where he served on the Executive Committee, as Co-Partner in Charge of the New York Office, and as Global Co-Chair of Gibson Dunn’s litigation practice. Prior to that, he was a partner at Clifford Chance where he served as Global Chair of the Litigation Practice and as a member of the Global Management Committee.\nMark received his Juris Doctor from Yale University Law School, where he was Articles Editor of the Yale Law \u0026amp; Policy Review, and his Bachelor of Arts degree with distinction from Cornell University.  He clerked for the Honorable John M. Walker, Jr. in New York. Partner Cornell University Cornell Law School Yale University Yale Law School U.S. Court of Appeals for the First Circuit U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Third Circuit U.S. Tax Court New York Board of Trustees of the American Friends of Hebrew University Judicial Clerk, Honorable John M. Waker, Jr., U.S. District Court for the Southern District of New York Represent Rio Tinto, the world’s second largest mining company, in an SEC suit alleging violations of Section 10(b), 17(a), internal controls requirements and books and records requirements, concerning the timing of a more than $3 billion impairment taken in connection with a mining project in Mozambique. Prior to trial the SEC dropped the 10(b), 17(a) and all scienter-based charges, settling for non-scienter books and records violations, a historic outcome for Rio Tinto. Represented Rio Tinto in defeating a Section 10(b) class action based on the same conduct as in the SEC case. The Second Circuit affirmed the dismissal by the District Court. Represented Vale S.A. in massive class actions relating to the collapse of the Fundao dam in Brazil. Defeated class certification in one class action, effectively ending it, and obtained dismissal of a second that was affirmed by the Second Circuit. Represented Vale S.A. in another massive class action resulting from the collapse of the Brumadinho dam in Brazil. (Case still pending.) Successfully represented half the board of directors of AeroJet RocketDyne against the other half of the board in a proxy fight, including trial to verdict in Delaware Chancery. Defending BlackRock in a major suit in Virgin Islands Superior Court by shareholders of two public companies alleging BlackRock fraudulently drove down the share price of the companies. Defending FanDuel and its directors in an action in New York State court brought by common shareholders challenging distribution of $550 million in merger proceeds. Defending a major global bank in a large arbitration brought by a corporate entity alleging breach of fiduciary duty and breach of contract in connection with the sale of a large energy asset. Defending Fareva S.A., a large European manufacturer, in a breach of contract suit brought by LG and Avon the Southern District of New York. Gerald Metals, the largest privately owned metals trading firm in the world, in litigation in Connecticut Superior Court brought by former senior executives and shareholders alleging breach of fiduciary duty and breach of contract in connection with shareholding and other agreements. Defended UBS in class actions alleging that primary dealers of the New York Federal Reserve Bank price-fixed the auction market for U.S. Treasury securities. Defended UBS in multiple LIBOR-related actions alleging price fixing, including cases where class certification was denied in connection with three separate putative classes. Won a complete trial verdict for global investment adviser Investcorp in a case brought by hedge fund Kortright Partners for $250 million for negligent misrepresentation. Won a significant trial verdict for a Susquehanna fund and two senior executives after a bench trial asserting fraud claims in the $115 million sale of Plimus to Great Hill. Obtained complete dismissal of a shareholder class action for AmTrust Financial, a Fortune 500 insurer, alleging violations of Section 11 of the 1933 Act and Section 10(b) of the Exchange Act, despite the Company’s restatement of financials and a disclosed SEC investigation. Served as the co-lead lawyer for Lynn Tilton, the “Diva of Distressed,” and defeated the SEC after a three-week trial in the SEC’s ALJ court, where the ALJ dismissed all fraud and negligence charges against Ms. Tilton. Obtained a rare reversal of a denial of summary judgment from the New York Appellate Division, on behalf of Trust Company of the West, on grounds the plaintiff hedge fund failed to establish loss causation in a case where TCW was the collateral manager for a large portfolio of mortgage-backed securities that failed to perform in the wake of the global financial crisis. TCW successfully argued the financial crisis caused the loss, not TCW’s management. Obtained affirmance by the New Jersey Appellate Division of a dismissal from the bench after oral argument of a complaint against Merck challenging its tax disclosures. Defended Corvex Management and The Related Companies in a two-week arbitration (the result of which was publicly disclosed) that resulted in invalidating all material anti-shareholder defenses of CommonWealth REIT, whose Trustees Corvex/Related ultimately removed in a consent solicitation.  Many major media outlets described the outcome as a “major victory” for Corvex/Related. Obtained the voluntary dismissal of a putative class action on behalf of Goldman Sachs, Citigroup, Merrill Lynch, Morgan Stanley, UBS and BNY Mellon Capital Markets – after three years of litigation – arising from BNYM’s foreign exchange business, alleging violation of the federal securities laws in connection with underwriting $2 billion of securities for BNYM. Defended Goldman Sachs, Citigroup, Bank of America, Merrill Lynch, J.P. Morgan, Deutsche Bank and Royal Bank of Scotland in a putative class action alleging violation of the federal securities laws in connection with underwriting $900 million of notes for MF Global Holdings. Resolved favorably for Moody’s the two most significant cases it had faced concerning ratings of structured investment vehicles.  Obtained summary judgment for Citigroup in connection with a securities fraud claim for $13.2 billion brought by Parmalat investors after Parmalat’s collapse. Led the team that achieved five significant victories for AllianceBernstein in securities litigation arising out of the Enron collapse, including a seven-week state court jury trial in which Alliance defeated the Florida state pension fund’s attempt to recover $3.2 billion in losses the fund sustained in Enron and other stocks, and AllianceBernstein won its damages counterclaim and costs.  The National Law Journal selected the trial victory as one of its “Top 10 Defense Verdicts of 2006.” Represented AllianceBernstein in the Newby securities class action in Houston, in which Enron shareholders and bondholders sought over $1 billion in damages against the company. Obtained summary judgment for AllianceBernstein and costs against plaintiffs’ counsel, a victory written about twice by the Wall Street Journal in editorials.","searchable_name":"Mark A. Kirsch","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":442758,"version":1,"owner_type":"Person","owner_id":5296,"payload":{"bio":"\u003cp\u003eLiv Kiser, a member of the federal trial bar, defends companies in high-stakes civil disputes arising from dangerous or toxic products or substances, consumer fraud, false advertising, breach of warranty, privacy violations, unfair competition and other torts.\u0026nbsp; A seasoned and vigorous advocate both in and outside of the courtroom, Liv's innovative approaches to complex legal questions have resulted in the development of new law favorable to her clients and entire industries.\u003c/p\u003e\n\u003cp\u003eLiv proactively works with companies in the supply chain of highly-regulated, consumer-facing industries -- from automotive to food, financial services, healthcare, personal care products, real estate, telecommunications, utilities, and others -- to identify and manage their legal risks, developing creative and cost-effective strategies for furthering their business interests, protecting brands and preserving consumer goodwill.\u0026nbsp; Liv regularly resolves cases at the earliest stages of litigation through creative strategies that (for example) operate to moot a class action or render the case uncertifiable. Liv has persuaded opposing counsel to dismiss cases without compensation by persuasively explaining applicable law.\u0026nbsp; Liv has successfully defeated class certification in cases that prior counsel believed to be unwinnable.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eLiv has defended some of the world's largest multi-national companies in high-stakes commercial, viral and multidistrict litigation, managing crisis situations in which simultaneous inquiries by state and federal regulators, international and local law enforcement and Congress are taking place. Liv has appeared in state and federal courts across the nation, and understands how courts are likely to apply the consumer protection laws in any given dispute.\u0026nbsp; Her clients consider her predictive skills as to how matters are likely to unfold and resolve as \"uncanny.\"\u0026nbsp; Protecting company reputations and preserving trust is a central focus of Liv\u0026rsquo;s practice.\u003c/p\u003e\n\u003cp\u003eLiv routinely and successfully defends companies facing\u0026nbsp;claims asserted under the laws of California\u0026nbsp;(including Cal. Bus. \u0026amp; Prof. Code 17200 (UCL), 17500, CLRA, CCPA, Prop 65) and other states (including the Illinois Biometric Privacy Act (BIPA)).\u0026nbsp; She has defeated numerous claims under the Telephone Consumer Protection Act (TCPA), the Americans with Disabilities' Act (ADA) and other state and federal laws.\u0026nbsp; She has substantial experience successfully defeating cases where plaintiffs seek recovery for alleged \"price premiums\" and/or \"overpayments.\"\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eLiv also has a very active pro bono practice, obtaining asylum for persecuted individuals and ensuring children with disabilities obtain necessary services.\u0026nbsp; She also represents incarcerated defendants in Constitutional cases.\u0026nbsp; Liv serves on the firm's Diversity Committee, and on committees within the Chicago office.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","slug":"livia-kiser","email":"lkiser@kslaw.com","phone":null,"matters":["\u003cp\u003eLead counsel is a proposed class action alleging arsenic in spices caused harm to consumers who purchased the products. Case resolved for\u0026nbsp;\u003cem\u003ede minimis\u003c/em\u003e\u0026nbsp;amount after recall implemented.\u003c/p\u003e","\u003cp\u003eLead counsel in a series of Safe Drinking Water and Toxic Enforcement Act of 1986 (California's \"Proposition 65\") relating to a variety of allegedly carcinogenic and toxic substances in food and other consumer products. Cases resolved on very favorable terms through informal negotiations.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging the engine compartments of certain model vehicles emit noxious and toxic substances into the vehicles' passenger cabins, allegedly rendering the vehicles undrivable and causing vehicle occupants to require medical treatment.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action brought under the Telephone Consumer Protection Act (TCPA) seeking more than $600 million in damages as a result of defendant allegedly having sent facsimiles to recipients that purportedly lacked legally-sufficient opt-out notices. Successfully defeated class certification on predominance grounds.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging vehicle transmissions are defective; persuaded Court to dismiss the Magnuson Moss Warranty Act claim for failing to name at least 100 named plaintiffs; Court rejected the notion it had jurisdiction over the MMWA claim based on diversity.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging violations of state and federal warranty laws brought on behalf of a Wisconsin resident. Liv successfully obtained dismissal of the case on grounds that Illinois lacked sufficient contacts to confer general personal jurisdiction over American Honda.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging violations to the Telephone Consumer Protection Act (TCPA) that was successfully resolved on very favorable terms prior to the filing of a responsive pleading.\u003c/p\u003e","\u003cp\u003eCo-lead counsel in a proposed class action against Toyota Motor Sales U.S.A. alleging excessive oil consumption in certain Toyota vehicles; successfully argued Plaintiff lacked standing; case was dismissed, with costs awarded to Toyota.\u003c/p\u003e","\u003cp\u003eIn a proposed class action brought by Oregon and Washington residents against Ford Motor Co., Inc. in California, successfully argued that the State of California lacked sufficient contacts to assert general personal jurisdiction over Ford. Plaintiffs declined to appeal the district court\u0026rsquo;s dismissal of Ford.\u003c/p\u003e","\u003cp\u003eLead counsel in an MDL consolidating nine consumer class actions filed throughout the U.S. alleging 2015 Honda CR-Vs vibrate excessively. Resolved favorably through a Rule 23(b)(2) settlement where the remedy is to provide \u0026ldquo;enhanced\u0026rdquo; notice of pre-existing, effective countermeasures to the relatively few consumers who complained.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging an internet advertising service provider breached its service agreements by invoicing allegedly misleading charges; successfully resolved after preliminary motion practice and targeted discovery of plaintiff.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action against U.S. automotive distributor and foreign parent alleging the pedal bracket assembly in certain vehicles was defective; Plaintiffs sought to certify classes and subclasses in more than ten states. Resolved on favorable terms after a favorable ruling on a motion to dismiss and targeted discovery of plaintiffs.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging Defendants sent unwanted facsimile advertisements to Plaintiff and members of the proposed classes. Defeated class certification by successfully proving Plaintiff and all of its counsel (more than 10 lawyers and 3 law firms) were inadequate.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3191}]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":1,"source":"smartTags"},{"id":105,"guid":"105.capabilities","index":2,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":3,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":4,"source":"capabilities"},{"id":71,"guid":"71.capabilities","index":5,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":6,"source":"capabilities"},{"id":762,"guid":"762.smart_tags","index":7,"source":"smartTags"},{"id":106,"guid":"106.capabilities","index":8,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":9,"source":"capabilities"},{"id":1015,"guid":"1015.smart_tags","index":10,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":11,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":12,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":13,"source":"smartTags"},{"id":1233,"guid":"1233.smart_tags","index":14,"source":"smartTags"},{"id":1256,"guid":"1256.smart_tags","index":15,"source":"smartTags"}],"is_active":true,"last_name":"Kiser","nick_name":"Liv","clerkships":[],"first_name":"Livia","title_rank":9999,"updated_by":202,"law_schools":[{"id":1451,"meta":{"degree":"J.D.","honors":"cum laude, Order of the Coif","is_law_school":"1","graduation_date":null},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"Named to 2025 Lawdragon 500 Leading Global Cyber Lawyers","detail":"Lawdragon"},{"title":"Named to 2025 Leading Lawyers ","detail":"Leading Lawyers"},{"title":"Named to Chambers 2024 Leading Lawyers in America","detail":"Chambers"},{"title":"Tier 2 - Leading Lawyer in 2024 for Transport\u003eRail and Road: Litigation and Regulation","detail":"Legal 500"},{"title":"Tier 1-Key Lawyer in 2024 for Dispute Resolution\u003eProduct Liability, Mass Tort \u0026 Class Actions-Defense: Consumer Products","detail":"Legal 500"},{"title":"Tier 1-Key Lawyer in 2024 for Dispute Resolution\u003eProduct Liability, Mass Tort \u0026 Class Actions-Defense: Auto/Transport","detail":"Legal 500"},{"title":"Named to Chambers 2024 General Commercial Litigation List","detail":"Chambers"},{"title":"Member of 2024 Lawdragon 500 Leading Global Cyber Lawyers","detail":"Lawdragon"},{"title":"Stand-Out Lawyer ","detail":"Thomson Reuters 2024"},{"title":"Leading Lawyer in 2023 in Transport: Rail and Road, Litigation and Regulatory","detail":"Legal 500"},{"title":"Recommended Lawyer in 2023 in Product Liability, Mass Tort, and Class Actions: Consumer Products: Defense ","detail":"Legal 500"},{"title":"Recommended Lawyer in 2022 in Product Liability, Mass Tort, and Class Actions: Consumer Products: Defense","detail":"Legal 500"},{"title":"Recommended Lawyer in 2022 in Product Liability, Mass Tort, and Class Actions: Auto/Transport: Defense","detail":"Legal 500"},{"title":"Named to Crain's Chicago Business's 2023 Notable Litigators and Trial Attorneys List","detail":"Crain's Chicago Business"},{"title":"Named to Chicago Lawyer's 2021 Top 50 Women in Law ","detail":"Chicago Lawyer"},{"title":"Named to Crain's Chicago Business's 2020 Notable Women in Law","detail":"Crain's Chicago Business"},{"title":"Leading Lawyer in 2022 in Transport: Rail and Road, Litigation and Regulatory ","detail":"Legal 500"},{"title":"Named to The Best Lawyers in America for Consumer Law","detail":"Best Lawyers In America"},{"title":"Recognized as a \"Leading Lawyer\"","detail":"Leading Lawyers Network"},{"title":"Named among the “Top Lawyers in Illinois” in Advertising \u0026 Media Law and Class Action Mass Tort Defense Law","detail":"Illinois Super Lawyer"}],"linked_in_url":"https://www.linkedin.com/in/livia-kiser-9a1b675/","seodescription":"Livia M. Kiser (Liv) is a lawyer of our Business Litigation Practice Group. Read more.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eLiv Kiser, a member of the federal trial bar, defends companies in high-stakes civil disputes arising from dangerous or toxic products or substances, consumer fraud, false advertising, breach of warranty, privacy violations, unfair competition and other torts.\u0026nbsp; A seasoned and vigorous advocate both in and outside of the courtroom, Liv's innovative approaches to complex legal questions have resulted in the development of new law favorable to her clients and entire industries.\u003c/p\u003e\n\u003cp\u003eLiv proactively works with companies in the supply chain of highly-regulated, consumer-facing industries -- from automotive to food, financial services, healthcare, personal care products, real estate, telecommunications, utilities, and others -- to identify and manage their legal risks, developing creative and cost-effective strategies for furthering their business interests, protecting brands and preserving consumer goodwill.\u0026nbsp; Liv regularly resolves cases at the earliest stages of litigation through creative strategies that (for example) operate to moot a class action or render the case uncertifiable. Liv has persuaded opposing counsel to dismiss cases without compensation by persuasively explaining applicable law.\u0026nbsp; Liv has successfully defeated class certification in cases that prior counsel believed to be unwinnable.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eLiv has defended some of the world's largest multi-national companies in high-stakes commercial, viral and multidistrict litigation, managing crisis situations in which simultaneous inquiries by state and federal regulators, international and local law enforcement and Congress are taking place. Liv has appeared in state and federal courts across the nation, and understands how courts are likely to apply the consumer protection laws in any given dispute.\u0026nbsp; Her clients consider her predictive skills as to how matters are likely to unfold and resolve as \"uncanny.\"\u0026nbsp; Protecting company reputations and preserving trust is a central focus of Liv\u0026rsquo;s practice.\u003c/p\u003e\n\u003cp\u003eLiv routinely and successfully defends companies facing\u0026nbsp;claims asserted under the laws of California\u0026nbsp;(including Cal. Bus. \u0026amp; Prof. Code 17200 (UCL), 17500, CLRA, CCPA, Prop 65) and other states (including the Illinois Biometric Privacy Act (BIPA)).\u0026nbsp; She has defeated numerous claims under the Telephone Consumer Protection Act (TCPA), the Americans with Disabilities' Act (ADA) and other state and federal laws.\u0026nbsp; She has substantial experience successfully defeating cases where plaintiffs seek recovery for alleged \"price premiums\" and/or \"overpayments.\"\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eLiv also has a very active pro bono practice, obtaining asylum for persecuted individuals and ensuring children with disabilities obtain necessary services.\u0026nbsp; She also represents incarcerated defendants in Constitutional cases.\u0026nbsp; Liv serves on the firm's Diversity Committee, and on committees within the Chicago office.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eLead counsel is a proposed class action alleging arsenic in spices caused harm to consumers who purchased the products. Case resolved for\u0026nbsp;\u003cem\u003ede minimis\u003c/em\u003e\u0026nbsp;amount after recall implemented.\u003c/p\u003e","\u003cp\u003eLead counsel in a series of Safe Drinking Water and Toxic Enforcement Act of 1986 (California's \"Proposition 65\") relating to a variety of allegedly carcinogenic and toxic substances in food and other consumer products. Cases resolved on very favorable terms through informal negotiations.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging the engine compartments of certain model vehicles emit noxious and toxic substances into the vehicles' passenger cabins, allegedly rendering the vehicles undrivable and causing vehicle occupants to require medical treatment.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action brought under the Telephone Consumer Protection Act (TCPA) seeking more than $600 million in damages as a result of defendant allegedly having sent facsimiles to recipients that purportedly lacked legally-sufficient opt-out notices. Successfully defeated class certification on predominance grounds.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging vehicle transmissions are defective; persuaded Court to dismiss the Magnuson Moss Warranty Act claim for failing to name at least 100 named plaintiffs; Court rejected the notion it had jurisdiction over the MMWA claim based on diversity.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging violations of state and federal warranty laws brought on behalf of a Wisconsin resident. Liv successfully obtained dismissal of the case on grounds that Illinois lacked sufficient contacts to confer general personal jurisdiction over American Honda.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging violations to the Telephone Consumer Protection Act (TCPA) that was successfully resolved on very favorable terms prior to the filing of a responsive pleading.\u003c/p\u003e","\u003cp\u003eCo-lead counsel in a proposed class action against Toyota Motor Sales U.S.A. alleging excessive oil consumption in certain Toyota vehicles; successfully argued Plaintiff lacked standing; case was dismissed, with costs awarded to Toyota.\u003c/p\u003e","\u003cp\u003eIn a proposed class action brought by Oregon and Washington residents against Ford Motor Co., Inc. in California, successfully argued that the State of California lacked sufficient contacts to assert general personal jurisdiction over Ford. Plaintiffs declined to appeal the district court\u0026rsquo;s dismissal of Ford.\u003c/p\u003e","\u003cp\u003eLead counsel in an MDL consolidating nine consumer class actions filed throughout the U.S. alleging 2015 Honda CR-Vs vibrate excessively. Resolved favorably through a Rule 23(b)(2) settlement where the remedy is to provide \u0026ldquo;enhanced\u0026rdquo; notice of pre-existing, effective countermeasures to the relatively few consumers who complained.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging an internet advertising service provider breached its service agreements by invoicing allegedly misleading charges; successfully resolved after preliminary motion practice and targeted discovery of plaintiff.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action against U.S. automotive distributor and foreign parent alleging the pedal bracket assembly in certain vehicles was defective; Plaintiffs sought to certify classes and subclasses in more than ten states. Resolved on favorable terms after a favorable ruling on a motion to dismiss and targeted discovery of plaintiffs.\u003c/p\u003e","\u003cp\u003eLead counsel in a proposed class action alleging Defendants sent unwanted facsimile advertisements to Plaintiff and members of the proposed classes. Defeated class certification by successfully proving Plaintiff and all of its counsel (more than 10 lawyers and 3 law firms) were inadequate.\u003c/p\u003e"],"recognitions":[{"title":"Named to 2025 Lawdragon 500 Leading Global Cyber Lawyers","detail":"Lawdragon"},{"title":"Named to 2025 Leading Lawyers ","detail":"Leading Lawyers"},{"title":"Named to Chambers 2024 Leading Lawyers in America","detail":"Chambers"},{"title":"Tier 2 - Leading Lawyer in 2024 for Transport\u003eRail and Road: Litigation and Regulation","detail":"Legal 500"},{"title":"Tier 1-Key Lawyer in 2024 for Dispute Resolution\u003eProduct Liability, Mass Tort \u0026 Class Actions-Defense: Consumer Products","detail":"Legal 500"},{"title":"Tier 1-Key Lawyer in 2024 for Dispute Resolution\u003eProduct Liability, Mass Tort \u0026 Class Actions-Defense: Auto/Transport","detail":"Legal 500"},{"title":"Named to Chambers 2024 General Commercial Litigation List","detail":"Chambers"},{"title":"Member of 2024 Lawdragon 500 Leading Global Cyber Lawyers","detail":"Lawdragon"},{"title":"Stand-Out Lawyer ","detail":"Thomson Reuters 2024"},{"title":"Leading Lawyer in 2023 in Transport: Rail and Road, Litigation and Regulatory","detail":"Legal 500"},{"title":"Recommended Lawyer in 2023 in Product Liability, Mass Tort, and Class Actions: Consumer Products: Defense ","detail":"Legal 500"},{"title":"Recommended Lawyer in 2022 in Product Liability, Mass Tort, and Class Actions: Consumer Products: Defense","detail":"Legal 500"},{"title":"Recommended Lawyer in 2022 in Product Liability, Mass Tort, and Class Actions: Auto/Transport: Defense","detail":"Legal 500"},{"title":"Named to Crain's Chicago Business's 2023 Notable Litigators and Trial Attorneys List","detail":"Crain's Chicago Business"},{"title":"Named to Chicago Lawyer's 2021 Top 50 Women in Law ","detail":"Chicago Lawyer"},{"title":"Named to Crain's Chicago Business's 2020 Notable Women in Law","detail":"Crain's Chicago Business"},{"title":"Leading Lawyer in 2022 in Transport: Rail and Road, Litigation and Regulatory ","detail":"Legal 500"},{"title":"Named to The Best Lawyers in America for Consumer Law","detail":"Best Lawyers In America"},{"title":"Recognized as a \"Leading Lawyer\"","detail":"Leading Lawyers Network"},{"title":"Named among the “Top Lawyers in Illinois” in Advertising \u0026 Media Law and Class Action Mass Tort Defense Law","detail":"Illinois Super Lawyer"}]},"ja":{"matters":[""]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":6111}]},"capability_group_id":3},"created_at":"2025-11-13T04:56:28.000Z","updated_at":"2025-11-13T04:56:28.000Z","searchable_text":"Kiser{{ FIELD }}{:title=\u0026gt;\"Named to 2025 Lawdragon 500 Leading Global Cyber Lawyers\", :detail=\u0026gt;\"Lawdragon\"}{{ FIELD }}{:title=\u0026gt;\"Named to 2025 Leading Lawyers \", :detail=\u0026gt;\"Leading Lawyers\"}{{ FIELD }}{:title=\u0026gt;\"Named to Chambers 2024 Leading Lawyers in America\", :detail=\u0026gt;\"Chambers\"}{{ FIELD }}{:title=\u0026gt;\"Tier 2 - Leading Lawyer in 2024 for Transport\u0026gt;Rail and Road: Litigation and Regulation\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Tier 1-Key Lawyer in 2024 for Dispute Resolution\u0026gt;Product Liability, Mass Tort \u0026amp; Class Actions-Defense: Consumer Products\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Tier 1-Key Lawyer in 2024 for Dispute Resolution\u0026gt;Product Liability, Mass Tort \u0026amp; Class Actions-Defense: Auto/Transport\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Named to Chambers 2024 General Commercial Litigation List\", :detail=\u0026gt;\"Chambers\"}{{ FIELD }}{:title=\u0026gt;\"Member of 2024 Lawdragon 500 Leading Global Cyber Lawyers\", :detail=\u0026gt;\"Lawdragon\"}{{ FIELD }}{:title=\u0026gt;\"Stand-Out Lawyer \", :detail=\u0026gt;\"Thomson Reuters 2024\"}{{ FIELD }}{:title=\u0026gt;\"Leading Lawyer in 2023 in Transport: Rail and Road, Litigation and Regulatory\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyer in 2023 in Product Liability, Mass Tort, and Class Actions: Consumer Products: Defense \", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyer in 2022 in Product Liability, Mass Tort, and Class Actions: Consumer Products: Defense\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyer in 2022 in Product Liability, Mass Tort, and Class Actions: Auto/Transport: Defense\", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Named to Crain's Chicago Business's 2023 Notable Litigators and Trial Attorneys List\", :detail=\u0026gt;\"Crain's Chicago Business\"}{{ FIELD }}{:title=\u0026gt;\"Named to Chicago Lawyer's 2021 Top 50 Women in Law \", :detail=\u0026gt;\"Chicago Lawyer\"}{{ FIELD }}{:title=\u0026gt;\"Named to Crain's Chicago Business's 2020 Notable Women in Law\", :detail=\u0026gt;\"Crain's Chicago Business\"}{{ FIELD }}{:title=\u0026gt;\"Leading Lawyer in 2022 in Transport: Rail and Road, Litigation and Regulatory \", :detail=\u0026gt;\"Legal 500\"}{{ FIELD }}{:title=\u0026gt;\"Named to The Best Lawyers in America for Consumer Law\", :detail=\u0026gt;\"Best Lawyers In America\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as a \\\"Leading Lawyer\\\"\", :detail=\u0026gt;\"Leading Lawyers Network\"}{{ FIELD }}{:title=\u0026gt;\"Named among the “Top Lawyers in Illinois” in Advertising \u0026amp; Media Law and Class Action Mass Tort Defense Law\", :detail=\u0026gt;\"Illinois Super Lawyer\"}{{ FIELD }}Lead counsel is a proposed class action alleging arsenic in spices caused harm to consumers who purchased the products. Case resolved for de minimis amount after recall implemented.{{ FIELD }}Lead counsel in a series of Safe Drinking Water and Toxic Enforcement Act of 1986 (California's \"Proposition 65\") relating to a variety of allegedly carcinogenic and toxic substances in food and other consumer products. Cases resolved on very favorable terms through informal negotiations.{{ FIELD }}Lead counsel in a proposed class action alleging the engine compartments of certain model vehicles emit noxious and toxic substances into the vehicles' passenger cabins, allegedly rendering the vehicles undrivable and causing vehicle occupants to require medical treatment.{{ FIELD }}Lead counsel in a proposed class action brought under the Telephone Consumer Protection Act (TCPA) seeking more than $600 million in damages as a result of defendant allegedly having sent facsimiles to recipients that purportedly lacked legally-sufficient opt-out notices. Successfully defeated class certification on predominance grounds.{{ FIELD }}Lead counsel in a proposed class action alleging vehicle transmissions are defective; persuaded Court to dismiss the Magnuson Moss Warranty Act claim for failing to name at least 100 named plaintiffs; Court rejected the notion it had jurisdiction over the MMWA claim based on diversity.{{ FIELD }}Lead counsel in a proposed class action alleging violations of state and federal warranty laws brought on behalf of a Wisconsin resident. Liv successfully obtained dismissal of the case on grounds that Illinois lacked sufficient contacts to confer general personal jurisdiction over American Honda.{{ FIELD }}Lead counsel in a proposed class action alleging violations to the Telephone Consumer Protection Act (TCPA) that was successfully resolved on very favorable terms prior to the filing of a responsive pleading.{{ FIELD }}Co-lead counsel in a proposed class action against Toyota Motor Sales U.S.A. alleging excessive oil consumption in certain Toyota vehicles; successfully argued Plaintiff lacked standing; case was dismissed, with costs awarded to Toyota.{{ FIELD }}In a proposed class action brought by Oregon and Washington residents against Ford Motor Co., Inc. in California, successfully argued that the State of California lacked sufficient contacts to assert general personal jurisdiction over Ford. Plaintiffs declined to appeal the district court’s dismissal of Ford.{{ FIELD }}Lead counsel in an MDL consolidating nine consumer class actions filed throughout the U.S. alleging 2015 Honda CR-Vs vibrate excessively. Resolved favorably through a Rule 23(b)(2) settlement where the remedy is to provide “enhanced” notice of pre-existing, effective countermeasures to the relatively few consumers who complained.{{ FIELD }}Lead counsel in a proposed class action alleging an internet advertising service provider breached its service agreements by invoicing allegedly misleading charges; successfully resolved after preliminary motion practice and targeted discovery of plaintiff.{{ FIELD }}Lead counsel in a proposed class action against U.S. automotive distributor and foreign parent alleging the pedal bracket assembly in certain vehicles was defective; Plaintiffs sought to certify classes and subclasses in more than ten states. Resolved on favorable terms after a favorable ruling on a motion to dismiss and targeted discovery of plaintiffs.{{ FIELD }}Lead counsel in a proposed class action alleging Defendants sent unwanted facsimile advertisements to Plaintiff and members of the proposed classes. Defeated class certification by successfully proving Plaintiff and all of its counsel (more than 10 lawyers and 3 law firms) were inadequate.{{ FIELD }}Liv Kiser, a member of the federal trial bar, defends companies in high-stakes civil disputes arising from dangerous or toxic products or substances, consumer fraud, false advertising, breach of warranty, privacy violations, unfair competition and other torts.  A seasoned and vigorous advocate both in and outside of the courtroom, Liv's innovative approaches to complex legal questions have resulted in the development of new law favorable to her clients and entire industries.\nLiv proactively works with companies in the supply chain of highly-regulated, consumer-facing industries -- from automotive to food, financial services, healthcare, personal care products, real estate, telecommunications, utilities, and others -- to identify and manage their legal risks, developing creative and cost-effective strategies for furthering their business interests, protecting brands and preserving consumer goodwill.  Liv regularly resolves cases at the earliest stages of litigation through creative strategies that (for example) operate to moot a class action or render the case uncertifiable. Liv has persuaded opposing counsel to dismiss cases without compensation by persuasively explaining applicable law.  Liv has successfully defeated class certification in cases that prior counsel believed to be unwinnable.\nLiv has defended some of the world's largest multi-national companies in high-stakes commercial, viral and multidistrict litigation, managing crisis situations in which simultaneous inquiries by state and federal regulators, international and local law enforcement and Congress are taking place. Liv has appeared in state and federal courts across the nation, and understands how courts are likely to apply the consumer protection laws in any given dispute.  Her clients consider her predictive skills as to how matters are likely to unfold and resolve as \"uncanny.\"  Protecting company reputations and preserving trust is a central focus of Liv’s practice.\nLiv routinely and successfully defends companies facing claims asserted under the laws of California (including Cal. Bus. \u0026amp; Prof. Code 17200 (UCL), 17500, CLRA, CCPA, Prop 65) and other states (including the Illinois Biometric Privacy Act (BIPA)).  She has defeated numerous claims under the Telephone Consumer Protection Act (TCPA), the Americans with Disabilities' Act (ADA) and other state and federal laws.  She has substantial experience successfully defeating cases where plaintiffs seek recovery for alleged \"price premiums\" and/or \"overpayments.\" \nLiv also has a very active pro bono practice, obtaining asylum for persecuted individuals and ensuring children with disabilities obtain necessary services.  She also represents incarcerated defendants in Constitutional cases.  Liv serves on the firm's Diversity Committee, and on committees within the Chicago office.   Livia Kiser lawyer Partner Named to 2025 Lawdragon 500 Leading Global Cyber Lawyers Lawdragon Named to 2025 Leading Lawyers  Leading Lawyers Named to Chambers 2024 Leading Lawyers in America Chambers Tier 2 - Leading Lawyer in 2024 for Transport\u0026gt;Rail and Road: Litigation and Regulation Legal 500 Tier 1-Key Lawyer in 2024 for Dispute Resolution\u0026gt;Product Liability, Mass Tort \u0026amp; Class Actions-Defense: Consumer Products Legal 500 Tier 1-Key Lawyer in 2024 for Dispute Resolution\u0026gt;Product Liability, Mass Tort \u0026amp; Class Actions-Defense: Auto/Transport Legal 500 Named to Chambers 2024 General Commercial Litigation List Chambers Member of 2024 Lawdragon 500 Leading Global Cyber Lawyers Lawdragon Stand-Out Lawyer  Thomson Reuters 2024 Leading Lawyer in 2023 in Transport: Rail and Road, Litigation and Regulatory Legal 500 Recommended Lawyer in 2023 in Product Liability, Mass Tort, and Class Actions: Consumer Products: Defense  Legal 500 Recommended Lawyer in 2022 in Product Liability, Mass Tort, and Class Actions: Consumer Products: Defense Legal 500 Recommended Lawyer in 2022 in Product Liability, Mass Tort, and Class Actions: Auto/Transport: Defense Legal 500 Named to Crain's Chicago Business's 2023 Notable Litigators and Trial Attorneys List Crain's Chicago Business Named to Chicago Lawyer's 2021 Top 50 Women in Law  Chicago Lawyer Named to Crain's Chicago Business's 2020 Notable Women in Law Crain's Chicago Business Leading Lawyer in 2022 in Transport: Rail and Road, Litigation and Regulatory  Legal 500 Named to The Best Lawyers in America for Consumer Law Best Lawyers In America Recognized as a \"Leading Lawyer\" Leading Lawyers Network Named among the “Top Lawyers in Illinois” in Advertising \u0026amp; Media Law and Class Action Mass Tort Defense Law Illinois Super Lawyer University of Illinois  Northwestern University Northwestern Pritzker School of Law Supreme Court of the United States U.S. Court of Appeals for the Second Circuit U.S. Court of Appeals for the Fifth Circuit U.S. Court of Appeals for the Seventh Circuit U.S. Court of Appeals for the Eighth Circuit U.S. Court of Appeals for the Ninth Circuit U.S. District Court for the Eastern District of Michigan U.S. District Court for the Northern District of Illinois U.S. District Court for the Southern District of Illinois U.S. District Court for the Northern District of Indiana U.S. District Court for the Southern District of Indiana U.S. District Court for the Eastern District of Wisconsin U.S. District Court for the Eastern District of Arkansas U.S. District Court for the Western District of Arkansas U.S. District Court for the Central District of California U.S. District Court for the Eastern District of California U.S. District Court for the Northern District of California U.S. District Court for the Southern District of California California Illinois Member, American Bar Association, Litigation Section Member, Illinois State Bar Association Member, The State Bar of California Lead counsel is a proposed class action alleging arsenic in spices caused harm to consumers who purchased the products. Case resolved for de minimis amount after recall implemented. Lead counsel in a series of Safe Drinking Water and Toxic Enforcement Act of 1986 (California's \"Proposition 65\") relating to a variety of allegedly carcinogenic and toxic substances in food and other consumer products. Cases resolved on very favorable terms through informal negotiations. Lead counsel in a proposed class action alleging the engine compartments of certain model vehicles emit noxious and toxic substances into the vehicles' passenger cabins, allegedly rendering the vehicles undrivable and causing vehicle occupants to require medical treatment. Lead counsel in a proposed class action brought under the Telephone Consumer Protection Act (TCPA) seeking more than $600 million in damages as a result of defendant allegedly having sent facsimiles to recipients that purportedly lacked legally-sufficient opt-out notices. Successfully defeated class certification on predominance grounds. Lead counsel in a proposed class action alleging vehicle transmissions are defective; persuaded Court to dismiss the Magnuson Moss Warranty Act claim for failing to name at least 100 named plaintiffs; Court rejected the notion it had jurisdiction over the MMWA claim based on diversity. Lead counsel in a proposed class action alleging violations of state and federal warranty laws brought on behalf of a Wisconsin resident. Liv successfully obtained dismissal of the case on grounds that Illinois lacked sufficient contacts to confer general personal jurisdiction over American Honda. Lead counsel in a proposed class action alleging violations to the Telephone Consumer Protection Act (TCPA) that was successfully resolved on very favorable terms prior to the filing of a responsive pleading. Co-lead counsel in a proposed class action against Toyota Motor Sales U.S.A. alleging excessive oil consumption in certain Toyota vehicles; successfully argued Plaintiff lacked standing; case was dismissed, with costs awarded to Toyota. In a proposed class action brought by Oregon and Washington residents against Ford Motor Co., Inc. in California, successfully argued that the State of California lacked sufficient contacts to assert general personal jurisdiction over Ford. Plaintiffs declined to appeal the district court’s dismissal of Ford. Lead counsel in an MDL consolidating nine consumer class actions filed throughout the U.S. alleging 2015 Honda CR-Vs vibrate excessively. Resolved favorably through a Rule 23(b)(2) settlement where the remedy is to provide “enhanced” notice of pre-existing, effective countermeasures to the relatively few consumers who complained. Lead counsel in a proposed class action alleging an internet advertising service provider breached its service agreements by invoicing allegedly misleading charges; successfully resolved after preliminary motion practice and targeted discovery of plaintiff. Lead counsel in a proposed class action against U.S. automotive distributor and foreign parent alleging the pedal bracket assembly in certain vehicles was defective; Plaintiffs sought to certify classes and subclasses in more than ten states. Resolved on favorable terms after a favorable ruling on a motion to dismiss and targeted discovery of plaintiffs. Lead counsel in a proposed class action alleging Defendants sent unwanted facsimile advertisements to Plaintiff and members of the proposed classes. Defeated class certification by successfully proving Plaintiff and all of its counsel (more than 10 lawyers and 3 law firms) were inadequate.","searchable_name":"Livia M. Kiser (Liv)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":436377,"version":1,"owner_type":"Person","owner_id":2589,"payload":{"bio":"\u003cp\u003eMadison Kitchens specializes in defending product manufacturers in the pharmaceutical, medical device, automotive,\u0026nbsp;consumer goods, and energy industries against class action and mass tort claims brought by plaintiffs across the United States.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMadison is a frequent author and speaker on class actions, complex litigation, and product liability.\u0026nbsp; He is the Co-Editor of the Fifth Edition of\u0026nbsp;\u003cem\u003eThe\u0026nbsp;Product Regulation and Liability\u003c/em\u003e\u0026nbsp;(eds. Varner \u0026amp; Kitchens), which analyzes the landscape of product liability law in 18 countries.\u0026nbsp; Additionally, he has written chapters in numerous practitioner treatises, including the ABA\u0026rsquo;s\u0026nbsp;\u003cem\u003eBusiness \u0026amp; Commercial Litigation in the Federal Courts\u0026nbsp;\u003c/em\u003e(4th ed.)\u0026nbsp;and\u0026nbsp;\u003cem\u003eDrug and Device Product Liability Litigation Strategy\u003c/em\u003e\u0026nbsp;(2d ed.).\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eMadison maintains an active appellate practice in addition to his trial work, and has authored briefs filed in the U.S. Supreme Court, U.S. Courts of Appeals, and state supreme courts.\u0026nbsp; Additionally, Madison has served as an instructor for Emory University School of Law\u0026rsquo;s Trial Advocacy Workshop and as a Barrister in the Bleckley Inn of Court.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eMadison graduated from Duke University,\u0026nbsp;\u003cem\u003emagna cum laude\u003c/em\u003e, in 2004 with a B.A. in Economics.\u0026nbsp; He earned his J.D. from Harvard Law School, with honors, in 2010.\u0026nbsp; While in law school, Madison served as Chief Articles Editor for the\u0026nbsp;\u003cem\u003eHarvard Journal of Law \u0026amp; Public Policy\u003c/em\u003e\u0026nbsp;and was a semifinalist in Harvard\u0026rsquo;s Ames Moot Court competition.\u0026nbsp; After law school, he clerked for the Honorable Frank M. Hull of the U.S. Court of Appeals for the Eleventh Circuit.\u003c/p\u003e","slug":"madison-kitchens","email":"mkitchens@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eKimberly-Clark\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eHalyard Health\u003c/strong\u003e\u0026nbsp;in class action litigation, parallel qui tam suits, government investigations, and a Lanham Act competitor suit challenging the design, labeling and advertising of Class II medical devices.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eSmileDirectClub\u003c/strong\u003e\u0026nbsp;in suit filed against the Georgia Board of Dentistry for alleged antitrust and constitutional violations.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eDaimler AG\u0026nbsp;\u003c/strong\u003eand\u0026nbsp;\u003cstrong\u003eMercedes-Benz USA\u003c/strong\u003e\u0026nbsp;in a putative class action pending in Georgia federal court alleging that the HVAC systems in various Mercedes-Benz vehicles are defective.\u003c/p\u003e","\u003cp\u003eRepresenting an\u0026nbsp;\u003cstrong\u003eSEC university\u003c/strong\u003e\u0026nbsp;in a putative class action pending in an MDL before the Northern District of Illinois that alleges the university failed to protect football players from concussion-related injuries.\u003c/p\u003e","\u003cp\u003eObtained summary judgment on behalf of\u0026nbsp;\u003cstrong\u003eHighstar Capital\u003c/strong\u003e\u0026nbsp;against minority shareholders\u0026rsquo; fraud and aiding and abetting claims arising out of $470 million acquisition.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;an\u0026nbsp;\u003cstrong\u003einternational automotive company\u003c/strong\u003e\u0026nbsp;and obtained final approval of class settlement\u0026nbsp;involving over 9 million class members in\u0026nbsp;\u003cem\u003eIn re: Takata Airbag Products Liability Litigation\u003c/em\u003e, 15-02599-MD-MORENO (S.D. Fla.).\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFord Motor Company\u003c/strong\u003e\u0026nbsp;in putative class actions filed in the Central District of California and Western District of Kentucky.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eObtained dismissal of putative class action at motion to dismiss stage on behalf of\u0026nbsp;\u003cstrong\u003eR.J. Reynolds Vapor Company\u0026nbsp;\u003c/strong\u003ein case alleging that its e-cigarette products exposed users to undisclosed and harmful levels of chemicals, in violation of Proposition 65 and California consumer protection statutes.\u0026nbsp;\u0026nbsp;\u003cem\u003eHarris v. R.J. Reynolds Vapor Co.\u003c/em\u003e, 2017 WL 3617061 (N.D. Cal. Aug. 23, 2017).\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMerck\u0026nbsp;\u003c/strong\u003ein multidistrict litigation involving allegations of injuries from use of the company\u0026rsquo;s osteoporosis medication, including in two bellwether trials in two different MDLs pending in federal courts in New York and New Jersey. \u0026nbsp;In\u0026nbsp;\u003cem\u003eGlynn v. Merck\u003c/em\u003e, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption.\u003c/p\u003e","\u003cp\u003eDefeated two proposed consumer class actions claiming that\u0026nbsp;\u003cstrong\u003eDaimler AG and Mercedes-Benz USA\u0026nbsp;\u003c/strong\u003ehad defrauded Mercedes E-Class owners in California, Texas, Florida, Georgia, New Jersey, Illinois, and Virginia by failing to disclose alleged defects in their fuel systems.\u0026nbsp;\u0026nbsp;\u003cem\u003eMcCabe v. Daimler AG\u003c/em\u003e, 160 F. Supp. 3d 1337 (N.D. Ga. 2015);\u0026nbsp;\u003cem\u003eBarinova v. Daimler AG, et al.\u003c/em\u003e, 2:14-cv-07684 (D. N.J. Apr. 21, 2015).\u003c/p\u003e","\u003cp\u003eDefeated class certification motion on behalf of\u0026nbsp;\u003cstrong\u003eHalliburton\u0026nbsp;\u003c/strong\u003ein class action and mass joinder cases in Oklahoma federal court brought by hundreds of plaintiffs alleging personal injuries and/or property damage from exposure to ammonium perchlorate.\u0026nbsp;\u0026nbsp;\u003cem\u003eMcCormick v. Halliburton Energy Servs., Inc.\u003c/em\u003e, 2015 WL 918767 (W.D. Okla. Mar. 3, 2015).\u003c/p\u003e","\u003cp\u003eDefeated expedited motion for preliminary injunction in Texas federal court seeking to require\u0026nbsp;\u003cstrong\u003eGeneral Motors\u003c/strong\u003e\u0026nbsp;to issue a nationwide \u0026ldquo;Park It Now\u0026rdquo; notice in connection with the GM ignition switch recall litigation.\u0026nbsp;\u0026nbsp;\u003cem\u003eSilvas v. Gen. Motors\u003c/em\u003e, LLC, 2014 WL 1572590 (S.D. Tex. Apr. 17, 2014).\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eKimberly-Clark\u003c/strong\u003e\u0026nbsp;in putative class actions in New York and California federal courts challenging the labeling and advertising of FDA-regulated products under state consumer protection laws and the FTC\u0026rsquo;s Green Guides.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ePurdue Pharma\u003c/strong\u003e\u0026nbsp;in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company\u0026rsquo;s marketing and promotion of its prescription pain medication.\u003c/p\u003e","\u003cp\u003eObtained dismissal of medical monitoring claims in groundwater contamination mass joinder cases in Oklahoma federal court.\u0026nbsp;\u0026nbsp;\u003cem\u003eMcCormick v. Halliburton Co.\u003c/em\u003e, 895 F. Supp. 2d 1152 (W.D. Okla. 2012).\u0026nbsp;\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":3,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":4,"source":"capabilities"},{"id":764,"guid":"764.smart_tags","index":5,"source":"smartTags"},{"id":1256,"guid":"1256.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Kitchens","nick_name":"Madison","clerkships":[{"name":"Law Clerk, Hon. Frank M. Hull, U.S. Court of Appeals for the Eleventh Circuit","years_held":"2010-2011"}],"first_name":"Madison","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"H.","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/madison-kitchens-8ab3a0147/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eMadison Kitchens specializes in defending product manufacturers in the pharmaceutical, medical device, automotive,\u0026nbsp;consumer goods, and energy industries against class action and mass tort claims brought by plaintiffs across the United States.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eMadison is a frequent author and speaker on class actions, complex litigation, and product liability.\u0026nbsp; He is the Co-Editor of the Fifth Edition of\u0026nbsp;\u003cem\u003eThe\u0026nbsp;Product Regulation and Liability\u003c/em\u003e\u0026nbsp;(eds. Varner \u0026amp; Kitchens), which analyzes the landscape of product liability law in 18 countries.\u0026nbsp; Additionally, he has written chapters in numerous practitioner treatises, including the ABA\u0026rsquo;s\u0026nbsp;\u003cem\u003eBusiness \u0026amp; Commercial Litigation in the Federal Courts\u0026nbsp;\u003c/em\u003e(4th ed.)\u0026nbsp;and\u0026nbsp;\u003cem\u003eDrug and Device Product Liability Litigation Strategy\u003c/em\u003e\u0026nbsp;(2d ed.).\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eMadison maintains an active appellate practice in addition to his trial work, and has authored briefs filed in the U.S. Supreme Court, U.S. Courts of Appeals, and state supreme courts.\u0026nbsp; Additionally, Madison has served as an instructor for Emory University School of Law\u0026rsquo;s Trial Advocacy Workshop and as a Barrister in the Bleckley Inn of Court.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eMadison graduated from Duke University,\u0026nbsp;\u003cem\u003emagna cum laude\u003c/em\u003e, in 2004 with a B.A. in Economics.\u0026nbsp; He earned his J.D. from Harvard Law School, with honors, in 2010.\u0026nbsp; While in law school, Madison served as Chief Articles Editor for the\u0026nbsp;\u003cem\u003eHarvard Journal of Law \u0026amp; Public Policy\u003c/em\u003e\u0026nbsp;and was a semifinalist in Harvard\u0026rsquo;s Ames Moot Court competition.\u0026nbsp; After law school, he clerked for the Honorable Frank M. Hull of the U.S. Court of Appeals for the Eleventh Circuit.\u003c/p\u003e","matters":["\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eKimberly-Clark\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eHalyard Health\u003c/strong\u003e\u0026nbsp;in class action litigation, parallel qui tam suits, government investigations, and a Lanham Act competitor suit challenging the design, labeling and advertising of Class II medical devices.\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eSmileDirectClub\u003c/strong\u003e\u0026nbsp;in suit filed against the Georgia Board of Dentistry for alleged antitrust and constitutional violations.\u0026nbsp;\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresenting\u0026nbsp;\u003cstrong\u003eDaimler AG\u0026nbsp;\u003c/strong\u003eand\u0026nbsp;\u003cstrong\u003eMercedes-Benz USA\u003c/strong\u003e\u0026nbsp;in a putative class action pending in Georgia federal court alleging that the HVAC systems in various Mercedes-Benz vehicles are defective.\u003c/p\u003e","\u003cp\u003eRepresenting an\u0026nbsp;\u003cstrong\u003eSEC university\u003c/strong\u003e\u0026nbsp;in a putative class action pending in an MDL before the Northern District of Illinois that alleges the university failed to protect football players from concussion-related injuries.\u003c/p\u003e","\u003cp\u003eObtained summary judgment on behalf of\u0026nbsp;\u003cstrong\u003eHighstar Capital\u003c/strong\u003e\u0026nbsp;against minority shareholders\u0026rsquo; fraud and aiding and abetting claims arising out of $470 million acquisition.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;an\u0026nbsp;\u003cstrong\u003einternational automotive company\u003c/strong\u003e\u0026nbsp;and obtained final approval of class settlement\u0026nbsp;involving over 9 million class members in\u0026nbsp;\u003cem\u003eIn re: Takata Airbag Products Liability Litigation\u003c/em\u003e, 15-02599-MD-MORENO (S.D. Fla.).\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eFord Motor Company\u003c/strong\u003e\u0026nbsp;in putative class actions filed in the Central District of California and Western District of Kentucky.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eObtained dismissal of putative class action at motion to dismiss stage on behalf of\u0026nbsp;\u003cstrong\u003eR.J. Reynolds Vapor Company\u0026nbsp;\u003c/strong\u003ein case alleging that its e-cigarette products exposed users to undisclosed and harmful levels of chemicals, in violation of Proposition 65 and California consumer protection statutes.\u0026nbsp;\u0026nbsp;\u003cem\u003eHarris v. R.J. Reynolds Vapor Co.\u003c/em\u003e, 2017 WL 3617061 (N.D. Cal. Aug. 23, 2017).\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMerck\u0026nbsp;\u003c/strong\u003ein multidistrict litigation involving allegations of injuries from use of the company\u0026rsquo;s osteoporosis medication, including in two bellwether trials in two different MDLs pending in federal courts in New York and New Jersey. \u0026nbsp;In\u0026nbsp;\u003cem\u003eGlynn v. Merck\u003c/em\u003e, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption.\u003c/p\u003e","\u003cp\u003eDefeated two proposed consumer class actions claiming that\u0026nbsp;\u003cstrong\u003eDaimler AG and Mercedes-Benz USA\u0026nbsp;\u003c/strong\u003ehad defrauded Mercedes E-Class owners in California, Texas, Florida, Georgia, New Jersey, Illinois, and Virginia by failing to disclose alleged defects in their fuel systems.\u0026nbsp;\u0026nbsp;\u003cem\u003eMcCabe v. Daimler AG\u003c/em\u003e, 160 F. Supp. 3d 1337 (N.D. Ga. 2015);\u0026nbsp;\u003cem\u003eBarinova v. Daimler AG, et al.\u003c/em\u003e, 2:14-cv-07684 (D. N.J. Apr. 21, 2015).\u003c/p\u003e","\u003cp\u003eDefeated class certification motion on behalf of\u0026nbsp;\u003cstrong\u003eHalliburton\u0026nbsp;\u003c/strong\u003ein class action and mass joinder cases in Oklahoma federal court brought by hundreds of plaintiffs alleging personal injuries and/or property damage from exposure to ammonium perchlorate.\u0026nbsp;\u0026nbsp;\u003cem\u003eMcCormick v. Halliburton Energy Servs., Inc.\u003c/em\u003e, 2015 WL 918767 (W.D. Okla. Mar. 3, 2015).\u003c/p\u003e","\u003cp\u003eDefeated expedited motion for preliminary injunction in Texas federal court seeking to require\u0026nbsp;\u003cstrong\u003eGeneral Motors\u003c/strong\u003e\u0026nbsp;to issue a nationwide \u0026ldquo;Park It Now\u0026rdquo; notice in connection with the GM ignition switch recall litigation.\u0026nbsp;\u0026nbsp;\u003cem\u003eSilvas v. Gen. Motors\u003c/em\u003e, LLC, 2014 WL 1572590 (S.D. Tex. Apr. 17, 2014).\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eKimberly-Clark\u003c/strong\u003e\u0026nbsp;in putative class actions in New York and California federal courts challenging the labeling and advertising of FDA-regulated products under state consumer protection laws and the FTC\u0026rsquo;s Green Guides.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003ePurdue Pharma\u003c/strong\u003e\u0026nbsp;in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company\u0026rsquo;s marketing and promotion of its prescription pain medication.\u003c/p\u003e","\u003cp\u003eObtained dismissal of medical monitoring claims in groundwater contamination mass joinder cases in Oklahoma federal court.\u0026nbsp;\u0026nbsp;\u003cem\u003eMcCormick v. Halliburton Co.\u003c/em\u003e, 895 F. Supp. 2d 1152 (W.D. Okla. 2012).\u0026nbsp;\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12349}]},"capability_group_id":3},"created_at":"2025-09-02T04:51:10.000Z","updated_at":"2025-09-02T04:51:10.000Z","searchable_text":"Kitchens{{ FIELD }}Representing Kimberly-Clark and Halyard Health in class action litigation, parallel qui tam suits, government investigations, and a Lanham Act competitor suit challenging the design, labeling and advertising of Class II medical devices.{{ FIELD }}Representing SmileDirectClub in suit filed against the Georgia Board of Dentistry for alleged antitrust and constitutional violations.  {{ FIELD }}Representing Daimler AG and Mercedes-Benz USA in a putative class action pending in Georgia federal court alleging that the HVAC systems in various Mercedes-Benz vehicles are defective.{{ FIELD }}Representing an SEC university in a putative class action pending in an MDL before the Northern District of Illinois that alleges the university failed to protect football players from concussion-related injuries.{{ FIELD }}Obtained summary judgment on behalf of Highstar Capital against minority shareholders’ fraud and aiding and abetting claims arising out of $470 million acquisition. {{ FIELD }}Represented an international automotive company and obtained final approval of class settlement involving over 9 million class members in In re: Takata Airbag Products Liability Litigation, 15-02599-MD-MORENO (S.D. Fla.).{{ FIELD }}Represented Ford Motor Company in putative class actions filed in the Central District of California and Western District of Kentucky. {{ FIELD }}Obtained dismissal of putative class action at motion to dismiss stage on behalf of R.J. Reynolds Vapor Company in case alleging that its e-cigarette products exposed users to undisclosed and harmful levels of chemicals, in violation of Proposition 65 and California consumer protection statutes.  Harris v. R.J. Reynolds Vapor Co., 2017 WL 3617061 (N.D. Cal. Aug. 23, 2017). {{ FIELD }}Represented Merck in multidistrict litigation involving allegations of injuries from use of the company’s osteoporosis medication, including in two bellwether trials in two different MDLs pending in federal courts in New York and New Jersey.  In Glynn v. Merck, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption.{{ FIELD }}Defeated two proposed consumer class actions claiming that Daimler AG and Mercedes-Benz USA had defrauded Mercedes E-Class owners in California, Texas, Florida, Georgia, New Jersey, Illinois, and Virginia by failing to disclose alleged defects in their fuel systems.  McCabe v. Daimler AG, 160 F. Supp. 3d 1337 (N.D. Ga. 2015); Barinova v. Daimler AG, et al., 2:14-cv-07684 (D. N.J. Apr. 21, 2015).{{ FIELD }}Defeated class certification motion on behalf of Halliburton in class action and mass joinder cases in Oklahoma federal court brought by hundreds of plaintiffs alleging personal injuries and/or property damage from exposure to ammonium perchlorate.  McCormick v. Halliburton Energy Servs., Inc., 2015 WL 918767 (W.D. Okla. Mar. 3, 2015).{{ FIELD }}Defeated expedited motion for preliminary injunction in Texas federal court seeking to require General Motors to issue a nationwide “Park It Now” notice in connection with the GM ignition switch recall litigation.  Silvas v. Gen. Motors, LLC, 2014 WL 1572590 (S.D. Tex. Apr. 17, 2014). {{ FIELD }}Represented Kimberly-Clark in putative class actions in New York and California federal courts challenging the labeling and advertising of FDA-regulated products under state consumer protection laws and the FTC’s Green Guides.{{ FIELD }}Represented Purdue Pharma in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company’s marketing and promotion of its prescription pain medication.{{ FIELD }}Obtained dismissal of medical monitoring claims in groundwater contamination mass joinder cases in Oklahoma federal court.  McCormick v. Halliburton Co., 895 F. Supp. 2d 1152 (W.D. Okla. 2012). {{ FIELD }}Madison Kitchens specializes in defending product manufacturers in the pharmaceutical, medical device, automotive, consumer goods, and energy industries against class action and mass tort claims brought by plaintiffs across the United States.\nMadison is a frequent author and speaker on class actions, complex litigation, and product liability.  He is the Co-Editor of the Fifth Edition of The Product Regulation and Liability (eds. Varner \u0026amp; Kitchens), which analyzes the landscape of product liability law in 18 countries.  Additionally, he has written chapters in numerous practitioner treatises, including the ABA’s Business \u0026amp; Commercial Litigation in the Federal Courts (4th ed.) and Drug and Device Product Liability Litigation Strategy (2d ed.). \nMadison maintains an active appellate practice in addition to his trial work, and has authored briefs filed in the U.S. Supreme Court, U.S. Courts of Appeals, and state supreme courts.  Additionally, Madison has served as an instructor for Emory University School of Law’s Trial Advocacy Workshop and as a Barrister in the Bleckley Inn of Court. \nMadison graduated from Duke University, magna cum laude, in 2004 with a B.A. in Economics.  He earned his J.D. from Harvard Law School, with honors, in 2010.  While in law school, Madison served as Chief Articles Editor for the Harvard Journal of Law \u0026amp; Public Policy and was a semifinalist in Harvard’s Ames Moot Court competition.  After law school, he clerked for the Honorable Frank M. Hull of the U.S. Court of Appeals for the Eleventh Circuit. Partner Duke University Duke University School of Law Harvard University Harvard Law School U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Ninth Circuit U.S. Court of Appeals for the Eleventh Circuit U.S. District Court for the Northern District of Georgia Georgia Court of Appeals of Georgia Supreme Court of Georgia Georgia Defense Lawyers Association Defense Research Institute (DRI) Executive Board, Federalist Society -- Atlanta Lawyers Chapter Law Clerk, Hon. Frank M. Hull, U.S. Court of Appeals for the Eleventh Circuit Representing Kimberly-Clark and Halyard Health in class action litigation, parallel qui tam suits, government investigations, and a Lanham Act competitor suit challenging the design, labeling and advertising of Class II medical devices. Representing SmileDirectClub in suit filed against the Georgia Board of Dentistry for alleged antitrust and constitutional violations.   Representing Daimler AG and Mercedes-Benz USA in a putative class action pending in Georgia federal court alleging that the HVAC systems in various Mercedes-Benz vehicles are defective. Representing an SEC university in a putative class action pending in an MDL before the Northern District of Illinois that alleges the university failed to protect football players from concussion-related injuries. Obtained summary judgment on behalf of Highstar Capital against minority shareholders’ fraud and aiding and abetting claims arising out of $470 million acquisition.  Represented an international automotive company and obtained final approval of class settlement involving over 9 million class members in In re: Takata Airbag Products Liability Litigation, 15-02599-MD-MORENO (S.D. Fla.). Represented Ford Motor Company in putative class actions filed in the Central District of California and Western District of Kentucky.  Obtained dismissal of putative class action at motion to dismiss stage on behalf of R.J. Reynolds Vapor Company in case alleging that its e-cigarette products exposed users to undisclosed and harmful levels of chemicals, in violation of Proposition 65 and California consumer protection statutes.  Harris v. R.J. Reynolds Vapor Co., 2017 WL 3617061 (N.D. Cal. Aug. 23, 2017).  Represented Merck in multidistrict litigation involving allegations of injuries from use of the company’s osteoporosis medication, including in two bellwether trials in two different MDLs pending in federal courts in New York and New Jersey.  In Glynn v. Merck, the jury returned a complete defense verdict, after which the court granted judgment based on federal preemption. Defeated two proposed consumer class actions claiming that Daimler AG and Mercedes-Benz USA had defrauded Mercedes E-Class owners in California, Texas, Florida, Georgia, New Jersey, Illinois, and Virginia by failing to disclose alleged defects in their fuel systems.  McCabe v. Daimler AG, 160 F. Supp. 3d 1337 (N.D. Ga. 2015); Barinova v. Daimler AG, et al., 2:14-cv-07684 (D. N.J. Apr. 21, 2015). Defeated class certification motion on behalf of Halliburton in class action and mass joinder cases in Oklahoma federal court brought by hundreds of plaintiffs alleging personal injuries and/or property damage from exposure to ammonium perchlorate.  McCormick v. Halliburton Energy Servs., Inc., 2015 WL 918767 (W.D. Okla. Mar. 3, 2015). Defeated expedited motion for preliminary injunction in Texas federal court seeking to require General Motors to issue a nationwide “Park It Now” notice in connection with the GM ignition switch recall litigation.  Silvas v. Gen. Motors, LLC, 2014 WL 1572590 (S.D. Tex. Apr. 17, 2014).  Represented Kimberly-Clark in putative class actions in New York and California federal courts challenging the labeling and advertising of FDA-regulated products under state consumer protection laws and the FTC’s Green Guides. Represented Purdue Pharma in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company’s marketing and promotion of its prescription pain medication. Obtained dismissal of medical monitoring claims in groundwater contamination mass joinder cases in Oklahoma federal court.  McCormick v. Halliburton Co., 895 F. Supp. 2d 1152 (W.D. Okla. 2012). ","searchable_name":"Madison H. Kitchens","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":428596,"version":1,"owner_type":"Person","owner_id":6838,"payload":{"bio":"\u003cp\u003eJohn Kleinjan focuses on executive compensation and employee benefits arrangements \u0026ndash; including their related tax, accounting, securities and corporate governance aspects \u0026ndash; particularly as they relate to public and private M\u0026amp;A deals, initial public offerings, corporate restructurings and other corporate transactions. John has advised on numerous transactions and has extensive experience in negotiating acquisition agreements and transaction-related executive employment and equity incentive arrangements (including rollover equity, profits interests and stock options). He also advises on Section 280G golden parachute matters that arise as a result of transactions, including guiding private companies through the shareholder cleansing vote process.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJohn also represents public and private companies, boards of directors and individual executives in the design and negotiation of employment and separation agreements, equity and cash incentive arrangements, severance arrangements, deferred compensation arrangements, change in control related arrangements, and other compensation and benefits arrangements.\u003c/p\u003e","slug":"john-kleinjan","email":"jkleinjan@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":28,"guid":"28.capabilities","index":0,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":1,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":2,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":3,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":4,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"}],"is_active":true,"last_name":"Kleinjan","nick_name":"John","clerkships":[],"first_name":"John","title_rank":9999,"updated_by":202,"law_schools":[{"id":659,"meta":{"degree":"J.D.","honors":"with honors","is_law_school":"1","graduation_date":"2016-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJohn Kleinjan focuses on executive compensation and employee benefits arrangements \u0026ndash; including their related tax, accounting, securities and corporate governance aspects \u0026ndash; particularly as they relate to public and private M\u0026amp;A deals, initial public offerings, corporate restructurings and other corporate transactions. John has advised on numerous transactions and has extensive experience in negotiating acquisition agreements and transaction-related executive employment and equity incentive arrangements (including rollover equity, profits interests and stock options). He also advises on Section 280G golden parachute matters that arise as a result of transactions, including guiding private companies through the shareholder cleansing vote process.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJohn also represents public and private companies, boards of directors and individual executives in the design and negotiation of employment and separation agreements, equity and cash incentive arrangements, severance arrangements, deferred compensation arrangements, change in control related arrangements, and other compensation and benefits arrangements.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12084}]},"capability_group_id":1},"created_at":"2025-06-03T16:47:17.000Z","updated_at":"2025-06-03T16:47:17.000Z","searchable_text":"Kleinjan{{ FIELD }}John Kleinjan focuses on executive compensation and employee benefits arrangements – including their related tax, accounting, securities and corporate governance aspects – particularly as they relate to public and private M\u0026amp;A deals, initial public offerings, corporate restructurings and other corporate transactions. John has advised on numerous transactions and has extensive experience in negotiating acquisition agreements and transaction-related executive employment and equity incentive arrangements (including rollover equity, profits interests and stock options). He also advises on Section 280G golden parachute matters that arise as a result of transactions, including guiding private companies through the shareholder cleansing vote process. \nJohn also represents public and private companies, boards of directors and individual executives in the design and negotiation of employment and separation agreements, equity and cash incentive arrangements, severance arrangements, deferred compensation arrangements, change in control related arrangements, and other compensation and benefits arrangements. Partner Florida State University Florida State University College of Law Emory University Emory University School of Law Georgia New York","searchable_name":"John Kleinjan","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":440298,"version":1,"owner_type":"Person","owner_id":2100,"payload":{"bio":"\u003cp\u003eAmanda Klingler is a partner in the firm\u0026rsquo;s Washington, D.C. and Chicago offices with extensive experience advising life science clients.\u0026nbsp; As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.\u0026nbsp; Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.\u0026nbsp; She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.\u0026nbsp;\u0026nbsp;Amanda, as a co-leader of the firm\u0026rsquo;s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmanda advises clients during internal and government investigations.\u0026nbsp; She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\u003c/p\u003e\n\u003cp\u003eAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\u003c/p\u003e\n\u003cp\u003eAmanda also has significant experience and expertise in FDA's regulation of tobacco products.\u003c/p\u003e","slug":"amanda-klingler","email":"aklingler@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cem\u003ePhillips Morris USA v. FDA,\u0026nbsp;\u003c/em\u003e202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eproduct liability litigation\u003c/strong\u003einvolving GlaxoSmithKline\u0026rsquo;s antidepressant Paxil\u0026reg;, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003ein limine\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eDaubert\u003c/em\u003echallenges.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team representing the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u0026nbsp;\u003c/strong\u003ein nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a\u0026nbsp;\u003cem\u003equi tam\u0026nbsp;\u003c/em\u003esuit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecompanies in preparing for FDA inspections,\u003c/strong\u003e\u0026nbsp;developing responses to FDA investigational observations (FDA-483 forms), and warning letters.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e\u0026nbsp;under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong\u003einternal investigations of pharmaceutical medical device manufacturers\u003c/strong\u003e\u0026nbsp;into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFDA regulatory due diligence reviews\u003c/strong\u003e\u0026nbsp;of target medical device, pharmaceutical manufacturers, and compounding pharmacies.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eradiation-emitting product requirements\u003c/strong\u003e\u0026nbsp;under the FDCA.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003elabeling and promotion requirements\u003c/strong\u003e\u0026nbsp;for FDA-regulated products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. Franck\u0026rsquo;s Lab\u003c/em\u003e, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFranck\u0026rsquo;s Lab\u003c/strong\u003e\u0026nbsp;in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA\u0026rsquo;s statute. Also served as the lead associate for Franck\u0026rsquo;s Lab in other FDA regulatory and state board of pharmacy matters.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eHill Dermaceuticals, Inc. v.\u003c/em\u003e\u0026nbsp;FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einnovator drug manufacturer\u003c/strong\u003e\u0026nbsp;in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer\u0026rsquo;s brand name products.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":174}]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":2,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":3,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":4,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":5,"source":"capabilities"},{"id":1199,"guid":"1199.smart_tags","index":6,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":7,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":8,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":9,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":10,"source":"capabilities"},{"id":1206,"guid":"1206.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Klingler","nick_name":"Amanda","clerkships":[],"first_name":"Amanda","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAmanda Klingler is a partner in the firm\u0026rsquo;s Washington, D.C. and Chicago offices with extensive experience advising life science clients.\u0026nbsp; As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.\u0026nbsp; Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.\u0026nbsp; She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.\u0026nbsp;\u0026nbsp;Amanda, as a co-leader of the firm\u0026rsquo;s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmanda advises clients during internal and government investigations.\u0026nbsp; She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\u003c/p\u003e\n\u003cp\u003eAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\u003c/p\u003e\n\u003cp\u003eAmanda also has significant experience and expertise in FDA's regulation of tobacco products.\u003c/p\u003e","matters":["\u003cp\u003e\u003cem\u003ePhillips Morris USA v. FDA,\u0026nbsp;\u003c/em\u003e202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eproduct liability litigation\u003c/strong\u003einvolving GlaxoSmithKline\u0026rsquo;s antidepressant Paxil\u0026reg;, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003ein limine\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eDaubert\u003c/em\u003echallenges.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team representing the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u0026nbsp;\u003c/strong\u003ein nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a\u0026nbsp;\u003cem\u003equi tam\u0026nbsp;\u003c/em\u003esuit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecompanies in preparing for FDA inspections,\u003c/strong\u003e\u0026nbsp;developing responses to FDA investigational observations (FDA-483 forms), and warning letters.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e\u0026nbsp;under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong\u003einternal investigations of pharmaceutical medical device manufacturers\u003c/strong\u003e\u0026nbsp;into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFDA regulatory due diligence reviews\u003c/strong\u003e\u0026nbsp;of target medical device, pharmaceutical manufacturers, and compounding pharmacies.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eradiation-emitting product requirements\u003c/strong\u003e\u0026nbsp;under the FDCA.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003elabeling and promotion requirements\u003c/strong\u003e\u0026nbsp;for FDA-regulated products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. Franck\u0026rsquo;s Lab\u003c/em\u003e, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFranck\u0026rsquo;s Lab\u003c/strong\u003e\u0026nbsp;in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA\u0026rsquo;s statute. Also served as the lead associate for Franck\u0026rsquo;s Lab in other FDA regulatory and state board of pharmacy matters.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eHill Dermaceuticals, Inc. v.\u003c/em\u003e\u0026nbsp;FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einnovator drug manufacturer\u003c/strong\u003e\u0026nbsp;in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer\u0026rsquo;s brand name products.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4350}]},"capability_group_id":2},"created_at":"2025-10-08T19:11:18.000Z","updated_at":"2025-10-08T19:11:18.000Z","searchable_text":"Klingler{{ FIELD }}Phillips Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.{{ FIELD }}Member of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in product liability litigationinvolving GlaxoSmithKline’s antidepressant Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions in limine and Daubertchallenges.{{ FIELD }}Member of a King \u0026amp; Spalding team representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.{{ FIELD }}Assisted companies in preparing for FDA inspections, developing responses to FDA investigational observations (FDA-483 forms), and warning letters.{{ FIELD }}Assisted pharmaceutical and medical device companies under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.{{ FIELD }}Conducted internal investigations of pharmaceutical medical device manufacturers into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.{{ FIELD }}Conducted FDA regulatory due diligence reviews of target medical device, pharmaceutical manufacturers, and compounding pharmacies.{{ FIELD }}Counseled companies on radiation-emitting product requirements under the FDCA.{{ FIELD }}Counseled companies on labeling and promotion requirements for FDA-regulated products.{{ FIELD }}United States v. Franck’s Lab, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for Franck’s Lab in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA’s statute. Also served as the lead associate for Franck’s Lab in other FDA regulatory and state board of pharmacy matters.{{ FIELD }}Hill Dermaceuticals, Inc. v. FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing innovator drug manufacturer in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer’s brand name products.{{ FIELD }}Amanda Klingler is a partner in the firm’s Washington, D.C. and Chicago offices with extensive experience advising life science clients.  As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling. \nAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.  Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.  She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.  Amanda, as a co-leader of the firm’s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products. \nAmanda advises clients during internal and government investigations.  She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\nAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\nAmanda also has significant experience and expertise in FDA's regulation of tobacco products. Amanda J Klingler Partner University of Richmond University of Richmond School of Law Saint Louis University Saint Louis University School of Law Loyola University Chicago Loyola University Chicago School of Law District of Columbia Illinois Phillips Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products. Member of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in product liability litigationinvolving GlaxoSmithKline’s antidepressant Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions in limine and Daubertchallenges. Member of a King \u0026amp; Spalding team representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony. Assisted companies in preparing for FDA inspections, developing responses to FDA investigational observations (FDA-483 forms), and warning letters. Assisted pharmaceutical and medical device companies under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA. Conducted internal investigations of pharmaceutical medical device manufacturers into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure. Conducted FDA regulatory due diligence reviews of target medical device, pharmaceutical manufacturers, and compounding pharmacies. Counseled companies on radiation-emitting product requirements under the FDCA. Counseled companies on labeling and promotion requirements for FDA-regulated products. United States v. Franck’s Lab, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for Franck’s Lab in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA’s statute. Also served as the lead associate for Franck’s Lab in other FDA regulatory and state board of pharmacy matters. Hill Dermaceuticals, Inc. v. FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing innovator drug manufacturer in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer’s brand name products.","searchable_name":"Amanda J. Klingler","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":443942,"version":1,"owner_type":"Person","owner_id":6678,"payload":{"bio":"\u003cp\u003eDavid H. Kupfer is a trial lawyer with extensive experience litigating complex commercial disputes and representing plaintiffs and defendants in civil and criminal matters and regulatory investigations. David has represented real estate and hospitality developers, lenders, and operators, financial institutions, life sciences, and technology firms, and venture and private equity funds in bankruptcy, state and federal courts, as well as in arbitration. He has also represented creditors in complex restructuring proceedings including the restructurings of Mallinckrodt Pharmaceuticals, JCPenney, and Claire\u0026rsquo;s.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDavid devotes significant time to pro bono work, and regularly represents low-income clients in fair housing and felony criminal matters.\u003c/p\u003e\n\u003cp\u003eDavid clerked for the Honorable Henry B. Pitman, U.S. District Court for the Southern District of New York.\u003c/p\u003e","slug":"david-kupfer","email":"dkupfer@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresenting Bath Club Entertainment and developer R. Donahue Peebles in actions against members of a neighboring condominium association and others \u0026ldquo;determined to interfere with the successful management of the historic Bath Club on Miami Beach.\u0026rdquo;\u003c/p\u003e","\u003cp\u003eRepresented private-equity magnate David Storper in several actions against Wilbur Ross and WL Ross \u0026amp; Co. involving breach of contract and breach of fiduciary duties related to WL Ross\u0026rsquo;s flagship private equity funds.\u003c/p\u003e","\u003cp\u003eRepresented AIB Group in an action against its prime broker, related to a five-year, $700 million foreign-exchange fraud.\u003c/p\u003e","\u003cp\u003eRepresented JPMorgan Chase in numerous actions in state and federal court related to mortgage-backed securities.\u003c/p\u003e","\u003cp\u003eRepresented Moody\u0026rsquo;s in a Department of Justice investigation.\u003c/p\u003e","\u003cp\u003eRepresented Fidelity National Financial\u0026rsquo;s Black Knight Unit in a securities opt-out action brought by Maverick Funds.\u003c/p\u003e","\u003cp\u003eRepresented Newlink Genetics in a 10b-5 class action related to a failed drug trial.\u003c/p\u003e","\u003cp\u003eRepresented ChromaDex in multiple actions in federal court against Elysium Health, related to false advertising, trade libel, and deceptive practices.\u003c/p\u003e","\u003cp\u003eRepresented Olo in a contract dispute with DoorDash.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Talc Creditors II in bankruptcy proceedings of LTL Management related to mass torts by Johnson \u0026amp; Johnson.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Unsecured Creditors in bankruptcy proceeding of pharmaceutical giant Mallinckrodt.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Unsecured Creditors in bankruptcy proceeding of JCPenney.\u003c/p\u003e","\u003cp\u003eRepresented liquidating trustee in fiduciary duty action against founders of Fuhu.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Unsecured Creditors in bankruptcy proceeding of Videology.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Unsecured Creditors in bankruptcy proceeding of Claire\u0026rsquo;s.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":38,"guid":"38.capabilities","index":1,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":2,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":3,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":36,"guid":"36.capabilities","index":7,"source":"capabilities"},{"id":1064,"guid":"1064.smart_tags","index":8,"source":"smartTags"}],"is_active":true,"last_name":"Kupfer","nick_name":"David","clerkships":[{"name":"Law Clerk, Honorable Henry B. Pitman, U.S. District Court for the Southern District of New York","years_held":"2011 - 2012"}],"first_name":"David","title_rank":9999,"updated_by":35,"law_schools":[{"id":722,"meta":{"degree":"J.D.","honors":"summa cum laude, Order of the Coif","is_law_school":"1","graduation_date":"2011-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Named a Rising Star","detail":"Super Lawyers, 2020-2023"}],"linked_in_url":"https://www.linkedin.com/in/david-kupfer-08710134/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDavid H. Kupfer is a trial lawyer with extensive experience litigating complex commercial disputes and representing plaintiffs and defendants in civil and criminal matters and regulatory investigations. David has represented real estate and hospitality developers, lenders, and operators, financial institutions, life sciences, and technology firms, and venture and private equity funds in bankruptcy, state and federal courts, as well as in arbitration. He has also represented creditors in complex restructuring proceedings including the restructurings of Mallinckrodt Pharmaceuticals, JCPenney, and Claire\u0026rsquo;s.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eDavid devotes significant time to pro bono work, and regularly represents low-income clients in fair housing and felony criminal matters.\u003c/p\u003e\n\u003cp\u003eDavid clerked for the Honorable Henry B. Pitman, U.S. District Court for the Southern District of New York.\u003c/p\u003e","matters":["\u003cp\u003eRepresenting Bath Club Entertainment and developer R. Donahue Peebles in actions against members of a neighboring condominium association and others \u0026ldquo;determined to interfere with the successful management of the historic Bath Club on Miami Beach.\u0026rdquo;\u003c/p\u003e","\u003cp\u003eRepresented private-equity magnate David Storper in several actions against Wilbur Ross and WL Ross \u0026amp; Co. involving breach of contract and breach of fiduciary duties related to WL Ross\u0026rsquo;s flagship private equity funds.\u003c/p\u003e","\u003cp\u003eRepresented AIB Group in an action against its prime broker, related to a five-year, $700 million foreign-exchange fraud.\u003c/p\u003e","\u003cp\u003eRepresented JPMorgan Chase in numerous actions in state and federal court related to mortgage-backed securities.\u003c/p\u003e","\u003cp\u003eRepresented Moody\u0026rsquo;s in a Department of Justice investigation.\u003c/p\u003e","\u003cp\u003eRepresented Fidelity National Financial\u0026rsquo;s Black Knight Unit in a securities opt-out action brought by Maverick Funds.\u003c/p\u003e","\u003cp\u003eRepresented Newlink Genetics in a 10b-5 class action related to a failed drug trial.\u003c/p\u003e","\u003cp\u003eRepresented ChromaDex in multiple actions in federal court against Elysium Health, related to false advertising, trade libel, and deceptive practices.\u003c/p\u003e","\u003cp\u003eRepresented Olo in a contract dispute with DoorDash.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Talc Creditors II in bankruptcy proceedings of LTL Management related to mass torts by Johnson \u0026amp; Johnson.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Unsecured Creditors in bankruptcy proceeding of pharmaceutical giant Mallinckrodt.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Unsecured Creditors in bankruptcy proceeding of JCPenney.\u003c/p\u003e","\u003cp\u003eRepresented liquidating trustee in fiduciary duty action against founders of Fuhu.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Unsecured Creditors in bankruptcy proceeding of Videology.\u003c/p\u003e","\u003cp\u003eRepresented the Official Committee of Unsecured Creditors in bankruptcy proceeding of Claire\u0026rsquo;s.\u003c/p\u003e"],"recognitions":[{"title":"Named a Rising Star","detail":"Super Lawyers, 2020-2023"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11629}]},"capability_group_id":3},"created_at":"2025-12-05T05:01:42.000Z","updated_at":"2025-12-05T05:01:42.000Z","searchable_text":"Kupfer{{ FIELD }}{:title=\u0026gt;\"Named a Rising Star\", :detail=\u0026gt;\"Super Lawyers, 2020-2023\"}{{ FIELD }}Representing Bath Club Entertainment and developer R. Donahue Peebles in actions against members of a neighboring condominium association and others “determined to interfere with the successful management of the historic Bath Club on Miami Beach.”{{ FIELD }}Represented private-equity magnate David Storper in several actions against Wilbur Ross and WL Ross \u0026amp; Co. involving breach of contract and breach of fiduciary duties related to WL Ross’s flagship private equity funds.{{ FIELD }}Represented AIB Group in an action against its prime broker, related to a five-year, $700 million foreign-exchange fraud.{{ FIELD }}Represented JPMorgan Chase in numerous actions in state and federal court related to mortgage-backed securities.{{ FIELD }}Represented Moody’s in a Department of Justice investigation.{{ FIELD }}Represented Fidelity National Financial’s Black Knight Unit in a securities opt-out action brought by Maverick Funds.{{ FIELD }}Represented Newlink Genetics in a 10b-5 class action related to a failed drug trial.{{ FIELD }}Represented ChromaDex in multiple actions in federal court against Elysium Health, related to false advertising, trade libel, and deceptive practices.{{ FIELD }}Represented Olo in a contract dispute with DoorDash.{{ FIELD }}Represented the Official Committee of Talc Creditors II in bankruptcy proceedings of LTL Management related to mass torts by Johnson \u0026amp; Johnson.{{ FIELD }}Represented the Official Committee of Unsecured Creditors in bankruptcy proceeding of pharmaceutical giant Mallinckrodt.{{ FIELD }}Represented the Official Committee of Unsecured Creditors in bankruptcy proceeding of JCPenney.{{ FIELD }}Represented liquidating trustee in fiduciary duty action against founders of Fuhu.{{ FIELD }}Represented the Official Committee of Unsecured Creditors in bankruptcy proceeding of Videology.{{ FIELD }}Represented the Official Committee of Unsecured Creditors in bankruptcy proceeding of Claire’s.{{ FIELD }}David H. Kupfer is a trial lawyer with extensive experience litigating complex commercial disputes and representing plaintiffs and defendants in civil and criminal matters and regulatory investigations. David has represented real estate and hospitality developers, lenders, and operators, financial institutions, life sciences, and technology firms, and venture and private equity funds in bankruptcy, state and federal courts, as well as in arbitration. He has also represented creditors in complex restructuring proceedings including the restructurings of Mallinckrodt Pharmaceuticals, JCPenney, and Claire’s.\nDavid devotes significant time to pro bono work, and regularly represents low-income clients in fair housing and felony criminal matters.\nDavid clerked for the Honorable Henry B. Pitman, U.S. District Court for the Southern District of New York. Partner Named a Rising Star Super Lawyers, 2020-2023 Touro College  Fordham University Fordham University School of Law Florida New Jersey New York New York City Bar Association UJA Young Leadership Committee Law Clerk, Honorable Henry B. Pitman, U.S. District Court for the Southern District of New York Representing Bath Club Entertainment and developer R. Donahue Peebles in actions against members of a neighboring condominium association and others “determined to interfere with the successful management of the historic Bath Club on Miami Beach.” Represented private-equity magnate David Storper in several actions against Wilbur Ross and WL Ross \u0026amp; Co. involving breach of contract and breach of fiduciary duties related to WL Ross’s flagship private equity funds. Represented AIB Group in an action against its prime broker, related to a five-year, $700 million foreign-exchange fraud. Represented JPMorgan Chase in numerous actions in state and federal court related to mortgage-backed securities. Represented Moody’s in a Department of Justice investigation. Represented Fidelity National Financial’s Black Knight Unit in a securities opt-out action brought by Maverick Funds. Represented Newlink Genetics in a 10b-5 class action related to a failed drug trial. Represented ChromaDex in multiple actions in federal court against Elysium Health, related to false advertising, trade libel, and deceptive practices. Represented Olo in a contract dispute with DoorDash. Represented the Official Committee of Talc Creditors II in bankruptcy proceedings of LTL Management related to mass torts by Johnson \u0026amp; Johnson. Represented the Official Committee of Unsecured Creditors in bankruptcy proceeding of pharmaceutical giant Mallinckrodt. Represented the Official Committee of Unsecured Creditors in bankruptcy proceeding of JCPenney. Represented liquidating trustee in fiduciary duty action against founders of Fuhu. Represented the Official Committee of Unsecured Creditors in bankruptcy proceeding of Videology. Represented the Official Committee of Unsecured Creditors in bankruptcy proceeding of Claire’s.","searchable_name":"David Kupfer","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null}]}}